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Abstract 
 
Neisseria meningitidis is a pervasive bacterial coloniser of the human 
nasopharynx with up to 40% carriage in the population. Paradoxically, 
invasive disease occurs in only ~1 in 100,000 individuals. Sophisticated 
immune evasion mechanisms allow the bacterium to persist in the host, yet 
these adaptations may also enable its transition from a harmless commensal 
to an invasive pathogen. Dendritic cells (DC) are principal controllers of 
mucosal immunity, and bacteria can exploit their maturation process to evade 
the immune system. In this study, it is reported for the first time that live 
serogroup B meningococcus (NmB) impedes DC maturation by disrupting 
STAT1 through dephosphorylation of tyrosine 701 (Y701). DC were therefore 
refractory to interferon stimulation—which is essential for DC function—and 
had low levels of maturation markers and other STAT1-dependent genes. 
Interestingly, infected DC retained the activity of other major signalling 
pathways, including the MAP kinases, which induced PD-L1hi DC that were 
CD4+ T-cell suppressive. Disruption of STAT1 also had the major effect of 
dampening SOCS1 and CISH expression, which are critical for homeostatic 
control of DC inflammatory cytokine production, and correlated with enhanced 
inflammatory cytokine production. Restoration of STAT1-Y701 
phosphorylation reprogrammed DC towards a typical CD86hi maturation state, 
normalised cytokine profiles and T-cell responses. These data establish an 
unconventional inflammatory pathway for the meningococcus, but also link 
immune evasion and pathogenesis via a shared mechanism. These findings 
elucidate how NmB may undermine immunity within the normal mucosa but 
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also inflict damage in the context of septicaemia due to uncontrolled 
inflammation. 
Word count: 59,942 
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APC Antigen presenting cell 
CD Cluster of differentiation  
DC Dendritic cell(s) 
DC-SIGN Dendritic Cell-Specific Intercellular adhesion molecule-3-
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FCS Foetal calf serum 
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MAPK Mitogen-activated protein kinase (ERK, p38, JNK) 
Meningococcus Neisseria meningitidis (no specific serogroup) 
MOI Multiplicity of infection 
mRNA Messenger RNA 
NF-κB Nuclear factor kappa B 
Nl Neisseria lactamica 
NmB Neisseria meningitidis serogroup B 
Opa Opacity protein 
PAMP Pathogen-associated molecular pattern 
PBMCs Peripheral blood mononuclear cells 
PBS Phosphate buffered saline 
PD-L1/PD-L2 Programmed death receptor ligand-1/2 
PFA Paraformaldehyde 
PMA Phorbol-12-myristate-13-acetate 
PorA/PorB Porin A/Porin B 
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TNF-α Tumor necrosis factor alpha 
 
 
 
Peer-reviewed publications produced during work on this thesis: 
 Stephenson HN, Mills DC, Jones H, Milioris E, Copland A, Dorrell 
N, Wren BW, Crocker PR, Escors D, Bajaj-Elliott M. Pseudaminic 
Acid on Campylobacter jejuni Flagella Modulates Dendritic Cell IL-10 
Expression via Siglec-10 Receptor: A Novel Flagellin-Host Interaction. 
 Journal of Infectious Diseases. (2014) 210 (9): 1487-1498. 
 Jones HE, Copland A, Hamstra HJ, Cohen J, Brown J, Klein N, van 
der Ley P, Dixon G. LOS oligosaccharide modification enhances 
dendritic cell responses to meningococcal native outer membrane 
vesicles expressing a non-toxic lipid A. 
 Cellular Microbiology. (2014) Apr;16(4):519-34 
The immunomodulation of dendritic cells by N. meningitidis 
 
10 
Index 
1. Chapter 1: Introduction 15 
1.1 Meningococcal Disease 15 
1.1.1 Epidemiology 15 
1.2 N. meningitidis microbiology 17 
1.2.1 N. meningitidis surface structure 19 
1.3 The Immune System 26 
1.3.1 Innate Immunity 28 
1.3.1.1 Pattern Recognition Receptors 28 
1.3.1.2 Cells of the Innate Immune System 34 
1.3.2 The Adaptive Immune System 46 
1.3.2.1 T-cells 46 
1.3.2.2 B-cells and Plasma Cells 50 
1.4 Pathophysiology of N. meningitidis 51 
1.4.1 Natural Immunity to N. meningitidis 52 
1.4.1.1 The interaction of NmB with DC 56 
2 Chapter 2 - Materials and Methods 59 
2.1 Materials 59 
2.1.1 General Consumables 59 
2.1.2 Cytokines and Chemokines 65 
2.1.3 Antibodies 66 
2.1.4 Inhibitors 70 
2.1.5 General Buffers and Media 71 
2.1.6 Foetal calf serum 73 
2.2 Methods 76 
2.2.1 Bacterial methods 76 
The immunomodulation of dendritic cells by N. meningitidis 
 
11 
2.2.1.1 Strains 76 
2.2.1.2 Bacterial culture 76 
2.2.2 Cell counting 77 
2.2.3 Isolation of Peripheral Blood Mononuclear Cells from Human Blood 77 
2.2.3.1 Enrichment of Monocytes from PBMCs 79 
2.2.3.2 Generation of DC from blood CD14+ monocytes 81 
2.2.3.3 Isolation of CD4+ T-cells from PBMCs 84 
2.2.4 General DC stimulation 86 
2.2.5 Bone marrow-derived dendritic cells 87 
2.2.6 DC migration assay 87 
2.2.7 T-cell polarisation assay 88 
2.2.8 T-cell proliferation assay 88 
2.2.9 Flow cytometry 89 
2.2.10 Intracellular flow cytometry 90 
2.2.10.1 Intracellular PhosFlow 91 
2.2.11 Lentivirus quantification 91 
2.2.11.1 Transfection of DC with lentivirus 94 
2.2.11.2 Lentivirus NF-κB assay 94 
2.2.12 Western Blot 95 
2.2.13 Enzyme-Linked Immunosorbent Assay 96 
2.2.14 Real-time PCR and analysis of gene expression 99 
2.2.14.1 RNA extraction 99 
2.2.14.2 First strand cDNA synthesis 101 
2.2.14.3 Primers and real-time PCR 101 
2.3 Statistics and Software 104 
3 Chapter 3: Viable N. meningitidis Subverts Dendritic Cell Maturation
 106 
3.1 Introduction 106 
The immunomodulation of dendritic cells by N. meningitidis 
 
12 
3.2 Aims and Objectives 111 
3.3 Results 112 
3.3.1 DC are activated upon stimulation with LPS 112 
3.3.2 DC are activated by killed NmB but not live NmB 114 
3.3.3 Differential effects of live NmB on mouse and human DC 121 
3.3.4 DC are activated by other viable bacterial pathogens 124 
3.3.5 Suppression of DC maturation by live NmB is dominant over exogenous 
stimuli 126 
3.3.6 Viable NmB selectively up-regulates the T-cell inhibitory molecule PD-L1
 126 
3.3.7 DC infected with live NmB have decoupled cytokine responses 128 
3.3.8 Live NmB induces low chemokine secretion 130 
3.3.9 Dysregulation of DC maturation is transcriptionally controlled 133 
3.4 Discussion 139 
4 Chapter 4: Dendritic Cell Signalling Pathways Induced by N. 
meningitidis 143 
4.1 Introduction 143 
4.2 Aims and Objectives 146 
4.3 Results 147 
4.3.1 Lentivirus transfection does not mature DC 147 
4.3.2 Inhibition of DC maturation by live NmB is NF-κB-independent 149 
4.3.3 Activation of mitogen activated protein kinases by NmB 153 
4.3.4 NmB induces normal activation of standard DC maturation pathways 156 
4.3.5 Live NmB infection results in selective tyrosine dephosphorylation of 
STAT1 158 
4.3.6 STAT1 activation correlates with CD86 expression and DC maturation 
  166 
The immunomodulation of dendritic cells by N. meningitidis 
 
13 
4.3.7 DC infected by live NmB still transcribe interferon 166 
4.3.8 Live NmB induces IFN hyporesponsiveness in DC 169 
4.3.9 JAK kinase signalling is intact in DC infected with live NmB 172 
4.3.10 Live NmB infection leads to suppression of SOCS protein expression 
  174 
4.3.11 JAK-STAT signalling is required for DC maturation in response to 
meningococcal antigens 176 
4.4 Discussion 178 
5 Chapter 5: N. meningitidis impairs DC immunological functions 186 
5.1 Introduction 186 
5.2 Aims and Objectives 190 
5.3 Results 191 
5.3.1 Live NmB suppresses the up-regulation of CCR7 191 
5.3.2 DC infected with live NmB have impaired chemotactic responses to 
CCL19 191 
5.3.3 LPS can Induce T-cell Proliferation via DC 194 
5.3.4 DC infected with live NmB show reduced allostimulatory capacity 197 
5.3.5 PD-L1 up-regulation by live NmB can be suppressed by inhibiting the 
MAPKs 199 
5.3.6 PD-L1 inhibition can enhance T-cell proliferation induced by DC infected 
with live NmB 201 
5.3.7 DC infected with live NmB show reduced TH1-like responses 203 
5.4 Discussion 208 
6 Chapter 6: Reversing the immunomodulation of DC by N. 
meningitidis 213 
6.1 Introduction 213 
The immunomodulation of dendritic cells by N. meningitidis 
 
14 
6.2 Aims and Objectives 217 
6.3 Results 218 
6.3.1 Dysregulation of DC maturation by live NmB is independent of apoptosis 
  218 
6.3.2 Live capsule, PilE, RmpM deficient NmB induce similar DC maturation 
profiles to live WT NmB 224 
6.3.3 Suppression of DC surface phenotype maturation by live NmB is 
independent of CEACAM1 and SHP-2 228 
6.3.4 Dysregulation of DC maturation requires active bacterial protein 
synthesis 231 
6.3.5 Sodium orthovanadate restores STAT1 phosphorylation in DC infected 
with live NmB 234 
6.3.6 Vanadate restores SOCS1 and normalises cytokine production 238 
6.3.7 Vanadate treatment enhances T-cell responses induced by live NmB 242 
6.3.8 A candidate virulence factor 245 
6.4 Discussion 251 
7 Chapter 7: Final Discussion and Future Work 256 
8 References 274 
The immunomodulation of dendritic cells by N. meningitidis 
 
15 
 
1. Chapter 1: Introduction 
1.1 Meningococcal Disease 
Meningococcal disease was first described in the 16th Century and the 
causative infectious agent, Neisseria meningitidis (the meningococcus), was 
first isolated in 1887 (Rosenstein et al., 2001). Meningococcal disease 
clinically manifests as septicaemia or haematological bacteraemia, which may 
or may not be accompanied by cerebral meningitis, i.e. inflammation of the 
meninges. Symptoms include headache, confusion, fever and haemorrhagic 
rash. Even with prompt medical treatment, the mortality rate is typically 
estimated to be 8-10% in developed countries (Thorburn et al., 2001). Long-
term sequealae in survivors are a cause of significant—and possibly 
underestimated—morbidity. Memory loss, cognitive deficits, deafness and 
behavioural problems have been reported several years post-discharge from 
healthcare services (Chandran et al., 2011). Moreover, meningococcal 
disease predominantly occurs in infants, adolescents, the elderly and the 
immunocompromised. As such, meningococcal disease presents a major 
current global health challenge that warrants further research into disease 
pathophysiology. 
1.1.1 Epidemiology 
Rates of meningococcal disease can vary greatly depending on geographical 
location. In sub-Saharan Africa, epidemics due to the infectious transmission 
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of N. meningitidis can affect up to 1% of the population. This has led to the 
region being called the 'meningitis belt'. Conversely, the incidence in 
European countries has recently been reported to be approximately 1 per 
100,000 (Harrison et al., 2009).  Several factors have been identified that may 
contribute to the large variation in epidemiological rates observed between 
developed and developing nations. Vaccination strategies in African countries 
have effectively reduced the burden of meningococcal disease, although 
socioeconomic factors and their effects on healthcare provisions have 
significantly mitigated these preventative efforts (Woods et al., 2000). 
Crowding of persons in the household or community has also been 
associated with meningococcal disease outbreaks, and this is strongly 
associated with lower-income areas (Baker et al., 2000; Deutch et al., 2004). 
Immunocompromisation by pathogens such as human immunodeficiency 
virus (HIV) may also vitally contribute towards the spread of meningococcal 
disease (Stephens et al., 1995), which is most prevalent in impoverished 
African countries. 
In developed nations, outbreaks of meningococcal disease have been shown 
to proceed directly after reported seasonal increases in cases of acute 
respiratory infections, e.g. influenza (Makras et al., 2001). It is thought that co-
infection may allow N. meningitidis to more easily spread between individuals 
and may also prelude infection and dissemination in the host. Smoking, 
sexual contact and alcohol consumption are also risk factors for developing 
disease (Harrison, 2010). Despite the disparity in incidence between 
geographical regions, the healthcare costs in containing specific epidemics of 
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meningococcal disease can be substantial for both low- and high-income 
countries (Anonychuk et al., 2013).  
1.2 N. meningitidis microbiology 
N. meningitidis is the etiological cause of meningococcal disease. The 
bacterium is a fastidious, diplococcal Gram-negative coloniser of the human 
nasopharynx and upper respiratory tract, however it may colonise other 
mucosal sites in certain demographics (Judson et al., 1978). In healthy 
individuals, Neisseria spp. can represent over 20% of the total microbial 
diversity in its ecological niche (Park et al., 2014). Indeed, up to 40% of the 
population may be carrying Neisseria meningitidis at any one time. There is 
no known natural reservoir of the meningococcus outside of the human 
mucosae, for reasons that will be discussed. N. meningitidis is a 
proteobacterium that belongs to the genus Neisseria; other members of the 
genus include the N. lactamica, N. sicca, N. elongata and N. gonorrhoeae. 
Many species of the Neisseria genus colonise the human nasopharynx 
asymptomatically and are rarely associated with disease, therefore they are 
usually considered commensal organisms. Only N. gonorrhoeae (which 
colonises the urethra) and N. meningitidis have pathogenic potential in 
humans, although N. lactamica may cause disease in exceptional 
circumstances (Zavascki et al., 2006). 
The genome of N. meningitidis was first sequenced in 2000, and revealed a 
highly compact genome of 2,272,351 base-pairs (Tettelin et al., 2000), which 
is approximately 50% fewer genes than laboratory strains of Escherichia coli 
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(Lo et al., 2009). Importantly, the analysis also revealed a very dynamic 
genome with many genes subject to high phase-shift variation. This is the 
process by which genes are activated and deactivated by site-specific 
recombination, epigenetic modification or slipped-strand mispairing. Thus, the 
genome of N. meningitidis possesses enormous plasticity compared to other 
bacteria. Virulence genes may be switched-on, -off or modified by mutation, 
due to selective pressures.    
N. meningitidis is also notable in its ability to readily uptake foreign DNA — a 
process that is called genetic transformation. Examination of foreign 
sequences within the meningococcal genome has revealed that many of 
these nucleotides have been acquired via horizontal gene transfer from co-
habiting bacteria within the human host. More surprisingly, some of these 
sequences appear to have been acquired from the human host, thus 
emphasizing the significant plasticity of the meningococcal genome (Putonti et 
al., 2013). To facilitate the uptake of DNA from the environment, N. 
meningitidis possesses over 2,000 DNA-uptake sequences (DUS) that enable 
the bacterium to efficiently incorporate DNA into its own genome (Vogel et al., 
2010). Genetic comparisons of meningococcal isolates between carriage and 
disease strains has revealed that this mechanism of horizontal gene transfer 
in the nasopharyngeal microbial reservoir is likely to be responsible for the 
acquisition of key virulence factors, hence the emergence of the bacterium as 
a pathogen of the human host (Schoen et al., 2008). It is likely that the 
dynamic genome and natural competence of N. meningitidis is likely to be the 
The immunomodulation of dendritic cells by N. meningitidis 
 
19 
most significant factor contributing towards the pathogenic potential of the 
organism. 
1.2.1 N. meningitidis surface structure 
The surface structure of N. meningitidis is subject to large variation due to the 
aforementioned dynamic genome. However, there are many conserved 
structures that have been found to contribute towards colonisation and 
virulence. 
As a Gram-negative bacterium, the meningococcus contains a relatively high 
amount of lipooligosaccharide (LOS) in its outer membrane. LOS is comprised 
of an inner core containing the immunogenic lipid A moiety bound to an 
oligosaccharide core with branching sugars. The LOS serves a structural 
purpose in the bacterium by supporting the architecture of the outer 
membrane, but the lipid A moiety is also an important virulence factor that 
binds to human immunological receptors and induces inflammation. 
Meningococcal LOS also protects the bacterium against the human immune 
system by the post-translational addition of sialic acid. Furthermore, natural 
variants in the lipid A moiety have been identified. LOS is typically hexa-
acylated (i.e. six fatty acid chains), however penta-acylated variants have 
been found in patients with less severe disease, establishing the lipid A 
moiety a major determinant of LOS pathogenicity (Fransen et al., 2009). 
Despite its importance in structural integrity and host-pathogen interactions, 
LOS is not strictly essential for meningococcal viability or growth in vitro, as 
has been demonstrated with LOS-deficient mutants (Steeghs et al., 1998). 
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N. meningitidis also contains porins in the outer membrane that are essential 
for survival. These proteins form β-barrel structures that allow the 
translocation of ions and molecules between the outer membrane (OM) and 
the periplasmic space (PS). The meningococcus contains two major porins: 
porin A (PorA) and porin B (PorB), which are immunodominant bacterial 
epitopes and typically generate robust immune responses in some cell types 
(Singleton et al., 2005). However, these porins can also modulate host 
immunity by preventing antimicrobial responses such as phagocyte activation 
(Bjerknes et al., 1995) and phagosome maturation (Mosleh et al., 1998). 
Furthermore, porins are implicated in the development of antibiotic resistance 
in Neisserial species, by allowing efflux of antimicrobial compounds (Olesky et 
al., 2006). 
Pili are another important meningococcal virulence factor. These are 
filamentous protein structures composed of polymeric pilin subunits; the 
dominant subunit is PilE, however other subunits (PilC, PilV and PilX) can be 
incorporated under various conditions (Virji, 2009). Pili are essential for 
mediating the attachment of the bacterium to the host tissue; in this role, they 
act as 'hook-like' molecules that allow colonisation of the human nasopharynx. 
As the pili are subject to intense antigen variation, it has been noted that pili 
from different strains of bacteria possess varying attachment affinities for 
human epithelial tissue (Nassif et al., 1993). Accordingly, comparisons 
between asymptomatic colonising and invasive strains of N. meningitidis have 
found that pili undergo significant phase variation — therefore, pili are heavily 
The immunomodulation of dendritic cells by N. meningitidis 
 
21 
implicated in the ability of the bacterium to transition from a harmless 
commensal to invasive pathogen (Rytkönen et al., 2004).  
Upon invasion, pili are directly toxic to human endothelial cells and also 
induce high levels of inflammatory mediators that result in vascular damage to 
the host. Importantly, the pro-inflammatory and toxic effects of pili can 
synergise with LOS to amplify the pathogenic effect of the bacteria (Dunn et 
al., 1995). Xenografts of human vasculature in a murine model of 
meningococcal disease have demonstrated the necessity of pili for vascular 
adhesion of the bacteria, tissue damage and an inflammatory response 
(Melican et al., 2013). Furthermore, the human receptor responsible for 
meningococcal adherence to endothelial cells has now been identified, and 
experimental evidence suggests that it is a ligand for type IV pili (Bernard et 
al., 2014). Thus, the evidence suggests that pili are critical for both 
colonisation and pathogenesis in the human host. 
Opacity-associated (Opa) proteins are expressed on the bacterial surface of 
Neisserial species. These proteins have a role in colony formation and 
bacterial aggregation (Dehio et al., 1998), thus affording resistance to human 
serum (Bos et al., 1997). Furthermore, gonococcal Opa proteins can 
modulate host immune cells. Notably, Opa can bind to human 
carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 
proteins, which are expressed on many cell types, and modulate cellular 
signalling events. The Opa-CEACAM interaction can effectively disable many 
immune cells and override their normal function (Boulton and Gray-Owen, 
2002). Although Opa proteins have been implicated in host attachment—in a 
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similar fashion to pili—in vivo colonisation experiments have found that they 
are not strictly necessary for this process (Jerse et al., 1994). However, many 
Opa variations are nevertheless associated with invasive disease. Opa 
proteins may therefore enhance adhesion, infection and invasive disease. 
Lastly, the meningococcal capsule is a sugar coat that surrounds the outer 
membrane of the bacterium. Encapsulated meningococcal are broadly 
grouped according to their capsular serotype, which is determined by the 
sugar structure of the capsule matrix. Serogroups A, B, C, W-135 and X are 
all associated with clinical disease. In the U.K. and many other developed 
countries, N. meningitidis serogroup B (NmB) remains the predominant 
disease-causing strain due to successful vaccination efforts against other 
strains; while serogroup A is rampant in the meningitis belt of sub-Saharan 
Africa. 
The capsule serves the function of protecting the bacterium from 
environmental insults and the human host. Since almost all invasive clinical 
strains are encapsulated, the capsule is considered to be the prime virulence 
factor for meningococcal disease (van Deuren et al., 2000). There is growing 
genetic evidence that the meningococcus began as an ordinary commensal of 
the human nasopharynx, but emerged as a pathogen upon acquisition of 
capsule genes from co-habiting organisms in its local environment (Schoen et 
al., 2008). 
The capsule is heavily hydrated, containing up to 95% water (Costerton et al., 
1981). The heavy water content is thought to enable environmental 
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transmission in the form of exhaled water droplets, therefore allowing the 
bacterium to temporarily survive between hosts while airborne. The capsule 
also covers and protects many protein structures on the surface that may be 
exposed to the many defences of the human immune system, by forming a 
physical barrier. Sialic acid within the capsule is extremely effective at 
neutralising the human complement system, which presents a major barrier to 
colonisation and invasive disease. Sialic acid is ordinarily present on the 
surface of human vascular tissue where it recruits the host molecule factor H 
(fH), which in turn prevents auto-reactions of the complement system — 
therefore the incorporation of this molecule into the capsule is a critical 
immune evasion strategy to avoid bacterial killing (Kugelberg et al., 2008). 
Complement is exceptionally abundant in oral and nasal mucous secretions 
(Lai A Fat et al., 1973; Ap et al., 2005), and so the evolution of the 
biochemical pathways allowing the subversion of this system are thought to 
be necessary for meningococcal colonisation.  
NmB is unique in that the capsule contains structural homology to human 
neural cell glycopeptides. This was first discovered in 1983 by researchers 
who incubated human brain tissue with NmB anti-sera and found cross-
reactivity with isolated bacterial capsule (Finne et al., 1983). Successful 
vaccines for other pathogenic serogroups have been based upon recombinant 
capsular polysaccharide to generate an immune response, but serogroup B 
capsule is poorly immunogenic, owing to the molecular mimicry of its 
structure. Furthermore, there are concerns that any induced immunogenic 
reaction would have the theoretical potential to induce an autoimmune 
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reaction, although experimental evidence for this is severely limited (Robbins 
et al., 2011). 
The overarching theme with nearly all meningococcal components is that the 
bacterium has evolved a myriad of refined mechanisms with the purpose to 
intricately adapt to its microenvironment in the human mucosae. These 
molecules are important for survival by serving physiological functions, e.g. 
the porins. However, many of these molecules have a dual function in 
modulating the host, especially the immune system. This bacterial 
multitasking or 'moonlighting' has been observed in many other bacteria, 
including Staphylococcus aureus, Mycobacterium tuberculosis and 
Streptococcus pneumoniae (Henderson and Martin, 2011). Due to the limited 
size of the average bacterial genome, this dichotomy of function is often an 
evolutionary necessity and advantage. Table 1-1 is a summary of Neisserial 
virulence factors and their dual functions. The common element to these 
molecules is that they provide a clear cellular function within the bacterium 
itself (e.g. nutrient acquisition, structural support), but also serve a major toxic 
or host-modulating role. The importance for bacteria to modify host function is 
demonstrated by the fact that some microbes encode essential proteins solely 
for this purpose. For example, M. tuberculosis contains tyrosine phosphatases 
without encoding any tyrosine kinases (Whitmore and Lamont, 2012). Hence, 
some bacterial proteins are solely involved in host modulation, and are 
essential for virulence. 
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Table 1-1. A list of meningococcal virulence factors and their role in 
pathogenesis. 
Virulence factor 
Cellular and 
physiological function 
Host modulation and 
pathogenesis 
Lipooligosaccharide 
(LOS) 
1. Colony formation 
(Albiger et al., 2003); 
2. Membrane structural 
integrity (Raetz, 1990) 
1. Invasion of endothelial 
cells (Lambotin et al., 
2005); 
2. Adherence to epithelial 
cells (Albiger et al., 2003); 
3. Inflammatory response 
(Dixon et al., 2001) 
Porin 1. Antibiotic efflux (Olesky 
et al., 2006); 
2. Nutrient acquisition 
(Achouak et al., 2001) 
1. Anti-apoptotic effect on 
lymphocytes (Massari et 
al., 2000); 
2. Inflammatory response 
(Singleton et al., 2005) 
Pilus 1. Motility (Mattick, 2002) 1. Adherence to epithelial 
cells (Virji et al., 1993); 
2. Adherence to 
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endothelial cells (Melican 
et al., 2013) 
Capsule 1. Survival outside the 
host (Swain and Martin, 
2007) 
1. Survival in host cells 
(Spinosa et al., 2007); 
2. Mitigation of 
complement (Schneider et 
al., 2007) 
Opacity protein 
(Opa) 
1. Colony formation (Dehio 
et al., 1998) 
1. Attenuation of adaptive 
immune responses (Yu et 
al., 2013); 
2. Invasion of epithelial cell 
barriers (Wang et al., 
1998) 
 
1.3 The Immune System 
The immune system is a collection of cells, processes and molecules that 
protect the host from bacteria, viruses, fungi, protozoans and tumours. To 
achieve this, the immune system must be able to distinguish 'self' from 'non-
self' and respond accordingly. When a pathogen (e.g. influenza) triggers an 
immune reaction, this typically results in clearance or control of the invading 
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microorganism. Under normal circumstances, the immune system does not 
mount an immunological defence to host cells and tissues due to specificity in 
recognising non-self antigens: molecular signatures that induce cellular and 
humoral immune responses. The non-responsiveness of the immune system 
to self-antigens is termed immunological tolerance. However, this equilibrium 
can be disrupted for various reasons in instances of autoimmune disease. 
Since this model was first proposed, our understanding of the immune system 
has come to appreciate that there is also a normal diversity of microflora 
occupying epithelial surfaces across the human body. The human mucosa 
contains billions of bacteria, viruses and fungi that constitute the microbiome. 
These microorganisms mostly exist in a symbiotic relationship, but can also 
confer many benefits to the host, while the host provides an environment rich 
in nutrients. For example, mucosal bacteria of the gut are responsible for 
generating metabolic by-products such as menaquinones (vitamin K) that are 
essential for human blood coagulation (Conly and Stein, 1992). The presence 
of certain commensal bacteria—those that are not normally associated with 
disease—can protect against allergy (Stefka et al., 2014) and viral infection 
(Abt et al., 2012). Moreover, more recent evidence has suggested that the 
microbiome can even influence brain development and behaviour in mice 
(Heijtz et al., 2011). Therefore, the prime importance of the microbiome to 
human health has added another level of complexity to the paradigm of self 
and non-self: that of the distinction between commensal and pathogenic 
microorganisms. 
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1.3.1 Innate Immunity 
The immune system may be divided into two broad elements: innate and 
adaptive immunity. Innate immunity is evolutionarily older than adaptive 
immunity, being an ancient form of host defence that is thought to have 
originated at approximately the same time as the origin of life over 3 billion 
years ago (Hoffmann and Reichhart, 2002). The innate immune system 
contains no immunological memory, i.e. repeated exposure to the same 
antigens will not generate any specific, protective immunity. This is due to the 
fact that the components of the innate immune system are germline-encoded, 
and have evolved to recognise constant threats in the form of conserved 
molecular signatures. 
1.3.1.1 Pattern Recognition Receptors  
Pattern recognition receptors (PRRs) are germline-encoded receptors that 
recognise pathogen-associated molecular patterns (PAMPs) and damage-
associated molecular patterns (DAMPs), also known as 'danger signals' 
(O’Neill et al., 2013). There are several different classes of PRRs, but the 
most extensively studied are the Toll-like receptors (TLRs), RIG-like receptors 
(RLRs) and NOD-like receptors (NLRs) (Creagh and O’Neill, 2006). These 
receptors are present on the surface of the cell (TLRs) and also within 
intracellular compartments and the cytosol itself (TLRs, RLRs and NLRs). 
When triggered by the necessary PAMPs, these PRRs induce intracellular 
signalling events that result in the production of pro-inflammatory cytokines 
such as interleukin-1 beta (IL-1β). Though these receptors have diverse 
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ligands (RLRs recognise intracellular viral antigens; NLRs recognise bacterial 
components), the common downstream cellular event is the direct or indirect 
activation of nuclear factor kappa-b (NF-κB) and the transcription of immunity-
related genes. PRRs are expressed on a wide array of immune and non-
immune cells. 
1.3.1.1.1  Toll-like receptors 
To date, there are ten identified TLRs in humans (see Table 1-2), which are 
type I integral membrane-bound receptors capable of sensing PAMPs and 
DAMPs. The events leading to the discovery of TLRs in the early 1990s were 
triggered by sequence comparisons between the interleukin 1 receptor-1 (IL-
R1; also known as the Toll–IL-1-resistence (TIR) domain) and the Toll 
proteins of Drosophila melagonaster (Gay and Keith, 1991). Toll proteins were 
hitherto only implicated in morphological changes in D. melagonaster, 
however the common element of NF-κB activation led to the discovery that 
these receptors were critical in the innate immune response (Lemaitre et al., 
1996). Eventually, human homologues were identified and constitutively-
active mutants were subsequently cloned into human cells, therefore proving 
their role in the innate immune response (Medzhitov et al., 1997). The ligands 
for all the TLR receptors—with the exception of TLR10—have now been 
discovered, and a summary of these interactions is provided in Table 2. 
Furthermore, it is now understood that TLRs can also recognise danger 
signals, adding another class of molecules to their repertoire of ligands. A 
well-characterised example of this is the binding of endogenous fatty acids to 
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TLR4 (Shi et al., 2006), which can act as released inflammatory mediators to 
prime the immune response before encountering a pathogen. 
Table 1-2 TLRs and their respective ligands - adapted from (Akira and 
Takeda, 2004). 
Toll-like Receptor Ligand 
TLR1 Triacyl lipopeptides 
TLR2 Peptidoglycan, porins, lipoteichoic 
acid, glycolipids 
TLR3 Double-stranded RNA 
TLR4 LPS, fatty acids 
TLR5 Flagellin 
TLR6 Zymosan 
TLR7 Single-stranded RNA 
TLR8 Single-stranded RNA 
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TLR9 CpG DNA 
TLR10 Unknown 
 
X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy 
have revealed the molecular structures of many TLRs, such as TLR3, TLR4 
and TLR9. Despite the differences in ligand specificity, the common element 
in TLR structure appears to be the extracellular domain, which forms 
hydrophobic leuceine-rich repeats that gain the quaternary structure of a 
horseshoe-like shape (Botos et al., 2011). Upon recognition of the appropriate 
ligands, TLRs will homo- or hetero-dimerise, leading to conformational 
changes that allow intracellular signalling through the TIR domain (Kawai and 
Akira, 2006). Most TLR pairs are homodimers, e.g. TLR4, but TLR2 will 
heterodimerise with TLR6 to recognise bacterial wall components.  
The TIR domain associates with adaptor molecules immediately downstream 
of the TLR receptor. Upon dimerisation, TIR will initiate a signalling cascade 
by binding to the adaptor molecules myeloid differentiation primary response 
gene 88 (MyD88) (in the case of TLR-1, -2, -4, -7, -8 and -9) or TIR domain-
containing adaptor protein inducing interferon (IFN)-β (TRIF) (in the case of 
TLR-3 and -4) (Kawai and Akira, 2006). MyD88 activation leads to the 
activation of interleukin-1 receptor-associated kinase (IRAK) 4 and IRAK2. In 
turn, IRAK2 phosphorylates TRAF6 that leads to the activation of NF-κB and 
the transcription of NF-κB-dependent genes. Furthermore, TRAF6 can also 
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activate the mitogen activated protein kinases (MAPKs) that activate 
activating protein 1 (AP-1) (O’Neill et al., 2013). 
TRIF activation, on the other hand, leads to recruitment of TANK-binding 
kinase-1 (TBK1) and the subsequent phosphorylation of interferon regulatory 
factor 3 (IRF3). Upon phosphorylation, IRF3 is activated and begins to 
transcribe IFN-β. Importantly, TRIF can also recruit the molecule receptor-
interacting protein 1 (RIP1), that also mediates activation of  NF-κB (O’Neill et 
al., 2013). 
These signalling events are usually divided into two branches: the MyD88-
dependent and the TRIF-dependent signalling axes. It should be noted, 
however, that there is considerable overlap between the two pathways. For 
example, the TRIF-dependent pathway can activate the NF-κB pathway 
indirectly: once transcribed, autocrine IFN-β can induce NF-κB signalling via 
the janus kinase (JAK) family (Kim et al., 2002). Indeed, modern approaches 
to studying intracellular signalling have revealed complex cascades that 
challenge traditional linear models (Lu et al., 2007). Genomic approaches to 
cell signalling have expanded the paradigm considerably by highlighting the 
crucial contribution of spatio-temporal dynamics to signalling outcomes 
(Kholodenko, 2006). Thus, a single stimulus can have seemingly paradoxical 
effects, dependent on the spatio-temporal organisation of the signalling 
network.  
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1.3.1.1.2 RLRs, NLRs and other C-type lectins 
While TLRs recognise a diverse array of PAMPs, there are other specialised 
receptors that act as sensors for microbial molecular patterns. NLRs exist in 
the cytosol; these are a family of more than ten proteins that contain a shared 
three-fold structure of (i) leucine-rich repeats (similar to TLRs), (ii) a 
nucleotide-binding oligomerisation (NOD) domain and (iii) a caspase 
recruitment domain (CARD) (Chen et al., 2009).  NLRs mainly recognise 
bacterial cell wall components, such as peptidoglycan (PGN). Once they 
recognise PGN, NLRs dimerise via their CARD domains and then activate the 
NF-κB pathway to drive the transcription of pro-IL-1β. Conversely, RLRs are 
PRRs that recognise viral ligands such as single-stranded and double-
stranded RNA (ssRNA; dsRNA). Engagement of RLRs with their required 
ligand induces both the NF-κB and IRF3 pathways, to induce pro-IL-1β and 
IFNs, in a similar fashion to TLR ligation (Yoneyama and Fujita, 2009). 
C-type lectin receptors (CLRs) are widely expressed on myeloid immune 
cells. These receptors are responsible for recognising carbohydrate motifs 
which are shared among viral, bacterial and fungal pathogens (Osorio and 
Reis e Sousa, 2011). The defining feature of CLRs is the presence of a C-
type lectin-like domain (CTLD), also known as the carbohydrate-recognition 
domain (CRD). These domains are rich in hydrophobic β-sheet structures and 
amino acids to coordinate Ca2+ binding, which facilitates recognition of 
carbohydrate sugars (Drickamer, 1999). Although the structure is highly 
evolutionarily conserved, there are known Ca2+-independent CTLDs which 
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instead utilise loop structures in carbohydrate recognition (Drickamer, 1999; 
Llera et al., 2001). 
Antigen recognition by CLRs leads to both signalling and endocytosis events. 
CLRs contain immune-modulating regions known as immunoreceptor 
tyrosine-based activation/inhibition motifs (ITAM/ITIM). Binding of a 
carbohydrate ligand to the transmembrane CLR results in a conformational 
change and the recruitment of intracellular phosphatases, namely SHP-1 and 
SHP-2. These phosphatases carry out diverse immunological functions by 
modulating critical mitogen-activated protein kinases (MAPKs), which are 
important in immune cell activation (Geijtenbeek and Gringhuis, 2009). 
Significantly, pathogens have exploited the ability of CLRs to modulate 
important steps in immune cell signalling. It was discovered that viral and 
bacterial pathogens could target the dendritic cell-specific intercellular 
adhesion molecule-3-grabbing non-integrin (DC-SIGN) receptor to interfere 
with TLR signalling. HIV-1 binds to DC-SIGN by the viral glycoprotein gp120 
which induces the phosphorylation of key proteins to prevent immune cell 
activation (Hodges et al., 2007). 
1.3.1.2 Cells of the Innate Immune System 
Innate immune cells ultimately originate from CD34+ haematopoetic precursor 
cells in the bone marrow and differentiate according to the environmental 
stimuli and physiological milieu that determine cell fate. These precursor cells 
may differentiate into further precursors such as the myeloid progenitor and 
the lymphoid progenitor. With important exceptions, the myeloid progenitor 
The immunomodulation of dendritic cells by N. meningitidis 
 
35 
gives rise to the cells of the innate system, while the lymphoid progenitor 
gives rise to cells of the adaptive immune system (Huang and Terstappen, 
1994). Innate immune cells express a wide array of PRRs that enable them to 
adequately respond to microbial threats. 
1.3.1.2.1 Granulocytes 
Granulocytes are immune cells with lobed nuclei containing granules filled 
with histamines, leukotrienes, enzymes and other inflammatory mediators. 
Granulocytes differentiate from precursor cells by stimulation with the 
cytokines IL-1, IL-6 and granular macrophage-colony stimulating factor (GM-
CSF). In humans, there are three types of granulocyte: basophils, eosinophils 
and neutrophils (Duffin et al., 2010). Basophils and eosinophils are heavily 
loaded with histamines, but also secrete cytokines that contribute towards 
allergic responses, such as IL-4. However, they have a critical role in 
protecting against helminths and other parasites (Chirumbolo, 2012). 
Neutrophils have been more extensively studied than other granulocytes, 
partly owing to their higher abundance in the peripheral circulation. 
Neutrophils are able to secrete their granular contents, and also form 
neutrophil extracellular traps (NETs): structures made of protein and DNA that 
are able to trap and disable extracellular bacteria (Brinkmann et al., 2004). 
Neutrophils are often the first cells to respond to bacterial infection. Their 
importance in this regard is highlighted by the fact that patients with primary 
neutrophil immunodeficiencies are often much more susceptible to bacterial 
infection (Dinauer, 2007). 
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1.3.1.2.2 Monocytes and Macrophages 
Monocytes derive from the macrophage and dendritic cell precursors (MDPs) 
in the bone marrow. MDPs give rise to Ly6C+ monocytes. These monocytes 
express a range of chemokine receptors, such as chemokine receptor 2 
(CCR2) and so respond to constitutively-expressed chemokines in the blood 
and lymphatic systems (Shi and Pamer, 2011). Therefore, monocytes are 
able to constitutively circulate and patrol the tissues of the body before 
encountering danger signals. Upon bacterial infection, the local release of a 
unique inflammatory cytokine and chemokine signature acts as an attractant 
to circulating monocytes. Chemokine ligands 2 and 7 (CCL2, CCL7) and IL-23 
have been shown to be particularly important for monocytes to quickly 
respond to Listeria monocytogenes and Salmonella typhumurium infection in 
vivo (Indramohan et al., 2012; Rydström and Wick, 2009). At the site of 
infection, monocytes can phagocytose and kill bacteria, albeit at a much 
reduced rate compared to neutrophils (Peterson et al., 1977; Steigbigel et al., 
1974). 
The epigenetic and cellular plasticity of monocytes gives rise to their second 
major function: a large reservoir of cells able to differentiate into macrophages 
or dendritic cells (DC) (Sica and Mantovani, 2012). Monocytes are specially 
adapted to respond to cytokine cues from their local environment. They are 
therefore able to differentiate into macrophages, which gain more honed 
functions in combating microbial infection. Upon stimulation with GM-CSF, 
macrophage-colony stimulating factor (M-CSF) or other inflammatory 
cytokines, monocytes begin to acquire a macrophage-like phenotype. This 
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differentiation process is accompanied by vast changes in gene expression, 
with an up-regulation in genes involved in lipid metabolism (e.g. lipases), 
cytokine recognition (e.g. interleukin receptors) and the inflammatory 
response (e.g. prostaglandins) (Hashimoto et al., 1999; Martinez et al., 2006). 
Therefore, macrophages are much more efficient at phagocytosing and killing 
bacteria than monocytes (Nagl et al., 2002). Depending on the exact 
combination of cytokines that monocytes receive, they may differentiate into 
classical (M1) or alternatively activated (M2) macrophages (Sica and 
Mantovani, 2012). The former are typical bactericidal macrophages, while the 
latter are markedly more anti-inflammatory. 
Notably, there are some specialised macrophages that do not derive from 
monocytes. Kupffer cells of the liver and yolk sac-derived macrophages do 
not derive from MDPs, but from separate lineages. Indeed, modern 
approaches to monocyte ontogeny have questioned the extent to which 
conventional monocytes contribute towards steady-state macrophage 
replenishment in tissues (Ginhoux and Jung, 2014). Nonetheless, monocytes 
and macrophages have overlapping yet specialised functions, and in cases of 
active infection, there is considerable experimental evidence that monocytes 
may replenish the macrophage pool. 
1.3.1.2.3 Dendritic cells 
Dendritic cells (DC) are professional antigen presenting cells (APCs) that act 
as sentinels of the immune system, bridging innate and adaptive immunity. 
DC are distributed throughout the body but are relatively more abundant at 
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mucosal sites. In the mucosa, DC are able to sample whole bacteria and 
antigens in the lumen by forming transepithelial dendrites (Rescigno et al., 
2001). In contrast to macrophages, once DC phagocytose and process 
antigens, they are able to migrate to lymph nodes and activate naive CD4+ T-
cells. DC are also the most potent cells at inducing T-cell proliferation and 
differentiation (Steinman and Cohn, 1974). Therefore, DC are critical for 
generating immune responses at mucosal sites.  
In the mucosa, DC must migrate to the mucosal-associated lymphoid tissue 
(MALT) in order to present antigen. In the human nasopharynx, tonsils are the 
primary sites of lymphoid tissue. These are part of a larger structure called the 
Waldeyer's ring, which is analogous to the nasopharynx-associated lymphoid 
tissue (NALT) in mice (Brandtzaeg, 2011). Importantly, lymphocytes primed in 
the tonsils may egress to cervical lymph nodes and the peripheral circulatory 
system.  
1.3.1.2.4 Dendritic cell subsets 
Dendritic cells are a heterogeneous group of cells with several lineages of 
ancestry. Like the T-cell field, the rapid speed at which technology has 
progressed has meant that there has been enormous diversification in DC 
subsets. This has been further complicated by differences in the methods 
used to isolate these cells, which can result in phenotypic artefacts and 
therefore erroneous classification of DC ontogeny (Collin et al., 2013). Indeed, 
there is considerable controversy as to whether many proposed subsets are 
bona fide DC— i.e. cells that are sufficiently distinct from macrophages 
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(Mabbott et al., 2010). However, very recent work by the Immunological 
Genome Consortium has underscored the significant transcriptional and 
phenotypic differences between DC and macrophages in vivo (Miller et al., 
2012).  
In humans, DC may be divided into two broad categories: (i) plasmacytoid DC 
(pDC) and (ii) myeloid DC (mDC; also called conventional or classical DC 
(cDC) in mice) (Ueno et al., 2010). CD123+ pDC are found in the blood and 
the mucosal tissues—including the tonsils—and can produce vast quantities 
of IFNs in response to viral antigens. Accordingly, pDC express high levels of 
TLR7, which recognises viral RNA (Rajagopal et al., 2010). Therefore, it has 
been suggested that pDC are primarily antiviral in function. pDC have a 
unique origin compared to mDC since they arise from a lymphoid progenitor, 
although the exact hierarchy of cell fate and ontogeny remains poorly defined 
in humans (Collin et al., 2011). 
mDC—as the name would suggest—arise from myeloid progenitor cells. 
These DC typically express CD1a and CD11c and can be further sub-divided 
into separate subsets such as Langerhans cells, CD14+ DC and interstitial DC 
(Chu et al., 2011). mDC are also expressed ubiquitously in tissues and the 
blood, although at a much lower frequency than macrophages and 
monocytes. Whereas pDC favour the development of antiviral and anti-
helminth type 2 immune responses (for which they were originally called 
'DC2'), mDC (also called 'DC1') favour the development of type 1 antibacterial 
responses (Banchereau et al., 2000; Ueno et al., 2010). Therefore, mDC are 
critical for controlling bacterial infections. Physiologically, monocytes can give 
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rise to mDC in vivo by the addition of an appropriate stimulus such as LPS, 
although as yet there is no evidence that monocytes can generate DC under 
steady-state conditions (Shi and Pamer, 2011). It should be noted that there is 
considerable plasticity among DC populations; it has been reported that under 
certain conditions, mDC can become pDC-like cells (del Hoyo et al., 2002) 
and vice versa (Zuniga et al., 2004). 
The study of human dendritic cell biology is largely dominated by the use of 
monocyte-derived DC (moDC). These cells are differentiated in vitro by the 
addition of IL-4 and GM-CSF to freshly isolated CD14+ monocytes extracted 
from peripheral blood (Sallusto and Lanzavecchia, 1994). Primary DC are 
extremely rare in human blood, necessitating the need for moDC in order to 
perform functional studies. Since monocytes are highly abundant in peripheral 
blood, high numbers of moDC can be generated with relative ease and 
convenience. Like primary DC, fully differentiated moDC can readily secrete 
pro-inflammatory cytokines and induce antigen-specific naive CD4+ T-cell 
responses in vitro (Langenkamp et al., 2000). Gene array analyses have 
revealed that moDC most closely resemble tonsillar mDC among all tested 
human ex-vivo subsets, thus making them an appropriate model for 
investigating DC responses to pathogens of the nasopharynx (Lundberg et al., 
2013).  
An alternative to moDC in the study of host-pathogen interactions is the use of 
tonsillar DC (tDC). However, this has several important disadvantages. 
Tonsillectomies are usually performed due to chronic inflammation and 
infections. Therefore, tDC may be aberrantly activated even before isolation. 
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Secondly, standard protocols involve aggressive techniques in order to 
remove the tDC from the dense tonsillar tissue (Cameron and Stent, 2001). 
As DC are exquisitely sensitive to their environment, any excess laboratory 
manipulation may lead to pre-activation. Studies examining tDC responses to 
standard immuno-activators (LPS, poly(I:C) and whole bacteria) have also 
been in disagreement. A prominent study found that tDC can produce high 
levels of cytokines but not up-regulate surface markers (Polak et al., 2008); on 
the other hand, another laboratory independently found that tDC can up-
regulate surface markers but secrete negligible levels of cytokines (Hallissey 
et al., 2014), despite using a similar protocol. The discrepancies in the 
available data may be partly explained by the great heterogeneity of tDC 
subsets (Stent et al., 2002; Summers et al., 2001). Alternatively, the clinical 
context and etiology of the tonsillectomy may influence the resulting tDC 
phenotype and function. 
1.3.1.2.5 Dendritic cell maturation 
DC express a wide variety of TLRs, NLRs, RLRs and CLRs in order to 
respond effectively to microbial challenges. Hence, DC become activated by 
various PAMPs or DAMPs.  The most well-studied of these responses is the 
response of DC to LPS, which serves as a model pathway with which to study 
DC maturation. Pivotally, DC can respond differently to specific TLR ligands, 
such as the immunological outcome would warrant. For example, viral RNA 
binds to DC-expressed TLR3 and induces potent IRF3 activity, inducing a 
robust antiviral response characterised by large quantities of the antiviral 
cytokine IFN-β (Vercammen et al., 2008). Commensal bacteria, on the other 
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hand, typically activate TLR2 via immunomodulatory glycoproteins (Tunis and 
Marshall, 2014). This results in production of IL-10 that suppresses the DC 
inflammatory response (Re and Strominger, 2004). 
DC maturation is a complex process involving cascades of intracellular 
signalling events that lead to vast phenotypic, morphological and functional 
changes. In an immature state DC are highly phagocytic but express low 
levels of 'maturation markers'. These are surface receptors involved in CD4+ 
T-cell co-stimulation, inhibition and antigen presentation. For example, 
immature human DC express low levels of co-stimulatory receptors CD40, 
CD80 and CD86; low levels of co-inhibitory receptors programmed death 
ligand receptor-1/2 (PD-L1 and PD-L2); and relatively low levels of antigen 
presentation molecules human leukocyte antigen (HLA) Class I and HLA-DR. 
Furthermore, immature DC produce negligible amounts of pro-inflammatory 
cytokines IL-1β, IL-6, IL-12 and TNF-α. Immature DC are thus poor inducers 
of CD4+ T-cell proliferation or differentiation, and they also fail to undergo 
chemotaxis in response to many chemokine signals (e.g. CCL19) 
(Banchereau et al., 2000). Therefore, immature DC are considered to be 
somewhat immunologically inert until activation. When DC mature, maturation 
makers are up-regulated and cytokine production ensues. 
Numerous gene array studies on DC maturation have revealed a process 
involving thousands of different genes and hundreds of various transcription 
factors (Türeci et al., 2003a). This complexity allows for enormous flexibility 
and fine-tuning with regard to handling microbial threats. However, the 
process of maturation may be reduced to two major signalling axes: the 
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MyD88-dependent and TRIF-dependent. Using mouse knock-out (KO) 
mutants, numerous groups have found that both MyD88 and TRIF-dependent 
signalling is fundamental for full DC maturation. Deletion of either of these 
pathways results in a immature or semi-mature DC upon stimulus with LPS or 
another immuno-adjuvant (Hoebe et al., 2003; Shen et al., 2008).  
Upon LPS stimulation, TLR4 signalling leads to activation of the MyD88 
pathway and the induction of NF-κB signalling. NF-κB is a heterodimeric 
transcription factor comprising of two subunits, p50 and p65, that are retained 
in the cytoplasm by the inhibitor IκB-α. MyD88 signalling results in the 
activation of the kinase IKKγ and phosphorylation of IκB-α. Phosphorylated 
IκB-α is targeted for ubiquitination and subsequent proteasomal degradation. 
Thereafter, NF-κB is able to translocate to the nucleus and transcribe target 
genes (Hayden and Ghosh, 2004). High levels of pro-inflammatory cytokine 
secretion by activated DC depends on the MyD88-NF-κB signalling axis, and 
either MyD88 deletion (Kawai et al., 1999) or pharmacological inhibition of 
NF-κB can significantly dampen cytokine production (O’Sullivan and Thomas, 
2002). Since this signalling pathway is rapidly induced after LPS stimulation, 
cytokine transcription is one of the first events to occur in DC maturation.  
LPS-TLR4 signalling also induces TRIF-dependent signalling, resulting in 
phosphorylation of the transcription factor IRF3 and transcription of IFN-β. 
IFN-β is then secreted by the DC and acts as an autocrine signalling loop that 
constitutes a late-phase maturation signal (Gautier et al., 2005; Honda et al., 
2003; Longman et al., 2007; Montoya et al., 2002; Pollara et al., 2006; Severa 
et al., 2006). In certain circumstances, autocrine IFN-γ can also fulfill this 
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function (Pan et al., 2004). IFN-β binds to IFN alpha receptor-1 (IFNAR1) 
expressed on the surface of the DC and signals via the receptor kinases JAK1 
and Tyk2. These kinases phosphorylate the transcription factors signal 
transducer and activator of transcription-1 (STAT1) and STAT2, which 
heterodimerise and then bind to IFN-stimulated response elements (ISREs) in 
gene promoters. DC surface maturation markers—such as HLAs, CD40 and 
CD86—have ISRE and STAT1-binding elements in their promoters (Lefebvre 
et al., 2001; Qin et al., 2005; Shi et al., 2006). Therefore, deletion of TRIF 
(Hoebe et al., 2003), blockade of IFNAR1 (Pollara et al., 2006), neutralisation 
of the autocrine IFN-β (Longhi et al., 2009), inhibition of JAK proteins (Kubo et 
al., 2013) or gene deletion of STAT1 (Johnson and Scott, 2007) can prevent 
the full up-regulation of DC maturation markers.  
Additionally, IFN-β can act as an amplification signal for DC maturation 
because it can also activate the NF-κB pathway by STAT1-independent IFN-β 
signalling. Upon IFN-β stimulation, there is also STAT-independent activation 
of MAPKs, PI3K and Akt, leading to a reinforcement signal amplifying NF-κB-
dependent cytokine production (Pollara et al., 2006). Thus, inhibition of JAK 
proteins in stimulated DC can also dampen pro-inflammatory cytokine 
production (Kubo et al., 2013), and even STAT1-KO APCs can up-regulate IL-
1β in response to IFN-β (Joshi et al., 2006), illustrating the dual function of the 
autocrine IFN loop. Given this central role of IFNs in DC biology, it is therefore 
unsurprising that the addition of exogenous IFN-β alone is sufficient to induce 
fully functional, mature DC (Pantel et al., 2014). 
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Importantly, TLR signalling also induces signalling by the three MAPKs: ERK, 
p38 and JNK. These kinases coordinate central aspects of DC maturation. 
For example, p38 activation induces phosphorylation of histone deacetylases 
that unwind heterochromatic regions and establish a chromatin landscape 
permissive to gene expression (Seguín-Estévez et al., 2014). JNK is 
important in the generation of reactive oxygen species (ROS) and together 
with ERK, the induction of certain co-inhibitory molecules (Fife et al., 2009). 
MAPKs function in ancillary roles in DC maturation, such as augmenting 
cytokine secretion or maturation marker expression, and inhibition of these 
kinases can modulate the resulting phenotype (Mitchell et al., 2010). 
Lastly, MAPKs functionally bridge TRIF and MyD88 signalling. STAT1 
depends on two critical phosphorylation events: serine 727 (S727) 
phosphorylation, and tyrosine 701 (Y701) phosphorylation. S727 
phosphorylation is necessary for full transcriptional activation of STAT1 and 
depends on p38, which is activated very early upon LPS stimulation; 
conversely, Y701 phosphorylation depends on JAK family kinases, which are 
optimally activated by the later IFN signal (Kovarik et al., 1999). Early MAPK 
signalling therefore 'primes' STAT1 for transcriptional activity, in preparation 
for the late-phase autocrine IFN loop. 
In summary, DC maturation requires cascades of signals that have distinct, 
yet overlapping functions. These signals may often amplify each other at 
different phases of the maturation process. Many transcription factors are 
necessary for DC maturation, yet it is less clear which are sufficient. However, 
this paradigm may be crudely simplified into two important points: (i) that 
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inflammatory cytokine production is largely dependent on the MyD88-
dependent pathway, and (ii) up-regulation of surface maturation markers is 
more dependent on the TRIF-dependent pathway.  
1.3.2 The Adaptive Immune System 
In evolutionary terms, the adaptive immune system is newer than innate 
immunity, and is less widespread across multicellular organisms. The 
adaptive immune system belongs only to jawed vertebrates, and is thought to 
have originated around 500 million years ago (Flajnik and Kasahara, 2010).  
During the course of an infection, the innate immune response responds 
quickly in the acute phase, while the adaptive immune system takes several 
days to respond (Miao et al., 2010). This is because the adaptive immune 
system has more specificity in recognising antigen, but also because there is 
usually clonal expansion of lymphocytes — the cells that mediate adaptive 
immunity. The expansion in antigen-specific lymphocytes leads to 
immunological memory, which is an absent feature in the innate immune 
system. 
1.3.2.1 T-cells 
T-cells originate from lymphoid progenitor cells in the bone marrow and then 
egress to the thymus to undergo thymic education (Sedwick, 2006). T-cells 
are unique in that they possess a T-cell receptor (TCR) that is able to 
recognise specific antigens when presented by HLA. TCRs are extremely 
diverse in their specificity, principally due to VDJ recombination, driven by 
non-homologous end-joining (NHEJ) which is utilised to rearrange TCR 
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segments into a high multiplicity of combinations (Malu et al., 2012). In the 
thymus, TCR+ T-cells undergo a selection process that eliminates those cells 
whose TCR binds too strongly or too weakly to antigen, thereby selecting the 
useful and rejecting the harmful T-cell clones (Klein et al., 2014).  
The TCR is co-expressed with CD4 or CD8, which separates T-cells into two 
major lineages (Germain, 2002). CD4+ T-cells are called T helper cells (TH) 
and recognise HLA Class II, which is only expressed on APC and a handful of 
other cell types. CD4+ T-cells secrete cytokines such as IL-4, IFN-γ and IL-17 
to modulate and coordinate the immune response. CD8+ T-cells recognise 
HLA Class I, which is more ubiquitously expressed. CD8+ T-cells are also 
called cytotoxic T-cells (TC) because they can induce cellular death to virally 
infected cells, or those expressing tumour antigens. 
Mature DC are able to migrate to the lymph nodes and present antigen to T-
cells. Since mature DC express high levels of HLAs and co-stimulatory 
molecules, they can present antigen on their surface and effectively stimulate 
lymphocytes to proliferate and differentiate into certain subsets. Like DC and 
monocytes, both naive and memory T-cells can patrol the body in a steady-
state, but they can also hone to sites of infection and lymph nodes (Worbs 
and Förster, 2009). Therefore, although most T-cells reside in lymphoid 
tissue, there are many opportunities for T-cell to encounter DC and undergo 
activation (Lewis et al., 2007) 
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1.3.2.1.1 T-cell Activation 
For DC to activate and polarise T-cells, they need to provide three critical 
signals (Escors et al., 2013). Signal one is the binding of peptide-loaded HLA 
(called major histocompatibility complex (MHC) in mice) to TCR. To do this, a 
DC physically associates with the T-cell and forms an immunological synapse 
(Huppa and Davis, 2003). CD4 or CD8 forms a co-receptor that helps to 
bridge the HLA-TCR interaction, and allows for specificity with regards to HLA 
Class I or II binding. On the T-cell, the TCR exists in a complex with CD3: the 
latter then signals via the intracellular kinases ZAP70 and Lck upon TCR 
stimulation, providing a positive signal for T-cell growth and division (Brownlie 
and Zamoyska, 2013). 
However, signal one is normally insufficient to induce T-cell activation. Indeed, 
the induction of signal one alone is likely to result in T-cell anergy. To fully 
commit a T-cell to activation (i.e. IL-2 production and proliferation), a second 
signal is required. The second signal is co-stimulation, which is induced by a 
variety of molecules such as CD40, CD80, CD86, ICOSL and OX40L (Chen 
and Flies, 2013). The best studied of these molecules is the B7 family. Mature 
DC have the phenotype CD80hi (B7-1hi)/CD86hi (B7-2hi) and these highly 
expressed molecules bind to CD28 expressed on the T-cell at the 
immunological synapse. This delivers a second PI3K/NF-κB-dependent signal 
to the T-cell that ensures activation (Logue and Sha, 2004). Importantly, it is 
now appreciated that the ultimate fate of DC-mediated T-cell activation 
depends on the subtle interplay of the whole repertoire of co-stimulatory and 
co-inhibitory receptors, many of which have uncharacterised functions (Reis e 
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Sousa, 2006). Indeed, DC can also express co-inhibitory receptors such as 
programmed death ligand-1 (PD-L1) and PD-L2. These restrict the T-cell 
response by providing a negative signal that induces SHP-1 and SHP-2 
phosphatase activity in the T-cell to counteract ZAP70 and Lck tyrosine 
phosphorylation (i.e. activation) from signal one (Sheppard et al., 2004). 
Signal three is the cytokine milieu that influences T-cell differentiation. Naive 
CD4+ T-cells (sometimes called TH0) can further differentiate into TH1, TH2, 
TH17 and TREG cell-types (Luckheeram et al., 2012). These subsets are 
defined by a hallmark transcription factor and cytokine signature: TH1 cells 
express the transcription factor T-bet, secrete IFN-γ and are important for 
immune responses to intracellular bacteria and viruses; TH2 cells express the 
transcription factor GATA-3, secrete IL-4 and are important in allergy and anti-
helminth responses; TH17 cells express the transcription factor RORC, 
secrete IL-17 and are important for immunity to extracellular bacteria and 
fungi; TREG express the transcription factor FOXP3, secrete IL-10 and are 
important for immunoregulation (Zhu and Paul, 2009). The cytokines secreted 
by mature DC influence the resulting CD4+ T-cell phenotype. For example, IL-
12 secretion by DC will promote the induction of T-bet and IFN-γ production in 
the T-cell (i.e. TH1 differentiation), whereas TGF-β secretion by the DC will 
promote the induction of FOXP3 and IL-10 production in the T-cell (i.e. TREG 
differentiation). 
CD4+ T-cells are critical for generating vigorous and protective immune 
responses to invading pathogens. Indeed, this is highlighted by the 
opportunistic bacterial infections associated with chronic HIV infection. CD4+ 
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T-cells are especially important for anti-bacterial immunity at mucosal sites 
(Hagiwara et al., 2003; Kadioglu et al., 2004). Significantly, impairment of 
CD4+ T-cells is associated with markedly increased microbial translocation 
across mucosal epithelial barriers (Perreau et al., 2014) and bacterial sepsis 
(Hawkins et al., 2006). In summary, the generation of useful CD4+ T-cell 
responses by DC is critical for protecting the host from microbial threats. 
1.3.2.2 B-cells and Plasma Cells 
Helper T cells are important for directing the immune response. However, B-
cells are able to differentiate into plasma cells, which are the effector cells of 
antibody production. Immunoglobulins such as IgA are secreted in gram 
quantities in the human mucosa on a daily basis (Brandtzaeg and Pabst, 
2004), highlighting the importance of B-cells in mucosal immunity. Primary B-
cell deficiency in humans results in a dramatic increase in morbidity 
associated with a higher rate of opportunistic infections (Conley et al., 2009).  
B-cells recognise antigen directly by the expression of the B-cell receptor 
(BCR), which is a receptor belonging to the immunoglobulin family. Unlike T-
cells, B-cells do not require antigen to be presented on MHC. The antigens 
that can induce direct B-cell proliferation are termed T-independent (T-I) 
antigens. T-I antigens are usually polysaccharides or TLR ligands such as 
LPS, and these antigens can induce B-cell responses and antibody 
production independently of any CD4+ T-cell help by binding directly to the 
BCR and TLR receptors (Mond et al., 1995). Notably, this predominantly 
results in the 'default' production of IgD or IgM antibodies. 
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B-cells can produce many different classes of immunoglobulin, these include: 
IgA, IgD, IgE, IgG and IgM. To undergo class switching, B-cells often require 
CD4+ T-cell help. B-cells can recognise T-cell dependent (T-D) antigen via the 
BCR. Once recognised by the B-cell, T-D antigens are internalised, 
endocytosed and presented on MHC in a similar way to DC. Hence, B-cells 
are also considered to be APCs. Once endocytosed, B-cells can present T-D 
antigens to the cognate CD4+ T-cell, and the B-cell-expressed co-stimulatory 
molecule CD40 can induce T-cell proliferation and cytokine production 
(Zubler, 2001). The T-cell derived cytokines can then induce B-cell class-
switching, i.e. from IgM to IgA/IgG production (Cerutti, 2008). B-cells can also 
then become memory B-cells or plasma cells — the latter of which are able to 
produce vast quantities of antibodies compared to the smaller effector B-cell. 
1.4 Pathophysiology of N. meningitidis 
Pathogenesis occurs by two related routes, the first being bacteria-mediated 
tissue destruction and the second being immune cell-mediated inflammation. 
Studies in vitro using human endothelial cells have shown that 
meningococcus can cause direct injury to the endothelial monolayer by 
causing cellular detachment and exerting direct cytopathic effects (Schubert-
Unkmeir et al., 2010). It has been found that N. meningitidis utilises the 
CD147 receptor to bind to endothelial cells, and this leads to colony formation 
in vitro and in vivo, resulting in vascular damage and dysfunction (Bernard et 
al., 2014). 
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Invasion of meningococci into the bloodstream causes a 'cytokine storm' that 
is caused by the elicitation of pro-inflammatory cytokines by bacterial 
mediators (Brandtzaeg et al., 2001). LOS is a major determinant of this 
reaction, since it binds to TLR4 and induces the production of these 
molecules. LOS can be found in high quantities in the blood of meningococcal 
disease patients, as well as multiple cytokines such as IL-1β, IL-6, IFN-γ and 
TNF-α (Pathan et al., 2003). These cytokines derive from many sources, 
including monocytes and neutrophils, and correlate with disease severity and 
organ dysfunction (Bozza et al., 2007; Lewis et al., 2013). Studies 
investigating meningococcal infection have also established the contribution 
of activated neutrophils to tissue destruction, finding a direct correlation 
between neutrophil adhesion to the endothelial layer and cellular apoptosis 
(Klein et al., 1996). 
The inflammation that accompanies invasive meningococcal disease 
ultimately results in severe vascular damage to the host, coagulation and 
endothelial dysfunction. 
1.4.1 Natural Immunity to N. meningitidis 
Natural immunity to N. meningitidis is a complex and little-understood subject, 
principally due to the lack of a good animal model. One of the major reasons 
behind this fact is the adaptation of Neisserial iron-acquiring transferrin 
proteins for the human host. These meningococcal transferrin proteins are not 
able to efficiently sequester iron from a murine host, and therefore growth of 
N. meningitidis in mice is significantly impaired (Holbein, 1981). As such, mice 
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can clear extremely high doses of non-replicative haematogenous bacteria in 
a way that does not truly imitate natural infection or disease (Oftung et al., 
1999). Therefore, studies relying on human data have been necessary to 
understand natural immunity to the meningococcus. 
N. meningitidis can colonise up to 40% of the population largely 
asymptomatically, yet disease only occurs in approximately 1 in 100,000 
invididuals in Western nations (Harrison, 2010). It has been inferred from this 
observation that natural immunity must offer reasonable protection against 
meningococcal disease. Indeed, colonisation of the human nasopharynx by N. 
meningitidis induces the production of IgA in the saliva which coincides with 
the presence of bactericidal IgG in the sera of colonised subjects (Robinson et 
al., 2002). Given its role in complement-mediated killing, IgG appears to be 
critical for protection against invasive meningococcal disease. 
Critically, colonisation with N. meningitidis offers some protection against 
invasive disease, but only offers moderate cross-protection against different 
strains (Reller et al., 1973). Colonisation with N. meningitidis also does not 
appear to prevent the re-acquisition of the same strain at a later date, or 
indeed a different strain to the one first encountered (Ala’Aldeen et al., 2000). 
It can hence be concluded that colonisation usually results in an immune 
response that offers some protection against invasive disease, but does not 
lead to (at least immediate) bacterial clearance.  
It is thought that the commensal N. lactamica (Nl) may provide cross-
protection to the meningococcus. Nl is unencapsulated, and so its pathogenic 
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potential is extremely limited. Various epidemiological studies have suggested 
that Nl acts as a protective commensal in the nasopharynx. Early studies in 
young children noted that Nl carriage was associated with a decreased risk of 
meningococcal disease (Gold et al., 1978). Mathematical modelling of 
epidemiological data has enforced this hypothesis, illustrating a reciprocal 
relationship between Nl carriage and incidence of meningococcal disease 
(Coen et al., 2000). 
Carriage of Nl in humans induces cross-reactive antibodies which have 
opsonophagocytic — but not bactericidal — activity against NMB (Evans et 
al., 2011; Gold et al., 1978). Animal immunisation models have further 
revealed that intraperitoneal inoculation with Nl induces cross-protective 
antibodies of sufficient titre to protect against lethal meningococcal challenge 
(Li et al., 2006). Furthermore, inoculation with OMVs derived from various 
strains of Nl also provides protective antibodies against meningococcal 
infection (Oliver et al., 2002). 
The question then remains: how does N. meningitidis transition from an 
asymptomatic commensal to an invasive pathogen? This central issue is 
largely unresolved, however the answer is likely to lie in the interplay between 
host, bacterial and environmental factors. For instance, it is known that hyper-
virulent (i.e. hyper-invasive) strains have caused outbreaks and epidemics of 
meningococcal disease. It is believed that this is due to the expression of 
certain Opa proteins that may allow tighter attachment of the bacterium to the 
epithelial surfaces of the nasopharynx (Callaghan et al., 2006). Indeed, hyper-
invasive strains of N. meningitidis that are associated with a higher incidence 
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of disease are genetically less diverse than carrier isolates (Read, 2014). 
There is thus strong evidence of bacterial determinants that may determine 
the ability of N. meningitidis to cause disease.  
Nonetheless, there are also many host factors that may play a role in 
meningococcal pathogenesis. Complement is abundant in the bloodstream 
and offers protection against the haematogenous spread of many invading 
microorganisms (Brown et al., 1983). In lieu of this, patients with complement 
and neutrophil deficiencies are statistically more likely to develop 
meningococcal disease than healthy individuals (Figueroa and Densen, 
1991). Large genome-wide association studies have confirmed that mutations 
in the complement pathway are significantly associated with risk of 
meningococcal disease (Davila et al., 2010). Neutrophils—which have high 
expression of complement receptors—have been shown to phagocytose and 
kill meningococci in vitro, therefore they may have a critical role in front-line 
defence against the bacterium (Ross et al., 1987). Neutropenia is an identified 
risk factor for invasive meningococcal disease, thus supporting the notion that 
neutrophils are central to host protection from N. meningitidis invasion (Peters 
et al., 2001; Smith et al., 2013). 
Other cells besides neutrophils are associated with protection from 
meningococcal disease. There is some evidence that adults with susceptibility 
to meningococcal disease have subtle B-cell immunodeficiencies (Foster et 
al., 2009). Similarly, primary and secondary T-cell immunodeficiencies have 
been linked with an increased risk of meningococcal disease (Cohen et al., 
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2010; Foster et al., 2010). Together, these data implicate both innate and 
adaptive immune responses in providing protection against invasive disease. 
Environmental factors can also modulate the risk of invasive meningococcal 
disease. Smoking has been noted as a risk factor, and so has domestic 
crowding (Fischer et al., 1997). Furthermore, influenza co-infection has long 
been associated with an increased risk of meningococcal disease (Makras et 
al., 2001). A mechanism has recently been proposed to account for this: it 
was found by Loh et al. that during elevated temperatures, N. meningitidis up-
regulates host resistance factors such as capsule and LOS (Loh et al., 2013). 
Therefore, N. meningitidis may exist in certain state of equilibrium with the 
host, which is disturbed in certain circumstances. 
1.4.1.1 The interaction of NmB with DC 
It was previously found by our laboratory that live NmB could inhibit DC 
maturation by a contact-dependent mechanism. Whereas killed NmB and its 
components (e.g. LOS) can robustly activate dendritic cells (Al-Bader et al., 
2004a; Dixon et al., 2001; Jones et al., 2008; Kolb-Maurer et al., 2001; 
Singleton et al., 2005; Uronen-Hansson et al., 2004a) as indicated by the up-
regulation of maturation markers and the production of pro-inflammatory 
cytokines, the culturing of DC with viable bacteria suppressed the phenotypic 
maturation of these cells (Jones et al., 2007). Since DC are critical for 
controlling immune responses, this phenomenon was investigated in the 
present study, providing the premise of the thesis, with the aim to uncover the 
mechanism behind the modulation of DC maturation by live NmB. Since 
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natural immunity to the meningococcus is observed in humans and is mostly 
protective from invasive disease, it was an interesting paradox that DC (which 
are vitally important for adaptive immune responses) should be inhibited by 
the bacterium.  
The thesis begins in Chapter 3 by exploring the background literature 
surrounding the interaction between NmB and DC, and also the experimental 
investigation of the basic interaction between NmB and DC, by interrogating 
the DC surface phenotype and also pro-inflammatory cytokine production 
induced by the bacterium. Previous results (i.e. the suppression of DC 
maturation) are re-capitulated, but the novel finding of enhanced pro-
inflammatory cytokine secretion is discovered, revealing a de-coupling of two 
fundamental aspects of DC maturation induced by NmB. This led to the 
analysis of DC signalling pathways in Chapter 4, with the aim to discover if 
NmB was targeting a major signalling pathway. The results show that NmB 
precisely de-activated a single transcription factor. This transcription factor 
(STAT1) was previously shown to be required for DC maturation. In Chapter 
5, the functional outputs of this effect are explored by using DC migration and 
T-cell co-culture assays. The hypothesis that the inhibition of DC maturation 
would result in impaired immunological functions is experimentally validated. 
In Chapter 6, the de-activation of STAT1 is pharmacologically reversed, which 
restores all aspects of DC function after infection with live NmB, thus 
providing good evidence that this transcription factor was being targeted by 
the bacterium to evade immunity. Furthermore, a candidate bacterial effector 
molecule is proposed. Finally in Chapter 7, the implications of these findings 
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and how they relate to our understanding of natural immunity to the 
meningococcus are discussed, particularly with relevance to vaccine 
development and paradigms of host-pathogen interactions. 
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2 Chapter 2 - Materials and Methods 
Ethics Statement 
Peripheral blood used for this study was obtained from healthy adult 
volunteers with written and informed consent. Consent and donations were 
recorded in accordance with the Institute of Child Health's Research 
Governance and Ethical Regulations. 
2.1 Materials 
2.1.1 General Consumables 
Below is a list of general consumables and their suppliers used in this study: 
Table 2-1 General consumables 
Reagent Supplier 
2-mercaptoethanol Sigma-Aldrich 
4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
(HEPES) 
Sigma-Aldrich 
5(6)-Carboxyfluorescein diacetate Sigma-Aldrich 
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N-succinimidyl ester (CFSE) 
BD CellFix Becton Dickinson 
BD Fix Buffer I Becton Dickinson 
BD Perm Buffer III Becton Dickinson 
Brefeldin A Sigma-Aldrich 
Bright-Glo Promega 
Bromthenol blue Sigma-Aldrich 
CD14 Monocyte Isolation beads Miltenyi Biotech 
CD19 B-cell Isolation Kit Miltenyi Biotech 
Chloramphenicol powder Sigma-Aldrich 
CL-XPosure X-ray Film Pierce 
Deoxyribonucleotide phosphates 
(dNTPs) 
Life Technologies 
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Dithiothreitol Life Technologies 
DMSO Sigma-Aldrich 
ECL Prime western blotting 
detection reagent 
Amersham 
Endotoxin-low bovine serum 
albumin (BSA) 
Fisher Scientific 
Ethylenediaminetetraacetic acid 
(EDTA) 
Sigma-Aldrich 
First strand buffer Life Technologies 
Glutamine x100 Life Technologies 
Glycerol Sigma-Aldrich 
Glycine Sigma-Aldrich 
Gonococcal agar Becton Dickinson 
Heparin sulfate  
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Ionomycin Sigma-Aldrich 
Lipopolysaccharide (LPS) from E. 
coli 
Sigma-Aldrich 
LS magnetic columns Miltenyi Biotech 
Lymphoprep StemCell Technologies 
Marvel dried skimmed milk powder Tesco 
Methanol Sigma-Aldrich 
Molecular biology grade ethanol Sigma-Aldrich 
Naive CD4 Isolation Kit Miltenyi Biotech 
Pan-CD4 Isolation Kit Miltenyi Biotech 
Paraformaldehyde powder Sigma-Aldrich 
PBS tablets Oxoid 
Penicillin/streptomycin x100 Life Technologies 
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Peptidoglycan from S. aureus Sigma-Aldrich 
Phorbol myristate acetate (PMA) Sigma-Aldrich 
Phosphate buffered saline (PBS) Life Technologies 
Plasticware Corning/BD 
Polyinosinic-polycytidylic acid 
(poly(I:C)) 
Sigma-Aldrich 
Polyvinylidene difluoride (PVDF) 
membrane 
Pierce Biotechnology 
Protamine sulfate Sigma-Aldrich 
Protease Inhibitor Cocktail Tablets Roche 
Random hexamer primers GE Healthcare 
Ready-SET-Go ELISA Human Kits 
(TNF-α, IL-1β and IL-6) 
eBioscience 
RNAse Out Life Technologies 
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RNEasy Mini Kit Qiagen 
Roche PhosStop Tablets Roche 
Roswell Park Memorial Institute 
medium-1640, (RPMI-1640) 
Life Technologies 
Saponin Sigma-Aldrich 
Sodium azide Sigma-Aldrich 
Sodium chloride Sigma-Aldrich 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich 
Staphylococcal enterotoxin B 
(SEB) 
Sigma-Aldrich 
Superscript II Reverse 
Transcriptase 
Life Technologies 
SYBR Green Mastermix Bio-Rad 
Triton-X 100 Sigma-Aldrich 
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Trypan Blue 0.4% solution Sigma-Aldrich 
Tween-20 Sigma-Aldrich 
Vitox Oxoid 
X-VIVO 15 media Lonza 
 
2.1.2 Cytokines and Chemokines 
Below is a list of cytokines and chemokines that were used in this study: 
Table 2-2 Cytokines and chemokines 
Cytokine Supplier 
Human C-C motif chemokine 19 
(CCL19) 
PeproTech 
Human granular-macrophage 
colony stimulating factor (GM-CSF) 
PeproTech / R&D 
Human interferon beta (IFN-β) PeproTech 
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Human interferon gamma (IFN-γ) PeproTech 
Human interleukin-2 (IL-2) PeproTech 
Human interleukin-4 (IL-4) PeproTech / R&D 
 
2.1.3 Antibodies 
Below is a list of antibodies (FC: Flow cytometry; F: Functional; WB: Western 
blot) that were used in this study: 
Table 2-3 List of antibodies 
Antigen Clone Application  Supplier 
CD1a HI149 FC eBioscience 
CD14 M5E2 FC Becton Dickinson 
CD3 UCHT1 FC Biolegend 
CD3 OKT3 F (co-culture) Biolegend 
CD4 OKT4 FC Biolegend 
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CD40 5C3 FC Becton Dickinson 
CD45RA HI100 FC Becton Dickinson 
CD45RO UCHL1 FC Becton Dickinson 
CD83 HB15e FC Becton Dickinson 
CD86 IT2.2 FC Biolegend 
DC-SIGN LWC06 FC eBioscience 
HLA Class I W6/32 FC eBioscience 
HLA-DR L203 FC R&D 
IFN-γ 25723.11 FC Becton Dickinson 
Isotype Control 
(IgG1, IgG2) 
n/a FC eBioscience 
IL-1β CRM56 FC eBioscience 
IL-4 8D4-8 FC Becton Dickinson 
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IL-6 MQ2-13A5 FC eBioscience 
IκB-α Polyclonal WB CellSignaling 
JAK1 6G4 WB CellSignaling 
JNK Polyclonal WB CellSignaling 
p-Akt D9E WB CellSignaling 
p-ERK D13.14.4E WB CellSignaling 
p-GSK-3 Polyclonal WB CellSignaling 
p-JAK1 Polyclonal WB CellSignaling 
p-JAK2 C80C3 WB CellSignaling 
p-JNK 81E11 WB CellSignaling 
p-NF-κB 93H1 FC CellSignaling 
p-p38 D3F9 WB CellSignaling 
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p-p65 93H1 WB CellSignaling 
p-S727 STAT1 Polyclonal WB CellSignaling 
p-S727 STAT1 K51-856 FC Becton Dickinson 
p-Src Polyclonal WB CellSignaling 
p-Tyk2 Polyclonal WB CellSignaling 
p-Y690 STAT2 Polyclonal WB CellSignaling 
p-Y701 STAT1 Polyclonal WB CellSignaling 
p-Y701 STAT1 4a FC Becton Dickinson 
p-Y705 STAT3 4/P-STAT3 FC Becton Dickinson 
PD-L1 29E.2A3 FC Biolegend 
PD-L1 Polyclonal F (blocking) Biolegend 
PD-L2 24F.10C12 FC Biolegend 
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SOCS1 A156 WB CellSignaling 
STAT1 Polyclonal WB CellSignaling 
α-rabbit IgG HRP n/a WB Cellsignaling 
β-actin 13E5 WB CellSignaling 
 
2.1.4 Inhibitors 
Below is a list of inhibitors that were used in this study: 
Table 2-4 List of inhibitors 
Inhibitor Supplier 
JAK inhibitor (Tofacitinib) Tocris 
JNK inhibitor (SP 600125) Sigma-Aldrich 
MEK/ERK inhibitor (PD 98059) Sigma-Aldrich 
NF-κB inhibitor (BAY 117082) Sigma-Aldrich 
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p38 inhibitor (SB 203580) Sigma-Aldrich 
SHP-2 inhibitor (NSC 87877) Tocris  
Sodium orthovanadate (pre-
activated) 
JENA Bioscience 
 
2.1.5 General Buffers and Media 
Below is a list of buffers and media that were used in this study, including 
recipes for their composition: 
Table 2-5 General buffers and media 
Buffer Composition 
Complete media RPMI containing 10% (v/v) FCS, 100 
U/mL streptomycin/penicillin and 2.4 
mM L-glutamine 
Cryopreservation media FCS containing 10% (v/v) DMSO 
ELISA wash buffer PBS containing 0.05% (v/v) Tween 
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Flow cytometry buffer PBS containing 0.2% (w/v) BSA and 
0.02% (v/v) sodium azide 
Laemmli buffer 20% (v/v) glycerol, 10% (v/v) 2-
mercaptoethanol, 0.004% (v/v) 
bromthenol blue, 0.2M Tris-HCl 
Lysis buffer 1% (v/v) Triton X-100, 50 mM Tris, 
100 mM NaCl and x1 Complete 
Roche PhosStop and Protease 
inhibitor cocktail tablets 
MACS buffer PBS containing 2% (v/v) FCS and 2 
mM EDTA 
Permeabilisation buffer Flow cytometry buffer containing 
0.2% (w/v) saponin 
Running buffer 25mM Tris, 192mM glycine, 1% (w/v) 
SDS 
Stripping buffer 10% (w/v) SDS, 0.5 M Tris-HCl, 0.1 
2-mercaptoethanol, pH 6.8 
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Transfection media X-VIVO 15 media supplemented with 
10% (v/v) FCS, 100 U/mL 
streptomycin/penicillin and 2.4 mM L-
glutamine, 100 ng/mL GM-CSF and 
50 ng/mL IL-4 
Transfer buffer 20% (v/v) methanol, 25mM Tris, 
192mM glycine 
 
2.1.6 Foetal calf serum 
FCS is known to vary depending on supplier and batch. This is largely due to 
variations in the background levels of contaminants and inflammatory factors 
(Opitz et al., 1977). Therefore, different FCS batches were tested for 
immunogenicity by a DC activation assay (for methodology of DC culture and 
activation, see sections 2.2.3.2 and 2.2.4). DC were cultured in the presence 
of 10% FCS from multiple suppliers, and then stimulated for 24h with PFA 
fixed (killed) 10 MOI (multiplicity of infection) NmB, in order to check normal 
activation. Levels of DC maturation were then measured by flow cytometric 
analysis of surface expression of CD40 and CD86, using MFI (median 
fluorescence intensity). FCS batches that induced high levels of background 
cell activation (i.e. high CD40 and CD86 expression) were excluded from the 
study. For all experiments, it was decided that endotoxin-low FCS from South 
America (Life Technologies/Gibco) would be used, as this serum gave 
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consistent DC activation profiles for all three batches tested (Figure 2-1). Prior 
to cell culture use and aliquoting, all FCS was heat-inactivated by incubation 
at 56°C for 30 mins. 
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CD40 CD86 
201 
58.3 
212 
54.5 
222 
54.9 
33.1 
9.89 
33.7 
8.44 
37.6 
8.03 
Batch 2 
Batch 1 
Batch 3 
 
Figure 2-1 Batch-testing of FCS. To measure background levels of DC activation, 
FCS was batch tested to ensure consistency between experiments. FCS quality is 
essential for the growth and activation of DC. To do this, DC were cultured in 
various heat-inactivated endotoxin-low FCS batches from South America (Gibco). 
DC were then either stimulated with 10 MOI killed NmB for 24h (blue histograms) 
or left unstimulated (grey histograms). CD40 and CD86 were then measured as 
indicators of DC maturation. MFI values are displayed on the histogram. 
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2.2 Methods 
2.2.1 Bacterial methods 
2.2.1.1 Strains 
Bacteria used in this study were predominantly of the strain N. meningitidis 
serogroup B strain H44/76 (B:15:P1.7,16), which was first isolated from a 
meningococcal disease patient in Norway in 1978 (Holten, 1979). This strain 
possesses a capsule and expresses pili. For one experiment, strain MC58 
was used, which is a serogroup B strain first isolated from a patient in the U.K. 
in 1991 (McGuinness et al., 1991). For other experiments, H44/76 and MC58 
isogenic mutants were constructed using allelic replacement with an antibiotic 
resistance cassette in the SiaD, RmpM and PilE genes, as previously 
described (Steeghs et al., 1998). These mutants were kind gifts from 
Professor Peter van der Ley (Netherlands Vaccine Institute, Netherlands). 
Campylobacter jejuni, Streptococcus pneumoniae and Lactobacilli reuteri 
were kindly provided and prepared by Dr Dagmar Alber (UCL Institute of Child 
Health, UK) and Ms Katja Brunner (UCL Institute of Child Health, UK). 
2.2.1.2 Bacterial culture 
Bacteria were grown from frozen 10% glycerol stocks overnight on 
gonococcal plates made of BD GC Agar supplemented with 1% Vitox growth 
nutrients in a humidified incubator at 37°C in 5% CO2. Bacterial number was 
determined by spectrophotometry at O.D.600. Bacteria were adjusted to O.D. = 
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1, and viability counts were used to determine that O.D.600 = 1 was equal to 1 
x 109/mL bacterial cells. This was used to calculate MOI for DC infection 
assays. Bacteria were killed by fixation in 0.5% paraformaldehyde (PFA) for 
20 mins at room temperature, and then washed extensively in PBS to ensure 
removal of PFA. Viability was checked by plating a sample of the killed 
bacteria stock on GC agar and incubating at 37°C in 5% CO2 overnight. Fresh 
stocks of killed bacteria were regularly made and stored at 4°C for no more 
than 1 week. 
2.2.2 Cell counting 
All cells were counted using a Neubauer hemocytometer and a light 
microscope. Briefly, small samples of cell suspensions were mixed in 1:1 
ratios with trypan blue and then a 10 μL aliquot was placed in the 
hemocytometer. All viable cells (i.e. non-blue) were counted within three 
diagonal 1 mm2 squares; an average of the three values was used in the 
calculation. Cell counts in the original sample were calculated according to the 
following formula: 
𝑇𝑜𝑡𝑎𝑙 𝐶𝑒𝑙𝑙𝑠 = (𝐶𝑒𝑙𝑙𝑠 𝐶𝑜𝑢𝑛𝑡𝑒𝑑 𝑃𝑒𝑟 𝑆𝑞𝑢𝑎𝑟𝑒 𝑥 10,000 𝑥 2) 𝑥 𝑉𝑜𝑙𝑢𝑚𝑒 (𝑚𝐿) 
2.2.3 Isolation of Peripheral Blood Mononuclear Cells from Human 
Blood 
To isolate PBMCs, healthy donors were bled using 50 mL syringes after 70% 
ethanol sterilisation of the skin. Peripheral blood was decanted into a 50 mL 
tube containing 10 U/mL heparin sulfate, and then inverted gently. Blood was 
then split in a 1:1 ratio with 37°C pre-warmed complete media.  
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Figure 2-2 Density separation of PBMCs from peripheral blood. Above is a 
diagram of heparin-treated blood that had been layered on Lymphoprep and 
centriuged at 800 x g for 20 mins at room temperature. The PBMC layer was then 
delicately extracted from the tube, with careful attention paid in order to remove 
minimal lymphoprep or plasma, as these contained contaminating cells (e.g. 
platelets and erythrocytes). 
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Diluted blood was then gently layered onto lymphoprep at a 3:1 ratio and 
centrifuged at 800 x g for 20 mins at room temperature. The PBMC layer (see 
Figure 2-2) was then carefully extracted from the tube and washed twice with 
complete media by centrifugation at 500 x g for 10 mins each. The 
supernatant was discarded after each wash. The remaining pellet represented 
the extracted PBMC. 
2.2.3.1 Enrichment of Monocytes from PBMCs 
To isolate monocytes from PBMCs, the PBMC pellet from the previous step 
was re-suspended in 30 mL ice-cold MACS buffer at 500 g for 10 mins. The 
supernatant was then discarded. The PBMC pellet containing <7 x 107 cells 
was then re-suspended in 300 μL MACS buffer, and 100 μL Miltenyi CD14 
Positive Selection Beads were added to the suspension. Cells were then 
incubated at 4°C for 30-60 mins. At the end of the incubation, 30 mL MACS 
buffer were added to the suspension, and cells were centrifuged at 500 x g for 
10 mins. The supernatant was discarded, and cells were re-suspended in 5 
mL ice-cold MACS buffer. Meanwhile, an LS magnetic column was attached 
to the Miltenyi Magnet system, and primed with 3 mL MACS buffer. The 5 mL 
cell suspension was then run through the column, which was subsequently 
washed with 3 x 3 mL aliquots of MACS buffer to ensure high purity of 
collected monocytes. The LS magnetic column containing the monocytes was 
then removed from the magnet, and the monocytes were extracted by 
plunging 5 mL of MACS buffer through the LS column into a fresh container.  
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Figure 2-3 Monocytes can be isolated from peripheral blood and enriched to a 
high purity. Samples of cells (~1 x 105) were taken pre- and post-MACS separation 
with magnetic CD14 positive-selection beads. Cells were stained with CD3 and 
CD14 antibodies in order to assess purity by flow cytometry. Top: FSC-SSC 
gating profiles used to assess monocyte and lymphocyte populations. Gates 
were set on live cells. Bottom: CD3-CD14 quadrants to show percentages of 
lymphocytes and monocytes both pre- and post-MACS separation. Quadrants 
were determined by isotype controls and unstained controls. Data are 
representative of two experiments. 
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The CD14-depleted PBMC fraction was then centrifuged at 500 x g for 10 
mins, and the pellet was re-suspended in cryopreservation media at 1 x 107 
cells / mL, and stored at -80°C in cryovials. 
2.2.3.2 Generation of DC from blood CD14+ monocytes 
Isolated human monocytes were initially checked for purity and phenotype by 
flow cytometry. For this, a sample of cells was taken before and after MACS 
separation, and these were assessed for the monocyte marker CD14 by flow 
cytometry. Purity (CD14+ cells) typically ranged from 96-98%. A 
representative purity assessment is shown in Figure 2-3. As can be seen, 
MACS separation induced CD14+ enrichment from 11.1% to 96.5%, with only 
minimal contamination from CD3+ lymphocytes. 
To differentiate into DC, purified monocytes were counted and re-cultured in 
fresh complete media containing 100 ng/mL recombinant GM-CSF and 50 
ng/mL recombinant IL-4. Monocytes were seeded at 2.5 x 105/mL in 6-well 
plates and cultured for 5-7 days at 37°C in 5% CO2. 
As can be seen in Figure 2-4, monocytes acquired a DC-like phenotype over 
the duration of the differentiation in IL-4 and GM-CSF. This was measured by 
flow cytometric analysis of the acquisition of the DC marker and lipid antigen 
presentation molecule CD1a, and also down-regulation of the monocyte 
marker CD14. By day 5, cells were CD14lo and CD1a+, which indicated a 
typical DC phenotype. Therefore, DC were harvested and used between days 
5-7 for all experiments. 
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Figure 2-4 Monocytes cultured in the presence of IL-4 and GM-CSF are able to 
differentiate into DC. Monocytes were cultured in 50 ng/mL IL-4 and 100 ng/mL 
GM-CSF for up to 7 days as described in the text of the Materials and Methods. At 
various times (as indicated on the histograms), cell samples (1 x 105) were 
aspirated from the culture and assessed for surface expression of CD1a (a DC 
marker) and CD14 (a monocyte marker) by flow cytometry. MFI values are 
displayed on the histogram. 
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Figure 2-5 DC differentiated from monocytes show a classic immature DC 
phenotype. Monocytes were differentiated in 50 ng/mL IL-4 and 100 ng/mL GM-
CSF for 7 days as described in the Materials and Methods, and on the final day of 
culture an aspirated sample of cells was assessed for characteristic DC markers. 
CD3 (to measure lymphocyte contamination), CD4, CD40, CD80, CD83, CD86, DC-
SIGN and HLA-DR (markers of DC activation and differentiation) were then 
measured by flow cytometry. Top: DC live gate. Bottom: Isotype controls are 
shown by solid lines, and specific antigens are shown in grey filled histograms. 
Data are representative of three experiments. 
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On day 7, DC were further analysed for surface phenotype (Figure 2-5), and 
were found to be CD3-CD4+CD40+CD83loCD80loCD86loDC-SIGN+HLA-DR+, 
which is consistent with previous reports and findings (Mallon et al., 1999). 
2.2.3.3 Isolation of CD4+ T-cells from PBMCs 
T-cells were isolated from frozen CD14-depleted PBMC stocks. For T-cell 
isolation, frozen PBMC were gently thawed at 37°C and immediately 
transferred to 30 mL pre-warmed (37°C) FCS. Cells were then centrifuged at 
500 x g for 10 mins and the supernatant was discarded. PBMC were then re-
suspended in 30 mL complete media and centrifuged again at 500 x g for 10 
mins, after which the supernatant was discarded. Cells were adjusted to a 
total cell count of less than 1 x 107 PBMC, and 40 μL ice-cold MACS buffer 
was then added to the cell pellet. Next, 20 μL Miltenyi Pan CD4+ or Naive 
CD4+ T-cell Antibody Cocktail was added to the cell suspension, and the cells 
were incubated at 4°C for 30 mins. After the first incubation, another 40 μL 
MACS buffer and 40 μL T-cell Microbead Cocktail was added to the cell 
suspension, and the cells were incubated for a further 30 mins at 4°C. Next, 
an LS column was attached to a Miltenyi Magnet system and primed with 3 
mL MACS buffer. Once the 3 mL had run through, the PBMC suspension was 
aliquoted onto the MS column, and allowed to pass through by gravity flow.  
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Figure 2-6 CD4+ naive T-cells can be enriched from CD14-depleted PBMCs by 
magnetic cell separation. Frozen CD14-depleted PBMC stocks underwent naive 
CD4+ T-cell enrichment using the Miltenyi CD4+ Naive T-cell Isolation Kit, as 
described in the Materials and Methods section. Samples of cells (1 x 105) were 
taken post-separation, and assessed for the T-cell markers CD4, CD45RA and 
CD45RO by flow cytometry. Top: FSC-SSC gating profiles used to determine T-
cell purity. Gates were set on live cells. Bottom: Percentage of naive and memory 
cells were measured, using a gate determined by an isotype control and 
unstained control. Data are representative of two experiments. 
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The flow-through was collected in a fresh container below the column. 
Immediately after the suspension had flowed through the column, it was 
washed with 3 x 3 mL MACS buffer, and then the entire flow-through was 
collected and centrifuged at 500 x g for 10 mins. The cell pellet represented 
the enriched T-cell fraction, which was used for the experiments. 
Flow cytometry was used to determine the purity of the T-cells. An aliquot of 
the cells was taken post-MACS separation, and assessed for CD4, CD45RA 
and CD45RO expression. T-cell enrichment typically generated CD4+ purity 
higher than 98%. As can be seen in Figure 2-6, naive CD45RA+ T-cells could 
be generated to high purity using MACS separation, with minimal CD45RO 
contamination. Similar results were obtained for the Miltenyi Biotech Pan 
CD4+ T-cell Isolation Kit (data not shown). 
2.2.4 General DC stimulation 
On day 5-7 of differentiation DC were harvested and washed twice (500 x g 
for 10 mins) in RPMI containing 10% FCS in order to wash off any remaining 
antibiotics. DC were re-counted by hemocytometer, re-suspended in fresh 
RPMI with 10% FCS and seeded in polypropylene tubes at 2.5 x 105/mL in 
500 μL total volume. DC were then stimulated in individual tubes with the 
relevant stimuli as indicated in figure legends and incubated at 37°C in 5% 
CO2 in a humidified incubator for indicated times. Some DC were also co-
treated with inhibitors, vehicle controls or co-stimuli. DC were then used for 
gene, protein or cellular analysis, or used in a further assay, as described in 
the relevant section. 
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2.2.5 Bone marrow-derived dendritic cells 
Bone marrow-derived dendritic cells (BM-DC) were kindly provided by Dr 
Holly Stephenson and Dr Nayani Pramanik (UCL Institute of Child Health, 
UK). These cells were prepared from the femurs of wild-type C57BL/6 mice 
aged 6-12 weeks as previously described (Stephenson et al., 2014). Once 
differentiated, BMDC were cultured and stimulated identically to human DC. 
2.2.6 DC migration assay 
To assess chemotaxis/migration, DC were stimulated as indicated in the 
figure legends, and then washed in complete media twice (500 x g for 10 
mins) and re-counted on a hemocytometer. Meanwhile, increasing 
concentrations of CCL19 diluted in complete media were placed in the wells 
of a Corning transwell-adapted 24-well plate at 600 μL per well. An 8 μm pore 
transwell was then inserted into the well, and 200 μL of DC suspension 
containing 2.5 x 105 cells was added to the upper compartment. The plate 
was then incubated at 37°C in 5% CO2 in a humidified incubator for 5 h, and 
then the transwells were carefully lifted out of the plate and discarded. The 
liquid in the bottom chamber was then mixed thoroughly, and an aliquot was 
taken for counting the migrated DC by hemocytometer. Cell counting was 
performed in triplicate and an average was taken. Visual inspection of the 
wells was also used to approximately confirm the readings on the 
hemocytometer. 
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2.2.7 T-cell polarisation assay 
To measure T-cell polarisation, T-cells were first isolated using the Naive 
CD4+ Isolation Kit. Meanwhile, stimulated or control DC were seeded in 
complete media into round-bottom 96-well plates at 5 x 104 cells per well in 
100 μL volume. SEB (10 ng/mL) was added to each well. 2.5 x 105 naive 
CD4+ T-cells were then added to each well, and allowed to divide for 5 days 
in 37°C and 5% CO2. On day 5, cells from the 96-well plate were aspirated 
and aliquoted into 2 mL fresh complete media containing 2 U/mL IL-2, in a 48-
well plate. T-cells were then re-incubated and allowed to expand for a further 
7-9 days. At the end of the culture, cells were treated with a cocktail of 
brefeldin A (1 μg/mL), PMA (100 ng/mL) and ionomycin (1 μg/mL) for 3 h. 
Cells were then harvested into polystyrene flow cytometry tubes and 
processed for flow cytometry according to the methodology described 
elsewhere. 
2.2.8 T-cell proliferation assay 
To measure T-cell proliferation, T-cells were first isolated using the Pan CD4+ 
T-Cell Isolation Kit. T-cells were then washed twice in PBS to remove protein 
(500 x g for 10 mins) and then re-suspended in 1 mL PBS. To the cell 
suspension, 1 μM of CFSE was added, and the cells were gently mixed and 
then incubated at 37°C in 5% CO2 for 8 mins, while protected from light. Then, 
2 mL FCS was added to the tube in order to stop the CFSE binding, and cells 
were re-incubated for a further 2 mins. After 2 mins, cells were washed twice 
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in complete media and then re-suspended to the desired concentration and 
volume.  
Meanwhile, stimulated or control DC were seeded in complete media into 
round-bottom 96-well plates at 5 x 104 cells per well in 100 μL volume. To 
some wells, SEB (10 ng/mL) or soluble anti-CD3 (clone OKT3, 1 μg/mL) was 
added. Then, T-cells were added at the concentration indicated in the relevant 
figure legends (e.g. for a 1:1 ratio, 5 x 104 CD4+ T-cells were added), and the 
total volume of each well was adjusted with complete media to make a final 
volume of 200 μL. On day 5, cells were transferred to polystyrene flow 
cytometry tubes and then processed in the usual way for flow cytometric 
analysis.  
2.2.9 Flow cytometry 
All flow cytometry experiments were performed by first transferring 1-2.5 x 105 
cells to Falcon round-bottom polystyrene flow cytometry tubes. 3 mL ice-cold 
flow cytometry buffer was then added to each tube, and cells were centrifuged 
at 500 x g for 10 mins, and the supernatant was discarded. For experiments 
involving surface staining, to ensure equal staining between samples, a 
master mix (containing the appropriate antibodies diluted in flow cytometry 
buffer) was made, and then 100 μL of master mix was added to the relevant 
tube. Cells were then gently mixed by pipetting, and then incubated at 4°C for 
30 mins while protected from light. After 30 mins, 3 mL flow cytometry buffer 
was added to the tubes and these were centrifuged at 500 x g for 5 mins, and 
supernatants were discarded. This step was then repeated to ensure removal 
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of any excess staining antibody. Finally, cells were then fixed in 100-200 μL 
BD CellFix and briefly vortexed. Samples were run and analysed on either a 
BD FACSCalibur or BD LSR II flow cytometer within 24h of fixation. FlowJo 
version 8.8.7 software was used to analyse flow cytometry data and generate 
figures. 
To determine positive and negative populations (e.g. CD45RA+ and CD45RA-
T-cells), isotype controls conjugated to the appropriate fluorochrome were 
sometimes used at equivalent concentration as the target antibody, as stated 
in the figure legends. Moreover, isotype controls were also used when first 
establishing the DC phenotype. However, isotype controls are often 
problematic, and it has been reported that they can give erroneous results 
(Keeney et al., 1998). Therefore, isotype controls were only used when 
needed in order to distinguish positive and negative populations. To 
determine the antibody concentrations to use in experiments, titration 
experiments were performed to determine the saturating concentration (data 
not shown). 
2.2.10 Intracellular flow cytometry 
To detect intracellular epitopes, cells were harvested and washed once (500 x 
g for 5 mins) and a surface stain (as described in section 2.2.8) was 
performed if needed. After the optional surface stain, cells were then fixed in 
300 μL BD CellFix for 30 mins at 4°C. Cells were then washed twice (500 x g 
for 5 mins): first with 3 mL flow cytometry buffer and then second in 
permeabilisation buffer. The supernatant was discarded. Cells were re-
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suspended in 100 μL of master mix (required antibodies diluted in 
permeabilisation buffer) and then incubated for a further 30 mins at 4°C 
shielded from light. Cells were then washed twice (500 x g for 5 mins; once 
with permeabilisation buffer and once with flow cytometry buffer) and re-
suspended in 100 μL BD CellFix ready for analysis on the flow cytometer. 
2.2.10.1 Intracellular PhosFlow 
For the detection of phosphorylated intracellular proteins by flow cytometry, 
DC were stimulated for the indicated time-points at 37°C before fixation with 
pre-warmed BD Fix Buffer at a 1:1 ratio with the cell media. Cells were fixed 
for 10 mins at 37°C and 5% CO2. Cells were washed once with PBS 
containing 2.5% FCS (500 x g for 10 mins) before a permeablisation step with 
1 mL BD Perm Buffer III. Cells were then incubated on ice for 30 mins, before 
washing three times in PBS containing 2.5% FCS. Cells were then stained 
with the following antibodies: AlexaFluor647-conjugated p-STAT1-Y701 or p-
STAT3-Y705 or PE-conjugated p-STAT1-S727 for 45 mins at 4°C while 
protected from light, before washing (500 x g for 5 mins), re-suepension in 
200 μL PBS and immediate analysis on a BD FACSCalibur or BD LSRII 
instrument. 
2.2.11 Lentivirus quantification 
All lentiviruses in this study were kind gifts from Dr Emma Chan (UCL Institute 
of Child Health, UK) and Dr Holly Stephenson (UCL Institute of Child Health, 
UK/ Max Plank Institute, Germany). Lentiviruses were HIV-1-based vectors 
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with self-inactivating (SIN) elements, and were generated as previously 
described (Chan et al., 2012).  
For determination of virus concentration, 293T cells (seeded by Dr Emma 
Chan) were grown in complete media at 37°C and 5% CO2 until sub-
confluent. Then, 1 x 105 cells per well were infected with serial dilutions of 
GFP-reporter (SEW) lentivirus (GFP-LV) stock and re-incubated for a further 
72h. At 72h, cells were harvested and then assessed for lentivirus 
transduction by flow cytometry. GFP+ cells were measured to distinguish 
those that had been effectively transfected with virus. 
To calculate virus titre, the amount of virus that gave 0-10% was selected, as 
this was unlikely to represent cells with multiple copies of virus (shown in 
Figure 2-7). Then, the background from the untransfected cells was 
subtracted (i.e. 0.35%) from the total, to give 7.69% GFP+ cells. Given that 
0.016 μL GFP-LV stock caused 7.69 x 103 HEK 293T cells to be transduced, 
it was assumed that 0.016 μL of GFP-LV stock contained 7.69 x 103 infectious 
particles. Therefore, the concentration of the GFP-LV virus stock was 
determined to be 4.8 x 108 IU/mL. This methodology was used to determine 
multiplicity of infection (MOI) for DC transfection experiments. 
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Figure 2-7 Titration of GFP-expressing lentiviral transfection of HEK-293T cells 
can be used to calculate virus titre. HEK-293T cells were grown in complete 
media until sub-confluent and infected with increasing doses (0.016 to 10 μL) of a 
lentivirus containing a GFP construct (LV-GFP). Cells were then re-incubated for 
72h and subsequently assessed for GFP expression by flow cytometry. Gating 
percentage of GFP+ cells was determined by an untransduced control.  
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2.2.11.1 Transfection of DC with lentivirus 
Transfection of DC with lentivirus was performed according to a previously 
published protocol (Breckpot et al., 2007), with some minor modifications. 
After monocyte isolation, DC were cultured in transfection media according to 
the standard protocol. However, on day 3 of differentiation, DC were 
harvested and then washed in X-VIVO 15 media twice by centrifugation at 
500 x g for 10 mins. 1 x 106 DC were re-suspended in a 100 μL droplet of 
'transduction cocktail' (X-VIVO 15 media containing 5 MOI lentivirus, 10 
μg/mL protamine sulfate) within a 6-well plate for 2h and incubated at 37°C in 
5% CO2 in a humidifed incubator. After 2h, 4 mL transfection media was 
added to each droplet, and DC were cultured as normal for a further 3 days. 
Transfection efficiency was assessed by flow cytometry by measuring GFP+ 
DC, and was further optimised in Chapter 4. 
2.2.11.2 Lentivirus NF-κB assay 
DC were transfected with a lentivirus containing a NF-κB reporter plasmid 
(from Dr Holly Stephenson, UCL Institute of Child Health, UK) (Stephenson et 
al., 2014) as previously described above. DC were then stimulated in 
technical duplicates for 4h as described in the relevant figure legends, and 
then 100 μL BrightGlo reagent was added for 2 mins before measuring 
luciferase activity on a luminometer.  
The immunomodulation of dendritic cells by N. meningitidis 
 
95 
2.2.12 Western Blot 
DC were stimulated at 2.5 x 105 cells/condition as described in the relevant 
figure legends. Cell lysates were made by adding 3 mL ice-cold PBS to DC 
and centrifuging samples for 10 mins at 500 x g. Supernatants were 
discarded, and 100 μL lysis buffer was added to the DC, and the cell 
suspension was vigorously pipetted more than 20 times, and incubated at 4°C 
for 30 mins. Cell lysates were frozen at -80°C until further use.  
Upon thawing, cell lysates were centrufiged at maximum speed for 10 mins, 
and the supernatant was extracted from the lysates in order to remove debris. 
Lysates were diluted in a 1:1 ratio with x2 Laemmli buffer and heated to 95°C 
on a heat-block for 10 mins. Samples were then loaded onto 12% acrylamide 
gels (purchased from Thermo Scientific or made in-house) in a Mini-Protean 
Tetra-Cell (Bio-Rad) system containing running buffer with an electrical 
current of 120mV applied for ~1.5 h. The acrylamide gel was then placed in a 
Mini-Protean Transfer System (Bio-Rad) with a PVDF membrane and transfer 
buffer, and an electrical current of 200mA was applied for 1h. The PVDF 
membrane was then blocked for 0.5-2h in 0.1% Tween-PBS containing 0.1-
5% powdered milk at room temperature. The primary antibody of interest was 
then added at a dilution of 1/1000 in a solution of 0.1% Tween-PBS containing 
1-5% powdered milk, and incubated in a 50 mL Falcon tube at 4°C for 16h 
under constant movement. The membrane was then washed in 0.1% Tween-
PBS three times in 10-minute intervals and incubated with a secondary HRP-
linked antibody in 0.1% Tween-PBS containing 0.1% powdered milk for 1h at 
room temperature. After washing three times for 5 mins in 0.1% Tween-PBS, 
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the membrane was then placed on a Kodak Biomax Cassette (Sigma) and 
exposed to reconstituted ECL solution for a few mins before exposure to X-
ray film and processing in a dark room by a developer. 
To ensure similar levels of protein loading, some PVDF membranes were 
bathed in stripping buffer for 30 mins and then washed extensively with 0.1% 
Tween-PBS. Membranes were then re-blocked and incubated with a different 
primary antibody. The same protocol as previously described was then used 
for the second blot after the initial strip and wash. 
2.2.13 Enzyme-Linked Immunosorbent Assay 
ELISAs for IL-1β, IL-6 and TNF-α were performed using the eBioscience 
Ready-SET-Go ELISA kits. For chemokines, Peprotech ELISA Development 
Kits were used. Supernatants used for these assays were aspirated from DC 
cultures and then passed through a 0.2 μm PVDF membrane filter in order to 
remove any cells or bacteria.  
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Figure 2-8 A standard curve used to calculate cytokine concentrations by ELISA. 
Shown is a representative standard curve calculated by using serial dilutions of 
recombinant human IL-1β (7.8 - 1000 pg/mL). Measured spectrophotometry values 
(O.D. 450 nm) are depicted by  (x-axis) and plotted against IL-1β concentration 
in pg/mL (y-axis), and a predicted line-of-best-fit was plotted using a quadratic 
polynomial fit (y = a+b*x+c*x2) on Revelation software. The correlation coefficient 
(R2) was >0.99, indicating a good quality standard curve. 
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First, an ELISA plate was coated with 50 μL of coating buffer, containing the 
diluted capture antibody (at 1 μg/mL) required for the assay. The plate was 
then incubated overnight at 4°C. After incubation, the plate was washed 
vigorously three times with saturating amounts of ELISA wash buffer. Then, 
the plate was blocked at room temperature for 1h with assay diluent at 100 μL 
per well. After blocking, the plate was again washed three times with ELISA 
wash buffer. Serial dilutions of the relevant recombinant protein were added in 
duplicate at 100 μL final volume with a typical range of 7.8-1,000 pg/mL. 100 
μL volume of samples were also added in duplicate to the plate. Samples 
were diluted 1:10-1:500 in assay diluent, using previously published cytokine 
quantities in response to meningococcal antigens as an approximate 
guideline (Jones et al., 2007; Kolb-Maurer et al., 2001). After the addition of 
samples, the plate was incubated overnight at 4°C, and then washed more 
than three times in ELISA wash buffer. Next, the plates were incubated with 
50 μL of detection antibody diluted in assay diluent. After 2h, plates were 
washed vigorously more than three times with ELISA wash buffer. Then, 50 
μL streptavidin-HRP conjugated antibody diluted in assay diluent was added 
to each well, and the plate was incubated at room temperature for 10 mins. 
After 10 mins, 50 μL stop solution (1M H2SO4) was added to each well in 
order to stop the reaction. The plate was read immediately on a Dynatech 
microplate reader at 450 nm wavelength, and sample values were calculated 
by a standard curve (see Figure 2-8), by using Revelation ELISA software.  
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2.2.14 Real-time PCR and analysis of gene expression 
2.2.14.1 RNA extraction 
For analysis of gene expression, 2.5 x 105 DC were lysed in 350 μL RNA 
Later buffer (RLT plus buffer, Qiagen) containing 1% 2-mercaptoethanol. 
Lysates were homogenised by passing through a QIAshredder (Qiagen) spin 
column by centrifugation at 15,000 x g for 2 mins and the flow-through was 
frozen at -80°C until RNA extraction. RNA was extracted using the Qiagen 
RNeasy Mini Plus Kit according to manufacturer’s instructions. In detail, 350 
μL of cell lysate was passed through a genomic DNA elimination column by 
centrifugation at 8,000 x g for 30 seconds before mixing with 350 μL buffer 
containing 70% ethanol. The sample (700 μL) was transferred to an RNeasy 
spin column and centrifuged at 8000 x g for 15 seconds to bind the RNA and 
flow-through was discarded. RNA attached to the column was then washed 
with 700 μL of Buffer RW1 followed by centrifugation at 8000 x g for 15 
seconds. The column was then washed twice with 500 μL of buffer RPE, 
before transfer of the RNeasy spin column to a new collection tube and 
centrifugation at 15,000 x g for 1 minute in order to remove residual buffer. 30 
μL of RNase-free water was added to the spin column membrane and the 
column was then placed in a 1.5mL Eppendorf tube and centrifuged at 8000 x 
g to elute the RNA. RNA was frozen at -80°C until use. RNA concentration 
and purity was assessed by Nanodrop spectrophotometry and was routinely 
found to have a 260/280 ratio above 1.8, indicative of high purity RNA. See 
Figure 2-9 for a typical plot and yield. 
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Figure 2-9 Representative emission spectrum of extracted DC RNA. RNA was 
extracted from DC as described in the Materials and Methods. A small sample of 
RNA diluted in RNAse-free H20 (1 μL) was then measured for purity and 
concentration by NanoDrop (Thermo Scientific) at 230 nm, after blanking the 
instrument with the appropriate solvent. RNA emits fluorescence at 260 nm, and 
260/280 ratio was calculated to be 1.98, which indicated high-purity RNA with 
minimal contamination. The concentration of RNA in this sample was calculated 
to be 31.4 ng/μL. 
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2.2.14.2 First strand cDNA synthesis 
RNA served as a template for cDNA synthesis using first strand cDNA 
synthesis by using the Superscript II Reverse Transcriptase kit (Life 
technologies) and random hexamer primers. First, 9 μL of purified RNA (max 
1 μg) was mixed with 2.5 μL of random hexamers (100 ng/μL) and incubated 
at 70°C for 10 mins. The following reaction mixture was used for cDNA 
synthesis: 4.5 μL 5x First Strand Buffer, 2 μL 0.1M DTT, 1 μL 10 mM dNTPs, 
1 μL RNAse Out and 0.5 μL Superscript II Reverse Transcript. 
8.5 μL of the cDNA synthesis cocktail was added to the 11.5 μL 
RNA/hexamer mix and incubated at room temperature for 10 mins before 
incubation at 42°C for 1h. cDNA synthesis was then terminated by incubation 
at 72°C for 10 mins, and 80 μL of RNase-free water added to the 20 μL cDNA 
reaction to give 100 μL of cDNA template, which was frozen at -20°C until 
use. 
2.2.14.3 Primers and real-time PCR 
Primers were designed using Primer Blast software (NCBI) and validated for 
specificity through the analysis of melt curves generated following PCR 
amplification using SYBR Green Mastermix on the Rotor-gene 6000 Corbert 
thermocycler (Qiagen). Each primer generated a single peak size was 
confirmed by agarose gel electrophoreisis. The reaction mix consisted of: 10 
μL x2 SYBR Green Mastermix, 6 μL DNase-free water, 1 μL forward primer at 
500 nM, 1 μL reverse primer at 500 nM, 2ul of cDNA template. 
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The following primer sequences were used:  
CD86 F: AGCACAGACACACGGATGAG, R: GGAAGGCCATCACAAAGAGA; 
IL6 F: GTGCCTCTTTGCTGCTTTCAC, R: GGTACATCCTCGACGGCATCT; 
IL1B F: GTAGTGGTGGTCGGAGATTCG, R: 
CTAAACAGATGAAGTGCTCCT; IL8 F: AATCTGGCAACCCTAGTCTGCTA, 
R: AAACCAAGGCACAGTGGAACA; IDO1 F: 
GAGAAGTTAAACATGCTCAGC, R: GACACAGTCTGCATAAACCAA; IFNB 
F: AGCTGCAGCAGTTCCAGAAG, R: AGTCTCATTCCAGCCAGTGC; IFNG 
F: TGACCAGAGCATCCAAAAGA, R: CTCTTCGACCTCGAAACAGC; CISH 
F: GTCCAGCCGAGTCCCCACTCC, R: TGCTCACCCCTGAACGCAGAG; 
SOCS1 F: GAGAACCTGGCTCGCATC, R: AACACGGCATCCCAGTTAAT; 
SOCS3 F: GTCACCCACAGCAAGTTTCC, R: 
TCACTGCGCTCCAGTAGAAG; TNFA and the house keeping gene GAPDH 
primers were from Qiagen (TNFA: QT01079561; GAPDH: QT01192646). 
For analysis of gene expression, the cDNA from samples was amplified using 
SYBR green technology (Bio-Rad) on a rotor-gene 6000 Corbert thermocycler 
(Qiagen) using the following conditions: 95°C 5 mins, then 40 cycles of 95°C 
30 seconds, 60°C 30 seconds and 72°C 30 seconds. Melt curve and SYBR 
green emission data were collected. Samples were run in technical duplicates 
and the average Cycle thresholds (Cts) of the duplicates determined for the 
gene of interest as well as the housekeeping gene GAPDH. A representative 
melt-curve showing a single PCR product is shown in Figure 2-10. 
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Temperature °C 
d
F
/d
T
 
Figure 2-10 A representative melt-curve showing a single product from RT-PCR. 
RNA was extracted from DC and converted to cDNA, and then copies of CD86 
mRNA were quantified by RT-PCR as described in the Materials and Methods. 
dF/dT (derivative fluorescence/derivative temperature) plotted against 
temperature (°C) showed a single peak, indicative of a single PCR product. 
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Expression of the gene of interest was first normalised to the housekeeping 
gene GAPDH using the deltaCt method, before standardising to T=0 DC 
expression using the -deltadeltaCT (-ddCT) method (Livak and Schmittgen, 
2001) and the following formulae: 
Treated DC gene dCT= (Treated DC gene of interest Ct) - (Treated DC 
GAPDH Ct) 
T=0 DC gene dCT = (T=0 DC gene of interest Ct) - (T=0 GAPDH Ct) 
-ddCT=(Treated DC gene )-(T=0 DC gene ) 
Fold change in expression = 2-ddCT =2-( -  
2.3 Statistics and Software 
All statistical analysis was done using GraphPad Prism (version 5.0) or 
Microsoft Excel (version 2010) software. Molecular modelling of proteins was 
performed using the SWISS model online software 
(http://swissmodel.expasy.org). All one- and two-way ANOVA statistical tests 
(as indicated in figure legends) were followed by a Bonferroni post-test in 
order to correct for multiple testing. 
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3 Chapter 3: Viable N. meningitidis Subverts 
Dendritic Cell Maturation 
3.1 Introduction 
Human DC express a multitude of TLRs, such as TLR2, TLR3, TLR4, TLR6 
and TLR9, in order to respond to microbial antigens (Muzio et al., 2000). Upon 
TLR stimulation, DC undergo a maturation program that involves the up-
regulation of maturation markers and the production of pro-inflammatory 
cytokines. However, many bacteria have developed sophisticated strategies 
to subvert this process. This is unsurprising, considering that DC maturation is 
critical for the effective clearance of many bacterial infections in vivo (Macedo 
et al., 2008; Schreiber et al., 2010), and many obligate pathogens depend on 
the human host for their own survival. 
There are two major ways by which pathogens can exploit dendritic 
maturation to divert immune responses to a favourable outcome. The first 
method is modulation of DC cytokine production. Cytokines are important for 
both priming non-immune cells to induce an anti-viral or anti-bacterial state 
(Miyajima et al., 1992), and also in polarising T-cell differentiation lineages 
(Chen and Flies, 2013). Furthermore, cytokines can recruit other immune cells 
to the site of infection (Vieira et al., 2009). Campylobacter jejuni can use 
flagellin to target DC immunoreceptors and induce IL-10 production that may 
suppress the host immune system and lead to bacterial persistence 
(Stephenson et al., 2014).  Helicobacter pylori can similarly induce TGF-β 
The immunomodulation of dendritic cells by N. meningitidis 
 
107 
secretion in DC to effect a tolerogenic microenvironment dominated by TREG 
differentiation (Kao et al., 2010). Within the Neisseria genus, N. gonorrhoeae 
can skew T-cell differentiation from a protective TH1/TH2 balance to a 
pathogenic and inflammatory TH17 response by inducing co-production of IL-6 
and TGF-β in myeloid DC (Liu and Russell, 2011; Liu et al., 2012).  
The second technique pathogens employ to evade the immune system via 
DC is modulation of expression of maturation markers. As previously 
discussed, maturation markers are involved in antigen presentation and the 
co-stimulation of T-cells. Arguably, the expression of DC maturation markers 
('signal 1' and 'signal 2') is more important for the initiation of adaptive 
immune responses than cytokine production ('signal 3'). Mature DC co-
cultured with naive T-cells in the presence of neutralising antibodies against 
IL-12 can still drive strong TH1 responses (Rissoan et al., 1999), and 
pharmacologically modified DC expressing low levels of CD86 yet producing 
high levels of IL-12 are still biased towards inducing a TH2 response, which is 
reversed upon CD86 up-regulation (Turnquist et al., 2010). Indeed, the 
expression of certain DC maturation markers alone is sufficient to generate 
TH1 responses independently of IL-12 (Soares et al., 2007). Patients with IL-
12 deficiency can still generate protective immunity to intracellular pathogens 
(Fieschi et al., 2003), and IL-12-KO mice develop protective TH1 responses 
against many bacteria (Jankovic et al., 2002). Therefore, the surface 
phenotype of mature DC may be sufficient for the initiation of effective cellular 
immune responses, but the cytokine signal is still an important enhancement 
factor towards cellular polarisation. 
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Pathogens can suppress the up-regulation of maturation markers on DC by a 
variety of mechanisms (Khan et al., 2012). Mycobacterium tuberculosis cell 
wall components target DC-SIGN to suppress DC maturation by active 
interference with the TLR pathway; thus, infected DC have low levels of 
CD40, CD80 and CD86 (Geijtenbeek et al., 2003). Similarly, Enterobacter 
sakazakii targets DC-SIGN via surface-expressed OmpA protein to inhibit 
MAPK activation and thus prevent DC maturation (Mittal et al., 2009). For 
many bacteria, the mechanism behind the inhibition of DC maturation is 
mechanistically unresolved, such as the interaction between Haemophilus 
ducreyi and human myeloid DC (Banks et al., 2007). 
Generally, viable bacteria have a higher availability of native antigens, and are 
therefore better able to mature DC. For example, viable Salmonella enterica 
activates DC very rapidly, but prolonged exposure to heat-killed bacteria is 
required for the same level of maturation (Kalupahana et al., 2005). Similarly, 
viable E. coli is slightly better than heat-killed bacteria at inducing DC 
maturation in vivo (Trez et al., 2005). However, for those bacteria that 
possess immune evasion mechanisms, the inhibition of DC maturation may or 
may not depend on bacterial viability. For instance, the LPS of Coxiella 
burnetti blocks TLR signalling and therefore does not induce DC maturation. 
This occurs whether the bacterium is viable or inactivated through heat-killing 
(Shannon et al., 2005). By contrast, viability is essential for the suppression of 
DC maturation by Yersinia enterocolitica, which depends on active 
transcription of genes within its virulence plasmid to inhibit maturation marker 
up-regulation within the host cell (Erfurth et al., 2004). 
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N. meningitidis and its virulence factors are potent inducers of human DC 
maturation. Meningococcal PorA protein alone can induce up-regulation of 
HLA-DR, CD40, CD80 and CD86. Furthermore, PorA alone can also induce 
IL-8 and modest IL-1β production (Al-Bader et al., 2004b). Meningococcal 
LOS is sufficient for the up-regulation of DC maturation markers and the 
secretion of pro-inflammatory cytokines (Kolb-Maurer et al., 2001), and similar 
results have been found in macrophages by using LOS-deficient mutant 
strains (Pridmore et al., 2001). Notably, the presence of LOS in the 
meningococcal cell membrane leads to higher levels of phagocytosis (Dixon 
et al., 2001) which elicits optimal IL-12 production in human DC (Uronen-
Hansson et al., 2004a). Consistent with these observations, capsule-deficient 
mutants of N. meningitidis provoke higher amounts of inflammatory cytokine 
production due to enhanced levels of phagocytosis (Kolb-Maurer et al., 2001). 
Given the robust maturation of DC by meningococci and its constitutive 
components, DC exposed to N. meningitidis and co-cultured with naive CD4+ 
T-cells leads to strong TH1 and TH2 immune responses (Steeghs et al., 2006). 
Moreover, N. meningitidis can drive DC-mediated TH17 polarisation in 
memory T-cells through potent production of IL-23 via intracellular NOD2 (van 
Beelen et al., 2007). 
While these studies have been conducted entirely on inactivated bacteria, it 
has been since shown that viable and killed N. meningitidis serogroup B 
(NmB) are differentially recognised by human DC (Jones et al., 2007). DC 
exposed to viable NmB had dampened levels of maturation marker up-
regulation compared to those exposed to killed bacteria. This was found to be 
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a contact-dependent mechanism and was independent of the method of 
bacterial inactivation. Importantly, the effect of live NmB was dominant over 
killed bacteria, underscoring the importance of this interaction for human 
immunity. Since large quantities of viable and killed bacteria can be recovered 
from the bodily fluids of patients with meningococcal septicaemia (Øvstebø et 
al., 2004), this observation is particularly pertinent. This could therefore 
represent a novel mechanism of immune evasion by the meningococcus, i.e. 
an evolutionary strategy employed by the bacterium to suppress effective 
immunity in the mucosal tissue. Since NmB is an obligate coloniser of the 
human host, with no non-human animal or environmental reservoir, immune 
evasion is an essential requirement for carriage in the nasopharynx (Lo et al., 
2009). The aim of this thesis therefore was to further characterise this 
interaction between live NmB and DC, starting with an investigation into the 
basic interaction between these cells. 
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3.2 Aims and Objectives 
The aim of the experiments in this chapter was to elucidate the basic 
interaction between NmB and DC. Based upon previous work in the 
laboratory, it was hypothesised that viable and killed NmB would exert 
differential effects on DC maturation. To investigate this, DC were stimulated 
under various conditions and tested for multiple aspects of activation by 
assessing all of the signals required to induce effective T-cell responses.  
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3.3 Results 
3.3.1 DC are activated upon stimulation with LPS 
It was first determined if DC differentiated from peripheral blood monocytes 
could respond to LPS. DC express high levels of TLR4 (Uronen-Hansson et 
al., 2004b), and it has been demonstrated that LPS can activate DC in vitro in 
numerous studies. Importantly, this would establish a useful positive control 
for DC maturation for the rest of the study. TLR4 contains TRIF and MyD88 
adaptors, and therefore a TLR4 agonist is an ideal control for full DC 
activation. LPS is a heterogeneous class of molecules, and some forms of 
LPS are much more immunogenic than others (Attridge et al., 2009). With this 
consideration, LPS derived from E. coli strain 0111:B4 was chosen for its 
immunogenic potency.  
DC were stimulated for 24h with tenfold incremental concentrations of LPS to 
test the threshold of activation. Flow cytometry was then used to measure 
CD40 and CD86 up-regulation, which are markers of DC maturation1. As 
Figure 3-1 shows, it was found that even low doses of LPS (0.01 μg/mL) were 
able to induce up-regulation of CD40 (unstimulated MFI: 73.1, LPS stimulated 
MFI: 131) and CD86 (unstimulated MFI: 118, LPS stimulated MFI: 818). 
Similar results were obtained after stimulation with up to 10 μg/mL LPS.  
                                            
1 The colour key grey: unstimulated, green: LPS, blue: killed NmB and red: 
live NmB is used throughout the entire study. 
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Figure 3-1 DC are matured by culture with the TLR4 agonist LPS. DC were 
stimulated for 24h with increasing concentrations of LPS derived from E. coli 
(from lowest to highest: 0.01, 0.1, 1 and 10 μg/mL), as described in the Materials 
and Methods. Stimulated DC are shown in green histograms, and unstimulated 
DC are in grey histograms. CD40 and CD86 expression were then measured by 
flow cytometry, gating on viable cells determined by FSC-SSC. MFI values are 
displayed on the histogram. Data are representative of two experiments. 
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To test pro-inflammatory cytokine production in response to LPS, DC were 
stimulated for 24h and IL-1β was measured by intracellular flow cytometry, as 
described in the Materials and Methods. As Figure 3-2 shows, like maturation 
marker expression, even small doses of LPS (0.01 μg/mL) induced cytokine 
production (2.55 %), and this reached near maximum (7.76 %) at 0.1 μg/mL. 
Interestingly, IL-1β production was reduced upon very high LPS stimulation, 
likely due to homeostatic negative regulation. Hence, DC easily reached 
maximum or near-maximum phenotypic maturation even with low doses of 
LPS. Based on these data and cost effectiveness, it was decided that 100 
ng/mL (0.1 μg/mL) LPS would be sufficient to induce DC maturation, and this 
was used as a positive control for all of the following experiments in the study. 
3.3.2 DC are activated by killed NmB but not live NmB 
As previously discussed, several studies have shown that killed NmB can 
induce DC maturation (Al-Bader et al., 2004b; Dixon et al., 2001; Kolb-Maurer 
et al., 2001; Steeghs et al., 2006; Uronen-Hansson et al., 2004a). Therefore, 
to reproduce these findings, and also to test cell responsiveness to 
meningococci in the present system, DC were stimulated with a range of 
doses (MOI 1, MOI 10 and MOI 100) of PFA-fixed bacteria, as described in 
the Materials and Methods. As Figure 3-3 shows, DC up-regulated co-
stimulatory molecules (CD40, CD86) and antigen presenting molecules (HLA 
Class I, HLA-DR) in response to even low doses (MOI 1) of killed NmB. And 
so similarly to LPS, killed NmB effectively induced DC maturation. 
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0.01 µg/mL LPS 
Figure 3-2 DC produce inflammatory cytokine IL-1β in response to LPS 
stimulation. DC were stimulated for 24h with increasing concentrations of E. coli 
LPS (0.01, 0.1, 1 and 10 μg/mL). DC were then fixed and peameabilised and 
intracellular IL-1β was measured by intracellular flow cytometry, as described in 
the Materials and Methods. Gating was determined by an unstained control. E.C. 
= empty fluorescence channel. Data are representative of two experiments. 
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Figure 3-3 Killed meningococci mature DC independetly of MOI. DC were 
stimulated for 24h with an MOI of 1, 10 or 100 (lowest to highest) PFA-fixed NmB, 
and DC surface expression of CD40, CD86, HLA Class I and HLA-DR (DC 
maturation markers) were measured by flow cytometry.  MFI values are displayed 
on the histogram. Data are representative of three experiments. 
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Next, DC were tested for their ability to mature after infection with live NmB. A 
previous study by Jones et al. has shown that DC fail to mature in response to 
viable forms of the bacteria (Jones et al., 2007). As Figure 3-4 shows, unlike 
killed NmB, live bacteria failed to induce DC maturation at a range of MOIs. 
Even at MOI 100, there was no up-regulation of surface maturation markers 
(e.g. unstimulated DC CD40 MFI: 40.4, live NmB-infected DC CD40 MFI: 
39.4). Furthermore, as Figure 3-5 shows, a time-course analysis of HLA Class 
I, CD40 and CD86 expression showed a persistent lack of maturation marker 
up-regulation, which also excluded differential kinetics as a reason for 
phenotype induced by live NmB. Since MOI 10 seemed to give the best 
activation of some maturation markers, all further experiments were 
performed with this dose unless otherwise stated. 
Using CD40 and CD86 as indicators of maturation marker up-regulation, the 
ability of DC to respond to LPS, killed NmB and live NmB was tested in 
multiple donors (Figure 3-6), and there was a significant difference between 
killed NmB and live NmB in the up-regulation of both CD40 and CD86 (p = 
<0.001). Killed NmB induced a mean average 4.8-fold increase in CD40 MFI, 
whereas live NmB induced only a 1.8-fold increase in CD40. Notably, in some 
donors there was a trend of minor up-regulation of maturation markers in 
response to live NmB. Importantly, control markers such as DC-SIGN were 
unaffected, meaning that the suppression of DC maturation was unlikely to be 
a general disruption of the DC cell membrane (data not shown). Therefore, 
live NmB consistently failed to induce maturation of DC. 
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Figure 3-4 Live meningococci fail to mature DC independently of MOI. DC were 
stimulated for 24h with an MOI of 1, 10 or 100 (lowest to highest) live NmB, and 
surface expression of CD40, CD86, HLA Class I and HLA-DR were measured by 
flow cytometry.  MFI values are displayed on the histogram. Data are 
representative of three experiments. 
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3.3.3 Differential effects of live NmB on mouse and human DC 
Mouse and human APC possess significant differences, such as the 
expression of different immunological receptors (Mestas and Hughes, 2004). 
For example, murine B-cells express TLR4 and will mitogenically respond to 
LPS, while B-cells do not express TLR4 and are largely inert when exposed to 
even high concentrations. Furthermore, mouse and human TLR4 differentially 
recognise meningococcal LOS (Steeghs et al., 2008), and mouse DC lack 
critical human pathogen receptors such as DC-SIGN. Given these 
differences, it was questioned whether murine bone marrow derived myeloid 
DC would display the same phenotype when exposed to viable meningococci. 
Mouse DC were cultured with killed and viable NmB for 24h at a range of 
MOIs, and surface expression of CD40, CD80, CD86 and MHC Class II were 
assessed by flow cytometry (Figures 3-7 and 3-8). Interestingly, for most 
surface maturation markers, viable NmB induced greater up-regulation of 
these molecules than killed bacteria (10 MOI killed NmB CD86 MFI: 14.7 vs 
10 MOI live NmB CD86 MFI: 25.8). There was a slightly lower amount of 
CD40 up-regulation in DC stimulated with live NmB, however this was only 
marginal, and there was approximately 4-fold up-regulation of CD40 MFI 
induced by all MOIs of live NmB compared to the control. These data 
emphasize the fundamental differences in the ability of murine and human DC 
to respond to pathogens adapted to the human mucosa — and therefore 
human DC were subsequently used for the rest of the study. 
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CD40 CD86 
MHC Class II 
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Killed NmB 
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43.8 
42.3 
43.7 
Figure 3-7 Killed meningococci mature murine DC. Murine bone marrow derived 
DC (BM-DC) were stimulated for 24h with an MOI of 1, 10 or 100 (lowest to 
highest) PFA-fixed killed NmB (blue histograms), and surface expression of 
CD40, CD86 and MHC Class II were measured by flow cytometry. Unstimulated 
control DC are shown in grey histograms. MFI values are displayed on the 
histogram. Data are representative of three experiments. 
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20.9 
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Figure 3-8 Live meningococci mature murine DC. Murine bone marrow derived DC 
(BM-DC) were stimulated for 24h with an MOI of 1, 10 or 100 (lowest to highest) 
viable NmB (red histograms), and surface expression of CD40, CD86 and MHC 
Class II were measured by flow cytometry. Unstimulated control DC are shown in 
grey histograms. MFI values are displayed on the histogram. Data are 
representative of three experiments. 
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3.3.4 DC are activated by other viable bacterial pathogens 
The possibility that other viable pathogenic or commensal bacteria would 
activate DC was investigated by using a Gram-positive pathogen (S. 
pneumoniae), Gram-negative pathogen (C. jejuni) or Gram-positive 
commensal (Lactobacilli reuteri) control. C. jejuni purportedly induces DC 
maturation whether viable or killed (Hu et al., 2006), and live S. pneumoniae 
(Noske et al., 2009) also induces DC maturation. Similarly, the commensal L. 
reuteri induces DC activation whether heat-killed or viable (Mohamadzadeh et 
al., 2005). The testing of these bacteria in the same infection protocol used 
within this study would therefore validate the results to a greater degree. 
DC were stimulated with LPS, killed bacteria or live bacteria and then surface 
expression of CD40 and CD86 was measured by flow cytometry. Unlike NmB, 
viable C. jejuni, S. pneumoniae and L. reuteri all induced up-regulation of 
CD40 and CD86 comparable to killed bacteria. For instance, C. jejuni induced 
270 CD86 MFI when killed but 322 CD86 MFI when viable, whereas L. reuteri 
induced 106 CD86 MFI when killed but 188 CD86 MFI when viable. S. 
pneumoniae was generally weaker at inducing DC maturation, likely due to 
the lack of endotoxin. These results suggested that the inhibition of maturation 
marker up-regulation by live NmB was unlikely to be an epiphenomenon of 
live bacterial infection per se—since these results resound with previously 
published work by other laboratories—but was rather a specific effect of live 
NmB. 
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C. jejuni L. reuteri S. pneumoniae 
Figure 3-9 DC are matured by many viable bacterial species. DC were stimulated 
with 100 ng/mL LPS (green), 10 MOI live (red) bacteria, 10 MOI killed (blue) 
bacteria or left unstimulated (grey) for 24h. Bacterial strains used were C. jejuni 
strain 11168H, L. reuteri strain DSM12246 and S. pneumoniae strain ATCC 11733.  
Bacteria were killed by the same method as NmB (see Materials and Methods). 
Surface expression of CD40 and CD86 was assessed by flow cytometry. MFI 
values are displayed on the histograms. Data are representative of two 
experiments.  
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3.3.5 Suppression of DC maturation by live NmB is dominant over 
exogenous stimuli 
The data reported so far were unclear as to whether the failure of live NmB 
infection to mature DC was due to a lack of signal or an active suppression. 
Hence, DC were stimulated for 24h with the TLR ligands peptidoglycan (PGN) 
(TL2/6), poly(I:C) (TLR3) and LPS (TLR4). This was to determine whether the 
effect of live NmB would be dominant over bacterial or viral ligands. As Figure 
3-10 shows, when DC were cultured alone with these stimuli, each induced 
strong up-regulation of CD86 (peptidoglycan CD86 MFI: 124; LPS CD86 MFI: 
365; poly(I:C) MFI: 365). However, when these ligands were used in 
conjunction with live NmB infection, the up-regulation of this marker was lost 
(e.g. live NmB + LPS CD86 MFI: 59). It can be concluded from these results 
that live NmB actively suppressed DC phenotypic maturation in the context of 
different TLR signals. 
3.3.6 Viable NmB selectively up-regulates the T-cell inhibitory molecule 
PD-L1 
DC also up-regulate negative T-cell co-stimulatory molecules in response to 
certain microbes. Some pathogens, such as HIV-1, S. typhimurium and M. 
tuberculosis can induce the expression of these molecules on phagocytes 
(Newland et al., 2011; Rodríguez-García et al., 2011; Schreiber et al., 2010).  
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However, this has not been shown for N. meningitidis. PD-L1 and PD-L2 can 
bind to T-cell expressed PD-1 and induce cellular anergy. Therefore, It was 
questioned whether NmB could induce the inhibitory co-stimulatory molecules 
PD-L1 and PD-L2. DC were stimulated for 24h with LPS, killed or live NmB 
and then surface expression of PD-L1 and PD-L2 was measured by flow 
cytometry (Figure 3-11). Strikingly, in contrast to CD40 and CD86 expression, 
PD-L1 was fully up-regulated by live NmB (LPS MFI fold up-regulation: 7.0 vs 
live NmB MFI fold up-regulation: 7.3). There was no significant difference 
between PD-L1 expression between DC stimulated with LPS, killed or live 
NmB. In contrast to PD-L1, PD-L2 failed to fully up-regulate after DC infection 
with live NmB. Indeed, there was a significant difference between PD-L2 
expression induced by LPS, killed NmB and live NmB (p = <0.05). A ratio 
comparison of CD86:PD-L1 MFIs revealed that live NmB selectively up-
regulated PD-L1 (p = <0.01), when compared to killed NmB. 
3.3.7 DC infected with live NmB have decoupled cytokine responses 
The up-regulation of DC maturation markers—antigen presenting molecules 
and co-stimulatory molecules—represents two ('Signal 1' and 'Signal 2') 
facets of full DC activation. To be considered bona fide mature cells, DC must 
also secrete cytokines (Signal '3'). Therefore, DC were tested for their ability 
to secrete the pro-inflammatory cytokines IL-1β, IL-6 and TNF-α. Previous 
reports claim that killed NmB induces high amounts of pro-inflammatory 
cytokine release from human DC (Kolb-Maurer et al., 2001). 
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To interrogate this immunological function, DC were stimulated for 24h with 
either LPS, killed or live NmB and then secreted cytokine was measured in 
the cell culture supernatants by ELISA (Figure 3-13). In contrast to the surface 
phenotype data, live NmB was able to induce higher levels of pro-
inflammatory cytokine secretion than both LPS and killed NmB (p = <0.01). 
This was most true for IL-1β (killed NmB: mean 575.4 pg/mL; live NmB: mean 
20,535 pg/mL) and TNF-α (killed NmB: mean 73.9 ng/mL; live NmB: mean 
299.9 ng/mL). Consequently, live NmB decoupled maturation marker 
expression and cytokine production. 
3.3.8 Live NmB induces low chemokine secretion 
DC also secrete chemokines in response to pathogens. These allow the DC 
to recruit other cells, such as neutrophils and monocytes, to the site of 
infection. Since infection with live NmB resulted in high-level production of 
cytokines, it was expected that this would also result in a similar trend with 
regards to chemokine production. DC were stimulated for 24h with LPS, killed 
or live NmB and supernatants were assessed for levels of MCP-1 and MIP-3α 
(Figure 3-13). Surprisingly, it was found that live NmB induced significantly 
less (p = <0.05) MCP-1 than the positive control LPS, and a similar trend 
compared to killed NmB. Similarly, there was a non-significant trend of lower 
MCP-1 levels in supernatants from infection with live infection compared to 
killed NmB, although these were similar between LPS and live NmB. 
Therefore, in contrast to pro-inflammatory cytokines, chemokine secretion 
was not enhanced by live NmB. 
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Figure 3-12 Live NmB induces enhanced pro-inflammatory cytokine release from 
DC compared to LPS and killed NmB. DC from 4-7 donors were for 24h with 100 
ng/mL LPS, 10 MOI kiled NmB or 10 MOI live NmB, and some were left 
unstimulated. Sterile (0.2 μm filtered) supernatants were collected and analysed 
for IL-1β , IL-6 and TNF-α protein levels by ELISA. Graphs depict mean averages ± 
SEM. Significance was tested by one-way ANOVA with a Bonferroni post-test  
(N.D. = none detected.) *P <0.05, **P <0.01, ***P <0.001 
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Figure 3-13 Reduced production of chemokines in DC infected with live NmB. DC 
from 3-6 donors were for 24h with 100 ng/mL LPS, 10 MOI kiled NmB or 10 MOI 
live NmB, and some were left unstimulated. Sterile (0.2 μm filtered) supernatants 
were collected and analysed for MCP-1 and MIP-3α protein levels by ELISA. 
Graphs depict mean averages ± SEM. Significance was tested by one-way ANOVA 
with a Bonferroni post-test.  *P <0.05, **P <0.01, ***P <0.001 
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3.3.9 Dysregulation of DC maturation is transcriptionally controlled 
The up-regulation of maturation markers is subject to transcriptional and post-
translational regulation. TLR signalling induces transcriptional changes in the 
DC due to activation of transcription factors such as NF-κB, AP-1 and STAT1. 
This results in an up-regulation of the transcription of genes such as CD40, 
CD86, IL1B, IDO1, IL6 and TNFA. Once co-stimulatory and antigen 
presentation molecules are transcribed and translated, they are also subject 
to post-translational modifications such as ubiquitination, which crucially 
determine their fate within the cell. The master regulator of this process is 
membrane-associated RING-CH1 (MARCH1), which can ubiquitinate 
molecules such as CD86 and label them for internalisation from the cell 
surface, which ultimately leads to proteasomal degradation (Corcoran et al., 
2011; Tze et al., 2011). Upon DC maturation, MARCH1 is down-regulated, 
thus stabilising the CD86 molecule and allowing it to persist at the cell 
surface. Similar mechanisms involving MARCH1 negative regulation have 
been found for HLA Class II and other DC maturation markers (De Gassart et 
al., 2008). Bacteria such as Francisella tularensis can subvert this process to 
prevent the induction of effective immune responses in macrophages (Wilson 
et al., 2009), and thus it seemed to be a plausible hypothesis that live NmB 
might be utilising a similar strategy. 
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Figure 3-14 The post-translational controller of DC maturation MARCH1 is down-
regulated by live NmB. DC were stimulated for 4 or 18h with either 100 ng/mL LPS 
(green), 10 MOI killed (blue) or 10 MOI live NmB (red). RNA was extracted and 
transcripts of MARCH1 mRNA were measured by RT-PCR  relative to a time 0 (T0 ) 
control, as described in the Materials and Methods. Bar graphs depict mean 
averages ± SEM. Data are from two individual donors. 
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To interrogate these processes, DC were stimulated for 4h and 18h with LPS, 
killed and live NmB and then RNA was extracted as described in the Materials 
and Methods. Transcripts of the MARCH1 gene at these time-points were 
then quantified by RT-PCR (Figure 3-14). As the data show, MARCH1 was 
down-regulated by LPS, killed NmB and live NmB at 4h and 18h (fold change 
in expression = < 0.6 for all conditions), implying normal post-translational 
control of CD86 and other molecules.  
To exclude the possibility of CD86 remaining in intracellular reservoirs, DC 
were assessed for surface vs. intracellular (intracellular and surface) levels of 
CD86, using a saponin-based cell permeabilisation method as described in 
the Materials and Methods (Figure 3-15). The data clearly show that 
intracellular CD86 was also depleted upon live NmB infection when compared 
to LPS and killed NmB (intracellular CD86 MFI killed NmB: 23; intracellular 
CD86 MFI live NmB: 9.67), which corresponded to the surface phenotype. 
There was an overall slight reduction in CD86 MFI across all conditions in the 
intracellular stain compared to the surface stain, however this was likely due 
to the fixation method interfering with the CD86 antibody epitope. Together, 
these data implicated transcriptional defects as the driver of DC dysregulation.  
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Figure 3-15 Upon infection with live NmB, CD86 is not stored in internal 
reservoirs. DC were stimulated for 24h with either 100 ng/mL LPS (green), 10 MOI 
killed (blue), 10 MOI live (red) NmB or left unstimulated (grey). CD86 was then 
measured on the cell surface (left) or within the saponin-permeabilised cell (right) 
via flow cytometry. MFI values are displayed on the histogram. Data are 
representative of two experiments. 
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Next, CD86, IL1B, IL6 and TNFA transcription were measured 4 or 18h post-
stimulation with LPS, killed and live NmB (Figure 3-16). Consistent with the 
flow cytometry and ELISA data, CD86 transcription was down-regulated by 
live NmB at 18h (mRNA fold change <1), whereas pro-inflammatory cytokine 
transcription was sustained. This was found to be a significant difference 
between killed and live NmB (p = <0.05), with a non-significant trend for 
TNFA. Taken together, these data strongly supported the theory that live NmB 
was suppressing DC maturation by a transcriptional defect that was selective 
to the maturation markers, while cytokine production was retained or 
enhanced during late-phase maturation. 
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3.4 Discussion 
In this chapter, the data have shown that live NmB failed to induce full DC 
maturation. This was indicated by the lack of maturation marker up-regulation 
upon infection with live bacteria, whereas positive controls induced vigorous 
DC activation. These results confirm earlier findings in the literature (Dixon et 
al., 2001; Jones et al., 2007). Additionally, this appeared to be an active 
suppression of the DC maturation process since the immuno-stimulatory 
activity of potent TLR ligands was completely blocked by live bacteria. It was 
also observed that mouse DC were able to respond effectively to viable NmB, 
as indicated by the up-regulation of antigen presentation and co-stimulatory 
molecules. This is perhaps unsurprising, given the major differences in human 
and mouse immunology. Nevertheless, these data do underscore the 
importance of the unique adaptations of an obligate human pathogen. 
Remarkably, DC were still able to produce vast quantities of the pro-
inflammatory cytokines IL-1β, IL-6 and TNF-α. Therefore, it would be more 
accurate to describe DC maturation in response to live NmB as dysregulated, 
as opposed to globally inhibited. Furthermore, this is a particularly unusual 
phenotype, since maturation marker expression and cytokine production are 
two tightly controlled and co-regulated aspects of DC maturation. Though 
many bacteria can manipulate DC maturation, the result is usually a complete 
inhibition of DC functions. For instance, E. sakazakii prevents DC maturation 
via MAPK deactivation and thus the cells cannot up-regulate CD40, CD86 or 
produce TNF-α (Mittal et al., 2009). Analogously, Mycobacterium leprae also 
suppresses both DC HLA-DR up-regulation and TNF-α production (Murray et 
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al., 2007). To the author's knowledge, the only pathogen that exerts a similar 
phenotype to the observations described herein is H. ducreyi, and the 
mechanism behind this interaction is completely unknown (Banks et al., 
2007). 
The enhancement of pro-inflammatory cytokine secretion would suggest that 
certain DC signalling pathways remained intact. What remained unclear from 
these data was how live NmB was able to induce higher amounts of pro-
inflammatory cytokine than killed NmB. One possible explanation was that 
viable bacteria were able to divide in culture, and therefore the higher 
quantities of cytokine in the supernatant may have merely reflected the higher 
amounts of bacterial PAMPs. If this were the case, it would still be an 
intriguing finding: that DC produce any cytokine at all in response to an 
infectious agent while remaining persistently CD86lo is a rare and 
unprecedented phenomenon. However, this was an unlikely interpretation for 
multiple reasons. As the LPS titration experiment showed, DC readily matured 
with even low doses of antigen, but reached a maximal plateau of activation, 
which was reflected in the 'capping' of CD86 up-regulation and IL-1β 
production. Similar findings have been reported elsewhere (Kolb et al., 2014), 
i.e. that high doses of LPS saturate the DC maturation response, and after a 
certain threshold, increasing doses fail to induce higher levels of CD80, CD86 
or IL6 transcription. Furthermore, chemokine secretion did not follow the same 
trend as pro-inflammatory cytokines, as the amounts secreted in response to 
live NmB were either lower or similar to killed NmB. Hence, these data 
suggested that the increased cytokine secretion induced by live NmB was not 
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due to bacterial growth or availability of PAMPs per se, but was rather a 
specific manipulation of DC maturation. 
These findings also suggest that the suppression of up-regulation of 
maturation markers was transcriptionally—as opposed to translationally—
controlled. The master CD86 protein regulator MARCH1 was equally down-
regulated by live NmB and positive controls. This would probably exclude 
ubiquitination, degradation and receptor recycling as the cause of low 
maturation marker expression. Additionally, a time-course experiment showed 
that CD86 and other markers had persistently low expression. CD86 can 
accumulate in intracellular reservoirs (Smyth et al., 1998), which would not be 
detectable by DC surface staining. To exclude the possibility that DC were 
transcribing CD86 but that it was not being transported to the cell surface, an 
intracellular stain was performed, revealing lower amounts of intracellular 
CD86 in DC infected with live NmB, which was directly comparable to cell 
surface quantities. In further support of this, an analysis of CD86, IL1B, IL6 
and TNFA mRNA transcripts indicated that live NmB suppressed the up-
regulation of maturation markers, while failing to down-regulate cytokine 
production. Collectively, these data implied that the dysregulation of DC 
maturation was transcriptionally controlled, and was unlikely to be a result of 
post-translational modifications to the maturation markers. 
Not all DC co-stimulatory molecules were suppressed by infection with viable 
bacteria. PD-L1, but not PD-L2, was up-regulated by live NmB to the same 
extent as positive controls. This was particularly interesting as PD-L2 is 
usually co-regulated with CD86 via the IFN-β-STAT1 pathway (Wiesemann et 
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al., 2008), whereas PD-L1 was found to be MAPK dependent in monocytes 
(Wölfle et al., 2011). In addition, the chemokines MCP-1 and MIP-3α have 
STAT1 binding sites in their promoters, and IFN-β or IFN-γ treatment induces 
transcription of these chemokines (Dai et al., 2008; Li et al., 2010; Pattison et 
al., 2013; Staab et al., 2013).  
There are compelling data in the literature that suggest mouse TRIF-/- DC 
may be able to mature solely via TLR2-mediated NF-κB activation (Weatherill 
et al., 2005); and intriguingly, the induction of pro-inflammatory cytokines by 
live NmB implicated this pathway as fully functional in human DC. Hence, 
these data supported the hypothesis that a specific NF-κB-independent 
pathway—likely a component of the IFN-STAT1 signalling axis—was being 
targeted by live NmB to disrupt human DC maturation. It is this possibility that 
is explored in the following chapter. 
The immunomodulation of dendritic cells by N. meningitidis 
 
143 
4 Chapter 4: Dendritic Cell Signalling Pathways 
Induced by N. meningitidis 
4.1 Introduction 
Dendritic cell maturation requires cascades of intracellular signals to produce 
a fully activated cell (Türeci et al., 2003b). Indeed, the most recent gene 
arrays have revealed that over 2,000 genes are differentially regulated during 
this process (Jin et al., 2010). The kinetics of DC maturation are important for 
assessing maturation, as the various aspects of cellular activation are subject 
to strict temporal control. For example, transcription of pro-inflammatory 
genes (e.g. il12p40) is a rapid event that can occur only mins after DC 
stimulation (Langenkamp et al., 2000). On the other hand, morphological and 
phenotypic changes can continue to occur over 24 hours post-stimulation 
(Verdijk et al., 2004). Therefore, it is important that DC maturation is assessed 
at both early and late stages, as it is a relatively extended process.  
As previously discussed, DC maturation requires two major signals: early 
MyD88-driven NF-κB signalling, which primarily induces cytokine 
transcription, and TRIF-dependent STAT1 signalling that results in an up-
regulation of the expression of surface maturation markers (Kolb et al., 2014). 
There is significant cross talk between these two signalling axes. TLR 
activation can induce early yet transient STAT1 signalling (Sikorski et al., 
2012), and the autocrine IFN axis can also amplify NF-κB activity via STAT1-
independent mechanisms (Gil et al., 2001). Discrete activation of unilateral 
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signalling pathways is therefore unlikely to occur to any stimulus; rather, 
models involving waves of signal amplification and repression are more 
biologically representative. 
STAT1 can be activated by type I and type II IFNs. IFN-α and IFN-β signal via 
IFNAR1/IFNAR2, leading to activation of the kinases JAK1 and Tyk2. This 
leads to phosphorylation of STAT1 and STAT2, which form a STAT1-STAT-2 
heterodimer in association with IRF9, and a STAT1-STAT1 homodimer, and 
then bind to ISRE and GAS (interferon-gamma -activated sites) sites, 
respectively. This results in the induction of STAT1-dependent genes, such as 
DC maturation markers. IFN-γ signals via the IFN gamma receptor (IFNγR) by 
activating JAK1 and JAK2, which induce the phosphorylation of a STAT1 
homodimer that activates GAS-dependent transcription (Platanias, 2005). 
Both IFN-β and IFN-γ autocrine loops have been described for DC 
maturation; but the ablation of STAT1 is sufficient in itself to prevent up-
regulation of DC maturation markers (Johnson and Scott, 2007). 
No data exist in the literature concerning the signalling induced by N. 
meningitidis in DC, and surprisingly little is known about the intracellular 
signalling events induced by the meningococcus in other phagocytes and 
non-immune cells. It is known that LOS from the bacterium can activate both 
the MyD88- and TRIF-dependent axes of the TLR4 pathway in monocytes, 
and that this results in the activation of NF-κB and the production of IFN-β (Liu 
et al., 2010). This has also been shown in HEK cells, whereby infection with 
N. meningitidis activates NF-κB and also IRF3-mediated IFN-β production 
(Mogensen et al., 2006a). Similarly, infection of epithelial cells results in 
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prolonged NF-κB signalling and the release of pro-inflammatory cytokines 
(Deghmane et al., 2011). The meningococcus is able to activate the MAPKs 
ERK, p38 and JNK in endothelial cells, leading to enhanced invasion and 
inflammatory cytokine release (Sokolova et al., 2004). In macrophages, N. 
meningitidis can modulate nitric oxide production (Stevanin et al., 2005), and 
this can lead to an inhibition of apoptotic signalling pathways (Tunbridge et al., 
2006).   
Differences in the signalling induced between viable and inactivated Neisseria 
spp. have been noted in several studies. In a HEK cell line, viable and killed 
N. meningitidis can activate transfected TLRs to equal extents, although 
viable bacteria can induce more TLR9 signalling (Mogensen et al., 2006b). 
However, more prominent differences in the immune response to live and 
killed have been observed. Viable N. lactamica can modulate peroxisome 
proliferator-activated receptor gamma (PPAR-γ) to suppress TLR2-NF-κB 
signalling, while killed bacteria cannot (Tezera et al., 2011). Moreover, 
viable—but not killed—N. meningitidis can suppress the induction of certain 
immunity genes in epithelial cell lines (Wong et al., 2011). In macrophages, 
infection with live N. gonorrhoeae results in higher cytokine production than 
killed bacteria, but this is independent of bacterial growth (Zughaier et al., 
2014). In summary, species-specific differences in Neisseria spp.-induced cell 
signalling exist, but none of the available data explain the phenotype exerted 
on DC by live bacteria. 
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4.2 Aims and Objectives 
The aim of the investigations in this chapter was to investigate the hypothesis 
that viable NmB was targeting a major pathway involved in DC maturation. 
Data from the previous chapter supported the concept of the bacteria 
manipulating a signalling pathway to decouple cytokine production and 
surface maturation, and so the key signalling molecules of the MyD88 and 
TRIF signalling axes, and other canonical pathways, were examined. 
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4.3 Results 
4.3.1 Lentivirus transfection does not mature DC 
Lentiviruses are useful biotechnological tools with which to study intracellular 
signalling events. Unlike adenoviral vectors, lentiviruses can be transfected 
without eliciting strong immune responses in the host cell (Morelli et al., 
2000). Despite being less immunogenic, DC express virus-recognising TLRs 
such as TLR3 and TLR7 that can detect high titres of lentivirus and therefore 
induce maturation in vitro (Breckpot et al., 2010). For this reason, careful 
optimisation of the transfection protocol is necessary in order to achieve a 
desirable balance of transfection rates and cellular activation.  
DC were first transfected with a lentivirus containing a constitutively active 
GFP reporter element (LV-GFP) (a kind gift from Dr Emma Chan, UCL) in 
order assess transfection rates and DC immuno-activation. Two different 
protocols were used: (1) using 1% heat-inactivated autologous human serum, 
as previously described (Breckpot et al., 2007); and (2) using heat-inactivated 
FCS. In contrast to previous reports, it was found that lentivirus transfection at 
MOI 5 performed in the presence of human serum was potently immunogenic, 
resulting in marked up-regulation of CD86 expression and low transfection 
rates (28%) (Figure 4-1). However, transfection in the presence of FCS did 
not induce DC maturation, and also had higher levels of transfection (50.1%). 
Therefore, FCS was used for all future transfections. 
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Figure 4-1 DC can be efficiently transfected with lentivirus without resulting in 
phenotypic maturation. DC were transfected with MOI 5 of a GFP-expressing 
lentiviral vector (LV-GFP) on day 3 of differentiation, and after 72h they were 
assessed for transfection rates (GFP+) and cellular activation (CD86 expression). 
Frequency of GFP+ cells (top) and CD86 MFI (bottom) are displayed on the 
graphs. FCS transfection: DC transfected in the presence of 10% FCS; AS 
transfection: DC transfected in the presence of 1% heat-inactivated autologous 
serum. Data are representative of two experiments. 
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4.3.2 Inhibition of DC maturation by live NmB is NF-κB-independent 
The NF-κB pathway is targeted by many bacteria to disrupt host cell immune 
responses (Rahman and McFadden, 2011). NF-κB activation is a direct result 
of early MyD88-dependent TLR signalling, and so it was hypothesised that 
NmB might be blocking this pathway in order to disrupt DC maturation. To 
interrogate this pathway, DC were transfected with a lentivirus containing an 
NF-κB reporter plasmid. Thus, any NF-κB transcriptional activity would be 
directly quantifiable by luciferase activity. DC were then stimulated for 4h and 
luciferase activity was quantified by luminometer (Figure 4-2). Unexpectedly, it 
was found that LPS, killed NmB and live NmB activated early NF-κB activity to 
similar extents, with all three conditions showing over 3-fold NF-κB 
transcriptional activity above the unstimulated control.  
To confirm this finding, IκB-α degradation was probed by Western blot. IκB-α 
is an inverse surrogate marker for NF-κB nuclear translocation, as it ordinarily 
captures the transcription factor in the cytoplasm to prevent spontaneous 
immune responses. IκB-α is ubiquitinated and subsequently degraded by the 
proteasome upon TLR signalling. In agreement with the previous data, it was 
found that IκB-α degradation occurred with similar kinetics in DC stimulated 
with killed or live bacteria. For both conditions (Figure 4-3), IκB-α degradation 
occurred between 30 mins and 3 h post-infection, with a recovery at 4h.  
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Figure 4-2 Live NmB induces normal transcriptional NF-κB activity. DC were 
transfected with a lentivirus containing an NF-κB luciferase reporter construct on 
day 3 of differentation.  After 72h, DC were then stimulated with LPS (100 ng/mL), 
10 MOI killed NmB or 10 MOI live NmB for 4h and NF-κB transcriptional activity 
was determined by luciferase activity by the addition of BrightGlo and measuring 
luminescence on a luminometer. Data shown are from two individual donors. 
Bars depict mean averages ± SEM. 
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Figure 4-3 DC stimulated with live or killed NmB induce rapid IκB-α degradation. 
DC were stimulated with either 10 MOI killed or 10 MOI live NmB (K = killed NmB, 
L = live NmB) for the indicated times and then cellular lysates were probed by 
Western blot for the presence of IκB-α, a surrogate marker of NF-κB activation. 
Some DC were left unstimulated and lysates were collected at 4h. β-actin was 
used as a loading control. Data are representative of two independent 
experiments. 
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Figure 4-4 NmB induces late-phase NF-κB phosphorylation. DC were stimulated 
with 100 ng/mL LPS (green), 10 MOI killed (blue) or  10 MOI live NmB (red) for 18h 
and p-NF-κB (p-p65) was measured by intracellular PhosFlow cytometry. MFI 
values are displayed on the histogram. Data are representative of one experiment. 
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Late-phase NF-κB activity was further validated by intracellular flow 
cytometry. At 18h post-stimulation, DC were assessed for NF-κB 
phosphorylation after stimulation with LPS, killed NmB or live NmB (Figure 4-
4). In agreement with the previous data, LPS, killed and live NmB displayed 
similar levels of NF-κB phosphorylation (LPS p-NF-κB MFI: 6.9; killed NmB p 
p-NF-κB MFI 7.17; live NmB p-NF-κB MFI: 7.97). 
4.3.3 Activation of mitogen activated protein kinases by NmB 
DC were next assessed for MAPK activity in response to viable and killed 
NmB. MAPKs are important in mediating central aspects of DC maturation, 
and pathogens may inhibit their activation to modulate cytokine production 
and up-regulation of maturation markers (Mittal et al., 2009). Therefore, 
inhibition of MAPKs can prevent effective T-cell responses. To test MAPK 
activation, DC were stimulated with killed NmB or live NmB for various times 
(as indicated in the figure legends) and then lysates were probed for MAPK 
phosphorylation by Western blot. As can be seen in Figure 4-5, it was found 
that both live and killed bacteria activated induced phosphorylation—and 
therefore activation—of the MAPKs ERK, p38 and JNK to similar extents at 2 
and 4h post-stimulation.  
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Figure 4-5 NmB induces the activation of multiple MAPK kinases. DC were 
stimulated with either 10 MOI killed or 10 MOI live NmB (K = killed NmB, L = live 
NmB) for the indicated times and then cellular lysates were probed by Western 
blot for the presence of ERK1/2 (T202/Y204), p38 (T180/Y182) and JNK1/2 
(T183/Y185) phosphorylation. Some DC were left unstimulated and lysed at 4h. β-
actin was used as a loading control. Black boxes indicate cropped blots to depict 
relevant lanes. Data are representative of three independent experiments.  
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Figure 4-6 Kinetics of JNK activation by NmB. DC were stimulated with either 10 
MOI killed or 10 MOI live NmB for up to 5 h, and cellular lysates were taken at the 
indicated time-points. Lysates were then probed for p-JNK and total JNK by 
Western blot. Fold induction (induced p-JNK - background p-JNK) was calculated 
relative to total JNK protein by densitometry using ImageJ software. Data are 
from one donor and representative of two experiments. 
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Since excessive JNK signalling can negatively regulate DC maturation 
(Handley et al., 2005), temporal dynamics of p-JNK was further quantified by 
densitometry, using total JNK protein as a control. As can be seen in Figure 4-
6, both killed and live bacteria induced a strong early signal (0.5 h) that then 
showed sustained activity up to 5 h post-stimulation. 
4.3.4 NmB induces normal activation of standard DC maturation 
pathways 
Several pathways of DC maturation have been reported to decouple cytokine 
production and up-regulation of maturation markers. These include GSK-3, 
which is constitutively active in immature DC and is deactivated upon 
maturation (Rodionova et al., 2007); Src family proteins, which can 
dysregulate aspects of DC maturation via modulation of ITAM-ITIM signalling 
(Napolitani et al., 2003); and Akt signalling, which can be also be modulated 
for the same purpose (Turnquist et al., 2010).  To interrogate these pathways, 
DC were stimulated with killed or live NmB for 4h or 18h, and phospho-
epitopes were probed by Western blot (Figure 4-7).  
Similarly to NF-κB and MAPK signalling, it was found that killed and live NmB 
activated/deactivated these signalling pathways to similar extents during both 
early (4h) and late (18h) maturation, thus implicating a different signalling 
pathway being targeted by live NmB to prevent full DC maturation. 
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Figure 4-7 Live and killed NmB display similar cellular signalling patterns.  DC 
were stimulated with either 10 MOI killed or 10 MOI live NmB (K = killed NmB, L = 
live NmB) for 4 or 18h and then cellular lysates were probed by Western blot for 
the indicated proteins: p-Src family kinases (Y416), p-GSK-3 (S21), p-p65 (S536) 
and p-Akt (S473). Some DC were left unstimulated and lysed at 18h. β-actin was 
used as a loading control. Black boxes indicate cropped blots to depict relevant 
lanes. Data are representative of two (p-Src, p-65, p-Akt) and four (p-GSK3) 
independent experiments. 
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4.3.5 Live NmB infection results in selective tyrosine 
dephosphorylation of STAT1  
Up-regulation of DC maturation markers depends on autocrine IFN signalling 
that activates STAT1. It was therefore hypothesised that live NmB might be 
modulating this pathway to prevent the up-regulation of CD86 and other 
maturation markers. STAT1 binding sites exist in the promoters of the 
maturation markers (Weatherill et al., 2005), and STAT1-KO DC are therefore 
poorly immunogenic in T-cell proliferation assays (Longhi et al., 2009). STAT1 
requires two major post-translational modifications in order to gain canonical 
signalling functions: (1) tyrosine phosphorylation of the Y701 residue, which 
allows it to dimerise and translocate to the nucleus, and (2) serine 
phosphorylation of the S727 residue, which potentiates and primes its full 
activation. 
DC STAT1-Y701 and -S727 phosphorylation was measured by Western blot 
at early (4h) and late (18h) maturation after stimulation with killed and live 
NmB (Figure 4-8). Remarkably, DC infected with live NmB showed virtually 
complete dephosphorylation of STAT1-Y701 at 18h, compared to 
phosphorylation at 4h. DC stimulated with killed NmB retained STAT1-Y701 
phosphorylation at both early and late maturation. By contrast, live NmB 
infection induced strong STAT1-S727 signalling at early (4h) and late (18h) 
maturation. Killed NmB followed the same trend.  
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Figure 4-8 Live NmB induces tyrosine dephosphorylation of STAT1. DC were 
stimulated for indicated times with 10 MOI killed NmB or 10 MOI live NmB (K = 
killed NmB, L = live NmB), and cell lysates were analysed for levels of the 
designated proteins by Western blot. Some DC were left unsitmulated and lysates 
were collected at 18h. STAT1 was used as a loading control. Black boxes indicate 
cropped blots to depict relevant lanes. Data are representative of four (STAT1-
Y701) or three (STAT1-S727 and STAT2-Y690) individual experiments. 
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Moreover, in juxtaposition to STAT1 activation, the activatory tyrosine 690 
(Y690) phosphorylation of STAT2 remained intact after DC exposure to both 
stimuli (Figure 4-8). DC were also tested for STAT3 activation, and STAT3 
tyrosine phosphorylation (Y705) was measured by intracellular PhosFlow after 
stimulation with various stimuli (Figure 4-9). LPS, killed and live NmB all 
induced similar levels of STAT3 phosphorylation (and therefore activation). 
Since Western blots are only semi-quantitative (Gassmann et al., 2009), it 
was decided that intracellular flow cytometry would be utilised in order to 
better quantify STAT1 activity. DC were stimulated with LPS, killed or live 
NmB for 18h and levels of STAT1-Y701 and STAT1-S727 phosphorylation 
were measured intracellularly using a PhosFlow protocol. Consistent with the 
Western blot data (Figure 4-10), LPS and killed NmB induced 1.44- and 1.45-
fold STAT1 p-Y701 induction above an unstimulated control, while STAT1 p-
Y701 induction by live NmB was virtually absent (1.0-fold). This was found to 
be a significant difference (p = <0.001) between live NmB and LPS and killed 
NmB. 
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Figure 4-9 DC infected with live NmB retain STAT3 activation. DC were stimulated 
for 18h with 100 ng/mL LPS (green histogram), 10 MOI killed NmB (blue 
histogram) or 10 MOI live NmB (red histogram) and assessed for STAT1 Y701 
phosphorylation by intracellular PhosFlow flow cytometry. Some DC were left 
unstimulated (grey histogram). MFI values are displayed on the histograms. Data 
are representative of three experiments. 
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Figure 4-10 Live NmB suppresses STAT1 tyrosine phosphorylation in DC. DC 
were stimulated for 18h with 100 ng/mL LPS (green histogram), 10 MOI killed NmB 
(blue histogram) or 10 MOI live NmB (red histogram) and assessed for STAT1-
Y701 phosphorylation by intracellular PhosFlow flow cytometry. Some DC were 
left unstimulated (grey histogram). Left: Data from a representative donor with 
MFI values displayed on the histogram. Right: Combined data from six individual 
donors showing fold-change in p-Y701 STAT1 MFI above the unstimulated 
control. Box-plots depict medians and interquartile ranges. Significance was 
tested by one-way ANOVA with a Bonferroni post-test. *P<0.05, **P<0.01, 
***P<0.001. 
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Figure 4-11 STAT1 serine phosphorylation is sustained in DC infected with viable 
NmB. DC were stimulated for 18h with 100 ng/mL LPS (green histogram), 10 MOI 
killed NmB (blue histogram) or 10 MOI live NmB (red histogram) and assessed for 
STAT1-S727 phosphorylation by intracellular PhosFlow flow cytometry. Some DC 
were left unstimulated (grey histogram). Left: Analysis of STAT1-S727 
phosphorylation at 18h post-stimulation in a representative donor with MFI values  
displayed on the histogram. Right: Calculation of STAT1 Serine:Tyrosine 
phosphorylation ratio  at 18h by the formula (STAT1 p-S272 MFI Fold 
Change/STAT1 p-Y701 MFI Fold Change) in 5 individual matched donors as 
indicated by lines. Significance was tested by paired t-test *P<0.05, **P<0.01, 
***P<0.001. 
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STAT1 p-S727 was also measured by intracellular flow cytometry. DC were 
stimulated with killed or live NmB for 18h and this epitope was quantified. 
Intriguingly, live NmB induced stronger STAT1 p-S727 phosphorylation (MFI: 
29.3) than LPS (MFI: 15.4) or killed NmB (MFI:16.4) (Figure 4-11). A 
comparison of tyrosine:serine STAT1 phosphorylation between killed and live 
NmB also showed that live NmB induced significantly more STAT1-S727 
phosphorylation compared to killed bacteria (p = <0.01). 
STAT1-Y701 phosphorylation is essential for STAT1 dimerisation and 
translocation into the nucleus, and this results in the transcription of STAT1-
dependent genes (Shuai et al., 1993). To confirm that the dephosphorylated 
STAT1 was not inducing target genes, the transcriptional activity of the well-
characterised STAT1-dependent reporter gene IDO1 (Chon et al., 1996) was 
measured by RT-PCR. As Figure 4-12 shows, DC infected with live NmB 
displayed significantly reduced (p = <0.05) levels of IDO1 compared to the 
positive controls LPS and killed NmB. The NF-κB-dependent gene IL8 was 
used as a control, and this showed both early and late IL8 transcription 
induced by live NmB. Notably, live NmB drove significantly stronger (p = 
<0.01) IL8 gene expression than killed NmB and LPS. Therefore, the data 
suggested that STAT1-dependent genes were being transcriptionally 
suppressed by live bacteria. 
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Figure 4-12 Live NmB can suppress STAT1 reporter genes while sustaining NF-κB 
reporter genes. DC were stimulated for the indicated times with 100 ng/mL LPS 
(green), 10 MOI killed NmB (blue) or 10 MOI live NmB (red), and then RNA was 
extracted to quantitatively assess IL8 (NF-κB-dependent gene) and IDO1 (STAT1-
dependent gene) mRNA expression relative to a time 0 (T0) control. Bar graphs 
depict mean averages ± SEM. Data are from four individual donors. Singificance 
was tested by two-way ANOVA with a Bonferroni post-test. *P<0.05, **P<0.01, 
***P<0.001. 
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4.3.6 STAT1 activation correlates with CD86 expression and DC 
maturation 
Interestingly, flow cytometric analysis of CD86lo and CD86hi populations after 
DC were stimulated with live NmB for 18h revealed more STAT1-Y701 
phosphorylation (MFI: 29.8) in the few CD86hi DC (Figure 4-13). This was not 
dependent on which stimulus the DC had received (data not shown). 
Moreover, a Spearman correlation test of raw flow cytometry data (CD86 
fluorescence vs. STAT1-Y701 fluorescence) using FlowJo data analysis 
functions showed a strong correlation (r = 0.56) between STAT1-Y701 
phosphorylation and CD86 expression in individual cells.  
4.3.7 DC infected by live NmB still transcribe interferon 
It was hypothesised that viable NmB may have been preventing normal 
STAT1 activation by disrupting the autocrine IFN loop that DC require for 
maturation. To test this, DC were stimulated for 4 and 18h with LPS, killed 
and live NmB and then IFNB and IFNG mRNA transcripts were measured by 
RT-PCR (Figure 4-14). Remarkably, DC infected with live NmB were actively 
producing much more IFN transcripts than either LPS or killed NmB. At 4h, 
live NmB induced >2000-fold induction of IFNB compared to the unstimulated 
T0 control, and significantly more than LPS (p = < 0.001) and killed NmB (p = 
< 0.01) at the same time-point.  
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Figure 4-13 DC CD86 expression correlates with STAT1 Y701 phosphorylation. 
Top: DC were gated on CD86lo and CD86hi populations and assessed for STAT1-
Y701 phosphorylation by intracellular PhosFlow flow cytometry after 18h 
infection with 10 MOI live NmB. MFI values are displayed on the histogram. 
Bottom: >59,000 DC infected with 10 MOI live NmB for 18h from a representative 
donor of six were analysed by PhosFlow flow cytometry for raw CD86 and STAT1-
pY701 flouresence values (Y and X axes, respectively). Correlation (r) and 
significance of pairing (p) was measured using a Spearman's rank test. 
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Figure 4-14 DC infected with live NmB still transcribe type I and type II IFNs. DC 
were stimulated for the indicated times with 100 ng/mL LPS (green), 10 MOI killed 
NmB (blue) or 10 MOI live NmB (red), and then RNA was extracted to 
quantitatively assess IFNB and IFNG mRNA expression relative to a time 0 (T0) 
control. Bar graphs depict mean averages ± SEM. Data are from four individual 
donors. Singificance was tested by two-way ANOVA with a Bonferroni post-test. 
*P<0.05, **P<0.01, ***P<0.001. 
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These data were very surprising, since these two cytokines are extremely 
potent inducers of STAT1 signalling, and late-phase Y701 dephosphorylation 
was observed at the same time-point of excess IFN production. This 
suggested a very potent inhibitory signal being delivered to STAT1, in order to 
over-ride these positive cytokine signals. 
To exclude the possibility that IFN was being transcribed but not secreted, DC 
were also primed for 2h with IFN-β and IFN-γ before infection with live 
bacteria. Despite priming with both cytokines (Figure 4-15), DC infected with 
live NmB were still unable to up-regulate CD86 in response to live bacteria, 
while uninfected DC were activated by the IFN priming, thus suggesting an 
active blockade of STAT1 activation rather than a lack of signal per se. 
4.3.8 Live NmB induces IFN hyporesponsiveness in DC 
DC were next tested for active hyporesponsiveness to brief IFN pulsing during 
the late maturation phase. At 18h post-stimulation, DC were pulsed with a 
high dose of IFN-γ, which is a potent STAT1 activator (Figure 4-16). 
Unstimulated, LPS- and killed NmB-treated DC all showed a strong induction 
of STAT1-Y701 phosphorylation after 15 mins of stimulation (51.2%, 86.5% 
and 83.6% respectively), while DC infected with live NmB showed blunted 
tyrosine phosphorylation (27.6%). This was found to be a significant trend 
between multiple donors (p = <0.01 killed NmB vs live NmB). 
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Figure 4-15 IFN priming is insufficient to restore DC maturation upon infection 
with live NmB. DC were primed for 2h with either 20ng/mL IFN-β or 20 ng/mL IFN-
γ and then some DC were stimulated for 24h with 10 MOI live NmB (red), alone or 
in combination with exogeneous IFN, or left unstimulated (grey). Surface CD86 
expression was assessed by flow cytometry. MFI values are shown on the 
histograms. Data are representative of three experiments; two different donors 
are shown for each cytokine. 
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Figure 4-16 DC are hyporesponsive to IFN pulsing after infection with NmB. DC 
were stimulated with 100 ng/mL LPS (green), 10 MOI killed NmB (blue) or 10 MOI 
live NmB (red) for 18h and then pulsed with 10 ng/mL IFN-γ for 15m. Some DC 
were left unstimulated (grey). Cells were then fixed and permeabilised and 
STAT1-Y701 phosphorylation was measured by intracellular PhosFlow flow 
cytometry. Left: Data from one representative donor, with gates showing 
percentage of 'STAT1 responders' as set by the unstimulated control.  Right:  
Combined data from three donors showing percent responsive DC to IFN-γ 
pulsing. Bars depict mean averages ± SEM. Significance was tested by one-way 
ANOVA with a Bonferroni post-test. *P<0.05, **P<0.01, ***P<0.001. 
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4.3.9 JAK kinase signalling is intact in DC infected with live NmB 
In order to induce STAT1 phosphorylation, IFN must bind to its cognate IFN 
receptor and cause JAK kinase activation. These JAK kinases (JAK1, JAK2 
and Tyk2) are bound to the IFN receptor and directly phosphorylate STAT 
proteins. Therefore, their activation (i.e. phosphorylation) was examined by 
Western blot. This would inform as to whether the IFN receptor was fully 
functional, as these kinases are the immediate downstream effectors of the 
cytokine-IFN receptor interaction. 
DC were stimulated for 18h with either killed NmB or live NmB, and cell 
lysates were probed for phosphorylation of JAK1, JAK2 or Tyk2 by Western 
blot (Figure 4-17). Interestingly, there were similar levels of phosphorylation 
induced by killed an live bacteria for p-JAK1, while there appeared to be more 
phosphorylation of p-JAK2 induced by live NmB. There were multiple bands 
detected for p-JAK2, which may reflect both the antibody polyclonality (e.g. 
binding multiple phosphate groups) and that JAK proteins undergo heavy 
post-translational modification (e.g., polyubiquitination) in response to 
cytokine signalling (Ungureanu et al., 2002). Tyk2 was also similarly activated 
by killed and live bacteria, and in some donors there was a trend for live NmB 
to induce stronger phosphorylation of this protein, which is consistent with the 
enhanced levels of IFN production induced by live bacteria. 
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Figure 4-17 DC infected with live NmB retain JAK kinase activation. DC were 
stimulated for indicated times with 10 MOI killed NmB or 10 MOI live NmB (K = 
killed NmB, L = live NmB), and cell lysates were analysed for levels of the 
designated proteins by Western blot (p-JAK1 Y1022/Y1023, p-JAK2 Y1007/Y1008, 
p-Tyk2 Y1054/Y1055). Some DC were left unsitmulated and lysates were collected 
at 18h. JAK1 was used as a loading control. Black boxes indicate cropped blots 
to depict relevant lanes. Data are representative of three experiments. 
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4.3.10 Live NmB infection leads to suppression of SOCS protein 
expression 
SOCS proteins are homeostatic molecules that negatively regulate the IFN 
and TLR pathways. SOCS1 and CISH1 (also known as CIS) are transcribed 
in response to STAT1 signalling (Lejeune et al., 2001), while SOCS3 can be 
induced by NF-κB or STAT3 signalling pathways (Pauli et al., 2008). These 
proteins can prevent the phosphorylation of STAT proteins by occluding the 
JAK-IFN receptor interaction or the JAK-STAT interaction. 
It was hypothesised that live NmB may be inducing these proteins to block 
STAT1 signalling and prevent DC maturation. To test this, DC were stimulated 
for 4h and 18h with LPS, killed or live NmB and SOCS1, SOCS3 and CISH 
mRNA was measured by RT-PCR (Figure 4-18). There was an observed 
trend of SOCS1 down-regulation by live NmB at 18h compared to positive 
controls, while there was a significant suppression of CISH1 gene expression 
at 18h (p  = <0.05 killed NmB vs. live NmB). SOCS3 was similar amongst all 
conditions tested. SOCS1 protein levels were further validated by Western 
blot, and there was a clear reduction in SOCS1 protein levels induced by live 
NmB infection. Therefore, SOCS proteins were in fact reduced by live NmB, 
excluding these molecules as the drivers of STAT1 dysregulation. 
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4.3.11 JAK-STAT signalling is required for DC maturation in response to 
meningococcal antigens 
A recent vaccinology study reported that the meningococcal vaccine 
Menomune, which consists of bacterial antigens (i.e. polysaccharides), 
activates that JAK-STAT pathway in human DC and induces a robust 
maturation response (Banchereau et al., 2014). Since live NmB was 
interfering with this pathway, It was questioned whether this signalling axis 
was important for the up-regulation of maturation markers in response to 
NmB. To test this, DC were stimulated with killed NmB for 18h in the presence 
of the JAK inhibitor tofacitinib or the NF-κB inhibitor BAY-11-7085 and CD40 
and CD86 up-regulation were measured. As Figure 4-19 shows, tofacitinib 
exerted a strong negative effect on up-regulation of maturation markers, and 
this effect was dose-dependent, with a maximal suppression at 500 μM. In 
contrast, BAY-11-7085 had only a minimal effect on maturation marker 
expression, highlighting the requirement for the IFN signalling axis for full DC 
maturation in response to NmB. 
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Figure 4-19 The IFN pathway is an important determinant of DC maturation 
responses to meningococcal antigens. DC were stimulated with 10 MOI killed 
NmB (blue shaded histogram) for 24h in the presence of the NF-κB inhibitor 
BAY11-7085, the JAK inhibitor tofacitinib or a vehicle control (0.5% DMSO). Some 
DC were left unstimulated (grey histogram). DC were then assessed for 
expression of CD40 and CD86 by flow cytometry. MFI values are displayed on the 
histogram. Data are representative of two experiments.  
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4.4 Discussion 
The data in this chapter support the concept of live NmB modulating a critical 
signalling path in DC maturation. While nearly all examined pathways had 
equivalent activation, there was differential induction of STAT1 signalling, 
likely mediated by the Y701 dephosphorylation. This led to IFN 
hyporesponsiveness in the DC that was linked to inhibition of maturation. 
Unlike previous reports, it was found that FCS induced higher lentivirus 
transfection rates and was less immunogenic than human serum. There are 
several reasons why these results may differ from those previously published. 
Human serum can contain varying amounts of contaminants such as platelets 
(Tammen et al., 2005), which can secrete bioactive chemokines and 
cytokines and also express CD40L (Henn et al., 1998), which are all potent 
inducers of DC maturation. It is known that gravitational forces (i.e. 
centrifugation) can activate immune cell signalling pathways (Verhaar et al., 
2014). It is possible that the harsh centrifugation of blood using an 'in-house' 
method may have activated contaminating platelets and resulted in the 
maturation of DC. Moreover, activated DC are much more resistant to 
lentiviral transfection. This is because activated DC up-regulate virus 
resistance factors upon sensing viral PAMPs (Cella et al., 1999). It is 
therefore plausible that this is why DC matured by autologous serum had 
lower rates of viral transfection. 
Using a lentivirus NF-κB reporter and IκB-α degradation assays, it was 
demonstrated that killed and live bacteria activated this pathway to similar 
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extents. Given that DC stimulated with killed and live NmB both induce a 
potent inflammatory response (i.e. TNF-α, IL-1β and IL-6 secretion), it is 
logical that NF-κB was found to be activated by both of these stimuli. 
However, while NF-κB is important for DC maturation, the extent to which it 
contributes towards a fully mature phenotype remains complex. The use of 
NF-κB inhibitors and MyD88-deficient mutant cells suggests that the early NF-
κB response predominantly induces cytokine signalling. However, some 
studies on CD40 transcriptional regulation have revealed a need for NF-κB 
'priming' at the enhancer elements of the promoter region, followed by late-
phase STAT1 association induced by autocrine IFN (Qin et al., 2005). 
Similarly, the CD86 promoter contains both NF-κB and STAT1 binding 
elements (Weatherill et al., 2005), despite TRIF signalling being reported the 
main driver of co-stimulatory molecule expression (Kolb et al., 2014). The 
extent to which certain DC genes depend on MyD88 or TRIF signalling, 
however, may ultimately depend on the TLR stimulus used, and there is 
undoubtedly synergism involving both pathways. 
NF-κB signalling in response to a stimulus such as LPS is usually biphasic, 
consisting of an early and late-phase response — the latter being primarily 
due to autocrine effectors (Kawai and Akira, 2007). The data do not 
completely eliminate the possibility that live NmB could be interfering with the 
late-phase NF-κB pathway. Indeed, the NF-κB assays mainly focused on the 
early response as a read-out for TLR engagement. However, this possibility is 
unlikely for three reasons. Firstly, p65 showed similar phosphorylation 
between killed NmB and live NmB at the 18th time-point. Secondly, flow 
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cytometric analysis of late maturation also confirmed this finding. And thirdly, 
IL8 transcription (which is NF-κB dependent) was robustly induced by live 
bacteria during late maturation. Therefore, it can be inferred from the data that 
the NF-κB pathway was normally induced by live bacteria, excluding this as a 
mechanism of DC modulation. 
MAPK activation was also sustained by live NmB, with equivalent kinetics in 
JNK activation in particular. MAPKs are required for diverse aspects of DC 
maturation — inhibition of any of the three can result in an aberrant phenotype 
(Nakahara et al., 2006). The observation that N. meningitidis can activate 
MAPKs in DC is consistent with reports in the literature of the bacterium 
activating these pathways in brain endothelial cells, leading to pro-
inflammatory cytokine release (Sokolova et al., 2004). Notably, some 
background activation of ERK was detected in the unstimulated control. This 
was likely due to the presence of growth factors (e.g. EGF) in the DC growth 
media resulting in baseline MAPK activation, since this has previously been 
reported in other cell types (Nakao et al., 2002). Background levels of p65 
phosphorylation and NF-κB transcription were also observed. Interestingly, a 
study by Kanada et al. (2011) found that there was a constitutive level of NF-
κB bound to the CD86 promoter in unstimulated DC (Kanada et al., 2011). It 
may be surmised that there is a basal level of constitutive NF-κB activity in 
cultured DC, which may be required for low-level transcription of certain 
molecules, and that these data are therefore consistent with previous findings. 
Even in an immature state, DC contain relatively high levels of CD86 and 
other co-stimulatory molecules compared to other immune cells. 
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DC also had normal activation of Akt and Src proteins upon infection with live 
bacteria, which are important for DC maturation. In addition, the inhibitory 
serine/threonine kinase GSK-3 was phosphorylated and therefore deactivated 
by positive controls and live NmB. GSK-3 plays a central role in integrating 
metabolic signalling pathways and coupling cytokine production with up-
regulation of maturation markers in DC (Alessandrini et al., 2011; Rodionova 
et al., 2007; Turnquist et al., 2010). Therefore, it may be considered a central 
checkpoint of DC maturation, connecting the PI3K-Akt, Wnt and TLR 
signalling axes. The observation that GSK-3 was undergoing similar 
repression by all stimuli tested would suggest that live NmB was targeting a 
very specific pathway downstream of most effector kinases. 
Strikingly, analysis of the STAT proteins revealed a stark difference in STAT1 
Y701 phosphorylation induced by live and killed bacteria. STAT1-Y701 was 
virtually dephopshorylated by live NmB at 18h, while there was still strong 
phosphorylation induced by stimulation with killed NmB. This effect was 
specific to the tyrosine residue, as STAT1-S727 was strongly phosphorylated 
by live bacteria. This activation state of STAT1 (pY701-off/p-S727-on) has 
been described in the literature as 'alternative activation' (Schroder et al., 
2007), and to the author's knowledge, has not been described in relation to a 
specific pathogen before. STAT1-Y701 is essential for STAT1 dimersation 
and nuclear translocation (Shuai et al., 1993b), and in agreement with this, it 
was found that classic STAT1 reporter genes such as IDO1 were down-
regulated in live NmB-infected DC. STAT2 and STAT3 were also unaffected 
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in these cells, showing equivalent phosphorylation patterns between killed 
and live bacteria.  
Paradoxically, the apparatus of the IFN pathway was fully functional as far as 
the data indicated. DC transcribed even higher amounts of IFNB and IFNG 
upon infection with live NmB compared to positive controls, and the JAK 
kinases were also fully activated. The STAT1-dependent SOCS genes 
SOCS1 and CISH were not fully up-regulated by live NmB compared to killed 
NmB, which excluded these as the drivers of the IFN signalling blockade, but 
failed to explain why STAT1 was not fully phosphorylated upon IFN-γ pulsing. 
SOCS3, which is dependent on STAT3 and NF-κB signalling (Lejeune et al., 
2001; Pauli et al., 2008), showed no significant difference between killed and 
live NmB. Thus, STAT1 was being precisely and selectively targeted by live 
NmB to a single residue, resulting in dephosphorylation despite relatively 
higher amounts of autocrine IFN and lower amounts of negatively regulating 
SOCS proteins. What remains unresolved from these data is how DC infected 
with live NmB transcribed higher levels of IFN genes and also pro-
inflammatory cytokines. However, this may be explained by data in the 
literature demonstrating that SOCS proteins (and in particular SOCS1) can 
negatively regulate both the IFN and TLR pathways (Baetz et al., 2004). In 
human DC, RNA silencing of SOCS1 alone causes massively enhanced 
cytokine production (Hong et al., 2009), and similar results have been found in 
vivo (Shen et al., 2004). Therefore, failure to up-regulate SOCS proteins by 
live NmB—presumably because of STAT1 tyrosine dephosphorylation—is 
likely to cause dysregulated pro-inflammatory cytokine production in DC. 
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STAT1 is a major target of viruses, given its pivotal role in anti-viral immunity 
(Goodbourn et al., 2000). However, few bacteria have been shown to 
manipulate this pathway. Currently, no Neisserial species has been 
demonstrated to target this signalling axis, and so these data are the first 
description of such a bacterium modulating host immunity in this particular 
way. STAT1 is essential for DC functions, but most of this work has been 
performed using murine cells.  In mice, IFNAR1-/- (Longhi et al., 2009) or 
STAT1-/- (Johnson and Scott, 2007) DC fail to up-regulate CD86 or other 
maturation markers upon TLR stimulation. Consistent with these findings, the 
data herein indicating that IFN-β and IFN-γ alone could induce CD86 up-
regulation, combined with the data showing the correlation between STAT1-
pY701 and CD86 expression, would strongly support the conclusion that both 
human and mouse DC require an IFN-derived STAT1 signal to up-regulate 
maturation markers. 
In further support of this, the pan-JAK inhibitor tofacitinib was used to block 
autocrine IFN signalling in response to killed NmB. Tofacitinib is a well-
characterised inhibitor that has previously been shown to potently suppress 
STAT1-Y701 phosphorylation and therefore reduce DC maturation marker 
expression (Kubo et al., 2013). In the present study, it was found that 
tofacitinib potently reduced CD40 and CD86 up-regulation in response to 
inactivated NmB, while the NF-κB inhibitor BAY 11-7085 had only a modest 
effect in reducing the expression of these molecules.  
Tofacitinib was selected to inhibit the JAK-STAT pathway for a number of 
important reasons. While many excellent inhibitors exist for STAT3 due to its 
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role in oncogenesis, STAT1 is traditionally been considered a less attractive 
target for inhibition, since its role in cancer is pro-apoptotic (Avalle et al., 
2012). Fludarabine has been suggested as a selective inhibitor of STAT1 
(Frank et al., 1999), however the data are controversial. Some studies 
suggest that fludarabine is ineffective in preventing STAT1 activation (Hanafi 
et al., 2014; Martinez et al., 2006), while others determine that fludarabine 
may in fact enhance STAT1-Y701 phosphorylation (Youlyouz-Marfak et al., 
2007).  
From these data, it may be suggested that the TRIF-dependent autocrine IFN 
axis may be more important than NF-κB signalling for up-regulation of 
maturation markers in response to meningococcal antigens. An important 
caveat to consider is that these inhibitors have varying potencies and 
toxicities, and so an exact comparison between the two pathways would be 
difficult to achieve in human cells.  
Another limitation with these data is the lack of information about maturation 
markers besides CD86 for certain assays. However, CD86 was chosen as a 
good candidate molecule for DC maturation in these assays for two reasons: 
(1) CD86 has a large MFI increase upon maturation (see Chapter 3), thus 
making it a sensitive marker of DC activation, and (2) at the time of performing 
the experiments, few antibodies for DC maturation markers had been 
experimentally validated for intracellular PhosFlow. The harsh methanol 
fixation required for measuring intracellular STAT1 phosphorylation destroys 
many protein epitopes, and thus CD40 staining while assessing STAT1 
phosphorylation would not have been possible with commercially available 
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antibodies. However, CD86, CD40 and HLA Class I & II are tightly co-
regulated, and are all up-regulated in response to IFN (data not shown). 
Therefore, it can be assumed that CD86 expression is representative of 
general maturation marker regulation.  
Collectively, these data suggest a mechanism by which NmB can elegantly 
manipulate DC signalling pathways by a precise modification of a single 
transcription factor. The findings in this chapter strongly indicate that live 
meningococci induce a highly specific tyrosine dephosphorylation of STAT1, 
blocking IFN signal transduction, and resulting in selective inhibition of 
maturation marker up-regulation. By contrast, NF-κB signalling was normal, 
and this may explain the earlier finding of sustained cytokine production. 
These data therefore provide a mechanism for the de-coupling of cytokine 
production and the up-regulation of DC maturation markers by the 
meningococcus. And lastly, these data support the paradigm of evidence in 
the literature that NF-κB is necessary, but not sufficient, for DC maturation. 
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5 Chapter 5: N. meningitidis impairs DC 
immunological functions 
5.1 Introduction 
A common misconception in the field of DC immunobiology is that phenotypic 
maturation (either the expression of maturation markers, or the production of 
pro-inflammatory cytokines) will result in effective immune responses (Reis e 
Sousa, 2006). Indeed, mature DC expressing high levels of co-stimulatory 
molecules and antigen presentation molecules can paradoxically induce 
tolerogenic T-cell responses in vivo in some circumstances (Albert et al., 
2001). The ability of DC to induce T-cell proliferation and differentiation 
depends on a number of competing positive (e.g. CD80/CD86) and negative 
(e.g. PD-L1) signals. Some of these DC-T-cell receptor molecules have poorly 
defined function. For example, there are conflicting reports regarding the role 
of PD-L2 in T-cell stimulation, specifically as to whether it has a positive (Gao 
et al., 2013) or negative (Pfistershammer et al., 2006) role in cellular 
immunity. It is therefore necessary to test the ability of immature or mature DC 
to induce T-cell responses, as immunogenicity cannot always be inferred from 
phenotypic data. 
DC are the most potent APC at driving T-cell responses, and are able to 
robustly polarise naive CD4+ T-cells into various subsets. The surface 
expression of DC maturation markers is the most critical requirement for this 
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process to occur, as T-cell proliferation and polarisation can still be induced 
independently of cytokine production (Jankovic et al., 2002). The exact 
repertoire of positive and negative co-stimulatory molecules determines 
whether DC-mediated T-cell stimulation occurs. For example, high levels of 
PD-L1 and low levels of B7 co-stimulatory molecules on DC are associated 
with T-cell anergy. This ratio has been noted in chronic viral infections 
(Benedict et al., 2008; Zheng et al., 2014), and is posited as a method by 
which pathogens may induce immunological 'exhaustion', thus allowing 
microbial persistence in the host. Moreover, M. tuberculosis can also induce 
PD-L1hiCD86lo DC in mice, and these are associated with cellular immune 
function impairment at the site of chronic bacterial infection (Schreiber et al., 
2010). S. typhimurium can also limit T-cell responses in murine models of 
autoimmunity by enhancing the expression of PD-L1 on DC (Newland et al., 
2011). Notably, this is independent of TREG induction and appears to be a 
direct immunosuppressive effect of the DC on immune cells. 
Another important aspect of DC maturation is the ability to elicit active 
immunological tolerance. DC are capable of inducing TREG expansion by 
secretion of anti-inflammatory cytokines, thus causing T-cells to express 
FOXP3. Probiotic bacteria can modulate DC to express high levels of IL-10, 
TGF-β and IDO, thus causing an expansion of FOXP3+ TREG and an 
amelioration of mucosal inflammatory responses (Kwon et al., 2010). 
Therefore, there are diverse mechanisms by which microbes can program DC 
to either evade or manipulate cellular immunity. 
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T-cell responses (i.e. cellular immunity) to N. meningitidis have received much 
less research attention than B-cell responses, as the presence of serum 
bactericidal antibody is essential for protection against N. meningitidis. . In 
fact, the 'gold standard' test for assessing protective immune responses to the 
meningococcus is the serum bactericidal assay (SBA) (Borrow et al., 2005). 
However, it has been postulated that this assay may in fact underestimate 
protective immunity to N. meningitidis (Welsch and Granoff, 2007). While B-
cells are responsible for antibody production, many B-cell functions, such as 
immunoglobulin class switching, require T-cell help. T-cell dependent antigens 
(such as outer membrane proteins) are not able to directly stimulate B-cells, 
and therefore require a B-cell-T-cell interaction.  
T-cells are important for protection against mucosal pathogens because they 
secrete cytokines that prime the epithelium to resist microbial threats (Pappu 
et al., 2012), and also because they recruit front-line phagocytes such as 
neutrophils to the site of infection (Appelberg, 1992). Furthermore, T-cells can 
induce B-cell IgA secretion as a general protective mechanism in the mucosal 
tissue (Bemark et al., 2012). It has been noted that T-cell deficiency in cases 
of primary immunodeficiency or secondary infection has resulted in an 
increased risk of meningococcal disease (Cohen et al., 2010; Foster et al., 
2010). Therefore, cellular immunity may play an important protective role in 
host resistance to the meningococcus. 
A second important DC function is the ability to undergo chemotaxis and 
migrate. DC maturation is accompanied by an up-regulation of the surface 
marker chemokine receptor 7 (CCR7) (Hansson et al., 2006). CCR7 is a 
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major chemokine receptor that binds to chemokine C-C motif chemokine 19 
(CCL19), which is a constitutively expressed chemokine present in the 
lymphatic system (Gunn et al., 1999). Ergo, DC that are fully activated can 
respond to this messenger cue and migrate to lymph nodes to present antigen 
to T-cells. 
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5.2 Aims and Objectives 
The aim of this chapter was to define and characterise DC function after 
infection with NmB. To do this, in vitro immunological assays were used. 
These assays measured chemotaxis, CD4+ T-cell proliferation and CD4+ T-
cell differentiation. The hypothesis was that live NmB would prevent effective 
T-cell proliferative functions in DC. 
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5.3 Results 
5.3.1 Live NmB suppresses the up-regulation of CCR7 
CCR7 is an important receptor for the migration of DC to lymphatic tissue. DC 
were tested for CCR7 surface expression in response to various conditions. 
DC were stimulated with LPS, killed NmB and live NmB for 24h and surface 
expression of CCR7 was measured by flow cytometry. As Figure 5-1 shows, it 
was found that both LPS and killed NmB induced an increase in the 
percentage of CCR7+ DC (39.8% and 35.2%, respectively); this was also 
reflected in an increase in MFI (7.03 MFI and 6.55 MFI, respectively). Live 
NmB inhibited CCR7 expression (23.2%), and there was also an inhibition of 
MFI up-regulation (4.22 MFI) compared to LPS and killed NmB. Therefore, the 
expression of CCR7 followed a similar pattern to other maturation markers, 
such as CD40 and CD86. 
5.3.2 DC infected with live NmB have impaired chemotactic responses 
to CCL19 
Given the suppression of CCR7 expression induced by live NmB, it was 
questioned whether this would result in DC that were unable to migrate in 
response to the CCR7 ligand, CCL19. To test this, an in vitro DC migration 
assay was used, based on a previously published methodology with some 
modifications (Bouma et al., 2007).  
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3.51 
4.22 
6.55 
7.03 
CCR7 
Figure 5-1 Live NmB induces reduced expression of CCR7 on DC compared to 
killed NmB or LPS. DC were stimulated with 100 ng/mL LPS (green), 10 MOI killed 
NmB (blue) or 10 MOI live NmB (red) for 24h. Some DC were left unstimulated 
(grey). Surface expression of CCR7 was then measured by flow cytometry. Left: 
Representative donor showing CCR7 MFI displayed on the histogram. Right: 
Representative donor showing percentage CCR7+ DC; gating was determined by 
an unstained control. Data are representative of three experiments 
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Figure 5-2 DC infected with live NmB are hyporesponsive to CCL19 in an in vitro 
chemotaxis assay. DC were stimulated for 24h with 100 ng/mL LPS (green), 10 
MOI killed NmB (green) or 10 MOI live NmB (red). Some DC were left unstimulated 
(grey). DC were then washed with complete media containing 100 U/mL 
penicillin/streptomycin and 2 x 105 DC were loaded into the upper compartment of 
a 8 μm pore transwell. In the lower compartment were various concentrations of 
CCL19. After 5h, migratory DC in the lower compartment were then counted by 
haemocytometer in duplicate. Data are from three experiments. Significance was 
tested by two-way ANOVA with a Bonferroni post-test.  * p < 0.05 ** p < 0.01 *** p < 
0.001 
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DC were first stimulated with LPS, killed NmB or live NmB for 24h. Then, DC 
were washed in antibiotic-containing media, counted and re-seeded in the 
upper chamber of an 8 μm pore transwell. In the bottom chamber, increasing 
concentrations of CCL19 were used, alongside a negative control with no 
CCL19. DC were then allowed to migrate for 5h, and the migrated DC in the 
lower chamber were quantified by haemocytometer.  
As expected, it was found that DC stimulated with LPS or killed NmB were 
able to migrate the most at 500 ng/mL CCL19 (mean average 6.9 x 104  and 
4.7 x 104 DC, respectively). This was a significant difference (p = <0.001) 
compared to the unstimulated control for both conditions. DC infected with live 
NmB had no significant difference compared to the unstimulated control at 
any concentration of CCL19. Therefore, good correlation was shown for 
CCR7 expression and DC migration to CCL19. 
5.3.3 LPS can Induce T-cell Proliferation via DC 
There are numerous protocols to assess the ability of DC to stimulate T-cell 
proliferation. In vitro DC-mediated T-cell responses are subject to a high 
number of variables, such as ratio, co-stimuli and kinetics (Langenkamp et al., 
2000), which  can critically influence the potency and phenotype of the T-cell 
response. Therefore, to investigate the potential of DC to induce T-cell 
responses after infection with live NmB, an optimisation experiment using 
bacterial antigen (LPS) was first performed to determine the best conditions 
with which to base further proliferation experiments. 
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CD4+ T-cells can respond to anti-CD3 antibodies (which mimic an MHC-
peptide signal (Verma et al., 2010)), super-antigens (which bind the TCR β 
chain and MHC Class II (Herman et al., 1991)) and allogeneic MHC (due to 
the high affinity of the TCR for MHC molecules generally (Felix and Allen, 
2007)). These co-stimuli were tested in an in vitro DC-T-cell co-culture model 
under various conditions. First, DC were stimulated with LPS for 24h and then 
washed and re-counted. DC were then co-cultured with CFSE-labelled 
allogeneic highly-purified (>96%) CD4+ T-cells at different ratios for 5 days, 
and T-cell proliferation was measured by flow cytometric analysis. 
The data show that for all conditions, a higher ratio of DC:CD4 T-cell was able 
to induce stronger proliferative responses. Also for all conditions, the use of 
SEB superantigen or soluble α-CD3 antibody was able to induce much 
stronger T-cell responses than the control without an added co-stimulus. For 
example, at a 1:1 ratio, unstimulated DC were able to induce 39.6% 
proliferation without a co-stimulus, but were able to induce 96.5% and 91.1% 
proliferation when the α-CD3 or superantigen was added to the co-culture. DC 
stimulated with LPS were also able to generally induce more T-cell 
proliferation than unstimulated DC. At a 1:1 ratio, DC stimulated with LPS 
before co-culture could induce 16.4% more proliferation than the unstimulated 
control. 
Based on these data, it was decided that allogeneic co-cultures without the 
use of co-stimuli would be used for all further proliferation experiments, as the 
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inclusion of α-CD3 or SEB induced near-maximum T-cell division even with 
unstimulated DC.  
5.3.4 DC infected with live NmB show reduced allostimulatory capacity 
It was hypothesised that DC infected with live NmB would not induce strong 
T-cell proliferative responses, since DC maturation markers are critical for 
delivering co-stimulatory signals. To investigate this, DC were stimulated for 
24h with LPS, killed NmB or live NmB and then washed in antibiotic-
containing media, re-counted and co-cultured with allogeneic CFSE-labelled 
CD4+ T-cells at a range of ratios. Some DC were cultured alone and checked 
for cell death for 4h after the initial antibiotic wash, and there was found to be 
no apoptosis during this period for any condition (data not shown). On day 5 
of the co-culture, CD4+ T-cells were assessed for proliferation using flow 
cytometry, by gating on the CFSEdim population. The percentage of cell 
division relative to the unstimulated control was then calculated. 
Interestingly, at 1:2, 1:5 and 1:10 DC:CD4+ T-cell ratios, DC infected with live 
NmB showed significantly reduced levels of induced T-cell proliferation 
compared to LPS and killed NmB (p = <0.01). At the 1:2 DC:CD4+ T-cell ratio, 
LPS and killed NmB induced 70% and 76% more proliferation than the 
unstimulated control, respectively. By contrast, live NmB induced -16% 
proliferation compared to the unstimulated control. Therefore, live NmB was 
able to actively suppress T-cell responses at a range of ratios, whereas the 
positive controls LPS and killed NmB enhanced T-cell proliferation. 
The immunomodulation of dendritic cells by N. meningitidis 
 
198 
Figure 5-4 DC infected with live NmB induce poor CD4+ T-cell proliferative 
responses at a variety of ratios. DC were stimulated for 24h with 100 ng/mL LPS 
(green), 10 MOI killed NmB  (blue) or 10 MOI live NmB (red); some DC were left 
unstimulated. DC were then washed in complete media containing 100 U/mL 
penicillin/streptomycin and and re-counted, and seeded at 5 x 104 in a 96-well 
plate with 1:2, 1:5 or 1:10 allogeneic CFSE labelled purified CD4+ T-cells for five 
days.  T-cell division was then measured on day 5 by flow cytometry, using 
CFSEdim cells as an indicator of proliferation. Data are shown as percentage 
induction relative to the unstimulated control using the formula [(%CFSEdim 
stimulus - %CFSEdim unstimulated control) / %CFSEdim unstimulated control x 
100] Data are from four individual donors. Significance was tested by two-way 
ANOVA with a Bonferroni post-test. * p < 0.05 ** p < 0.01 *** p < 0.001 
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5.3.5 PD-L1 up-regulation by live NmB can be suppressed by inhibiting 
the MAPKs 
Since live NmB seemed to be actively suppressing the induction of T-cell 
proliferation, it was speculated that the selective up-regulation of PD-L1 (see 
Chapter 3) might be actively inhibiting T-cell division. Therefore, it was first 
seen whether PD-L1 up-regulation by live NmB could be prevented, in order 
to test this hypothesis. 
It has been reported that PD-L1 up-regulation on APCs is driven by MAPK 
signalling (Wölfle et al., 2011), therefore this signal transduction pathway was 
interrogated. ERK (via MEK), p38 or JNK were inhibited with the following 
inhibitors: PD 325901, SB 203580 or SP 600125. The remaining DC were 
cultured in a vehicle control (0.5% DMSO). DC were then infected with live 
NmB. As can be seen in Figure 5-5, the inhibition of all three MAPKs 
suppressed PD-L1 up-regulation in response to live NmB infection to various 
extents. With MEK inhibition, PD-L1 was lowered from 1225 MFI to 703 MFI; 
with p38 inhibition 1225 MFI to 492 MFI, and with JNK inhibition 1225 MFI to 
328 MFI. Therefore, JNK was the most potent at inducing PD-L1 expression. 
When tested in multiple donors, there was a significant trend for JNK inhibition 
to greatly reduce PD-L1 expression induced by live NmB (p = < 0.01). From 
these data, it can be concluded that live NmB utilised MAPKs to induce PD-L1 
expression. 
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Figure 5-5 The up-regulation of PD-L1 by live NmB depends on MAPK signalling. 
DC were stimulated for 24h with 10 MOI live NmB in the presence of a vehicle 
control (0.5% DMSO). For some conditions, DC were infected in the presence of 
10 μM MEK inhibitor (MEKi) (PD 325901), 10 μM  p38 inhibitor (p38i) (SB 203580) 
or 10 μM  JNK inhibitor (JNKi) (SP 600125). Some DC were left unstimulated. 
Surface expression of PD-L1 was then assessed by flow cytometry. Left: 
Histogram showing unstimulated DC (grey), live NmB-infected DC (red), and live 
NmB-infected DC in the presence of various inhibitors (red unshaded). MFI values 
are displayed on the histogram. Data are from a representative donor. Right:  
Pooled data from six individual donors showing PD-L1 MFI in response to live 
NmB, either in the presence of a vehicle control (0.5% DMSO) or 10 μM JNKi. Box-
plots depict medians and interquartile ranges. Significance was tested by paired 
t-test. * p < 0.05 ** p < 0.01 *** p < 0.001 
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5.3.6 PD-L1 inhibition can enhance T-cell proliferation induced by DC 
infected with live NmB 
The extent to which selective PD-L1 up-regulation contributed towards the 
suppression of CD4+ T-cell proliferation was next investigated. It was 
hypothesised that inhibition or blockade of PD-L1 might enhance the T-cell 
responses induced by DC infected with live NmB. 
DC were stimulated for 24h with LPS, killed NmB or live NmB and then 
washed in antibiotic-containing media, re-counted and co-cultured with 
allogeneic CFSE-labelled CD4+ T-cells at a range of ratios. For some 
conditions, DC were also cultured with a JNK inhibitor (SP 600125) during 
infection. For other conditions, a PD-L1 blocking antibody was used during the 
entirety of the co-culture. As can be seen in Figure 5-6, live NmB induced 
poor T-cell proliferative responses compared to LPS and killed NmB (9% vs 
68.1% and 67.3%, respectively). However, the use of the JNK inhibitor greatly 
enhanced T-cell proliferation (41.5%), and so did the use of the PD-L1 
blocking antibody (29.7%). These levels almost reached the level induced by 
the unstimulated control (54%). These data suggest PD-L1 is essential for the 
active suppression of CD4+ T-cell proliferation by DC infected with live NmB. 
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5.3.7 DC infected with live NmB show reduced TH1-like responses 
DC are able to polarise naive CD4+ T-cells into TH1 or TH2 effectors, which 
can be defined by the ability to produce IFN-γ and IL-4. To test the ability of 
live NmB to induce these T-cell cytokine signatures, T-cells were analysed for 
intracellular cytokine production. 
DC were stimulated with either killed NmB or live NmB and then co-cultured 
with allogeneic high purity (>98%) naive (CD45RA+) CD4+ T-cells for 5 days. 
T-cells were then stimulated with PMA and ionomycin in the presence of 
brefeldin A for 3h, and analysed for IFN-γ and IL-4 by intracellular flow 
cytometry. It was found that T-cells only produced negligible amounts of 
cytokine (Figure 5-7), with DC stimulated with killed NmB inducing 4.03% IFN-
γ+ T-cells and live NmB inducing only 1.53% IFN-γ+ T-cells. However, there 
was a trend for killed NmB inducing more TH1-type responses and live NmB 
inducing more TH2-type responses, as live NmB induced 5.82% IL-4
+ T-cells 
while killed NmB only induced 2.95% IL-4+ T-cells. 
It was therefore decided that a protocol utilising the superantigen SEB and the 
use of IL-2 expansion as previously described (van Beelen et al., 2007) would 
be used to achieve higher levels of cytokine production. As controls for TH1 
and TH2 polarisation, poly(I:C) (TH1) and cholera toxin (CT) (TH2) were used, 
as these have been previously reported to induce such responses (de Jong et 
al., 2002). 
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Figure 5-7 Allogeneic co-cultures in the absence of co-stimuli induce minimal 
cytokine production in naive CD4+ T-cells. DC were stimulated with 10 MOI killed 
NmB, 10 MOI live NmB or left unstimulated for 24h. DC were then washed in 
complete media containing 100 U/mL penicillin/streptomycin and and re-counted, 
and seeded at 5 x 104 in a 96-well plate with 1:5 allogeneic purified naive CD45RA+ 
CD4+ T-cells for five days. On day 5, T-cells were stimulated with PMA (100 
ng/mL) and ionomycin (1 μg/mL) for 3h in the presence of brefeldin A (1 μg/mL) 
for 3 h. Intracellular levels of IL-4 and IFN-γ were then determined by intracellular 
flow cytometry, using a permeabilisation protocol.  Gates were set by an isotype 
control on live T-cells. Data are representative of three experiments. 
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DC were stimulated for 24h with LPS, killed NmB, live NmB, poly(I:C) or CT. 
DC were then washed in antibiotic-containing media, re-counted and co-
cultured with allogeneic naive CD4+ T-cells in the presence of SEB. On day 5, 
T-cells were expanded with IL-2. On day 12-14, T-cells were then stimulated 
with PMA and ionomycin for 3h in the presence of brefeldin A, and production 
of IFN-γ and IL-4 were measured by intracellular flow cytometry. 
As Figure 5-8 shows, it was found that both poly(I:C) and CT were able to 
induce IFN-γ (unstimulated: 34.6% IFN-γ+; poly(I:C): 42.7% IFN-γ+) and IL-4 
(unstimulated: 8.43%; CT: 11.8%) T-cell cytokine production above that of the 
unstimulated control. Therefore, DC were able to effectively polarise naive T-
cells to desired phenotypes. With regards to NmB, killed NmB induced 57.1% 
IFN-γ+ and 9.47% IL-4+ T-cells, while live NmB induced 49.3% IFN-γ+ and 
15% IL-4+ T-cells. The reduction in TH1-type cells was found to be significantly 
reduced across multiple donors by live NmB in comparison to killed NmB (p = 
< 0.01), while there was a non-significant trend in most donors for live NmB to 
induce stronger TH2-type responses (Figure 5-9). 
Taken together, these data demonstrate that live NmB can suppress T-cell 
proliferation via PD-L1, and also impair the generation of TH1-type responses 
in naive CD4+ T-cells.  
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Figure 5-9 Live NmB suppresses the induction of TH1-type responses by DC. DC 
were stimulated with 10 MOI killed NmB, 10 MOI live NmB or left unstimulated for 
24h. DC were then washed in complete media containing 100 U/mL 
penicillin/streptomycin and re-counted, and seeded at 5 x 104 in a 96-well plate 
with 1:5 allogeneic purified naive CD45RA+ CD4+ T-cells for five days. On day 5, T-
cells were expanded in fresh media with 10 U/mL rhIL-2 for a further 7-9 days. 
Cells were then stimulated with PMA (100 ng/mL) and ionomycin (1 μg/mL) for 3h 
in the presence of brefeldin A (1 μg/mL) for 3 h. Intracellular levels of IL-4 and 
IFN-γ were then determined by intracellular flow cytometry, using a 
permeabilisation protocol. Data are from five individual donors. Significance was 
tested by paired t-test. * p < 0.05 ** p < 0.01 *** p < 0.001 
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5.4 Discussion 
DC migration and T-cell stimulation are the critical immunological 'outputs' of 
the maturation process. Herein, it was found that live NmB modulated both of 
these processes, resulting in functionally paralysed DC. This is a logical 
finding given the previous data, considering the phenotype induced by the 
viable bacterium that was explored in the Chapter 3. 
DC migration was impaired by live NmB in a CCL19 chemotaxis assay, 
showing minimal chemotaxis compared to the unstimulated control. This 
correlated with CCR7 expression, since live NmB also failed to up-
regulate/induce CCR7 on DC. It should be noted that there was a significant 
trend for LPS to induce more chemotaxis than killed NmB at 500 ng/mL 
CCL19, and a non-significant trend at 50 ng/mL. This may be partially 
explained by the modest increase in expression of CCR7 induced by LPS. 
Alternatively, the phagocytosis of whole bacteria may have led to DC being 
unable to migrate as effectively through the transwell pores. 
In vitro CCL19 migration assays correlate well to in vivo DC migration, as has 
been previously published. For example, the parasite Toxoplasma gondii can 
induce the up-regulation and acquisition of DC CCR7 in vitro, which renders 
DC hypermigratory to CCL19. The parasite can induce the same phenotype in 
vivo, which then allows it to hijack migratory DC and gain access to the 
lymphatic tissue of the brain in mice (Fuks et al., 2012). Similarly, Wiskott-
Aldrich syndrome patients have impaired DC chemotaxis in transwell CCL19 
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assays in vitro, and this is reflected in Wiskott-Aldrich syndrome protein 
(WASP) mutant murine DC (Bouma et al., 2007).  
An important limitation to these data is that CCL19-mediated chemotaxis is 
just one aspect of DC motility and migration. General DC motility in response 
to activatory stimuli involves more widespread changes in cytoskeletal 
structure and actin filamentation besides CCR7 up-regulation (Verdijk et al., 
2004). If time had permitted, a DC-endothelial cell assay in order to 
investigate the effect of live NmB on DC endothelial transmigration would 
have been carried out. Moreover, although DC can migrate to the lymphatic 
tissue and polarise naive T-cell differentiation, T-cells can patrol lymphatic 
tissue and home to mucosal sites of inflammation and infection (Sallusto et 
al., 1999). Therefore, these data describing the inhibited migratory functions 
of DC in response to live meningococci must be considered in the wider 
context of more general impaired immunological functions. 
It was also found that live NmB induced the selective up-regulation of PD-L1 
via the MAPKs ERK, p38 and JNK, although JNK inhibition was the most 
potent at reducing its expression. All of these signalling molecules were 
shown to be activated by live NmB in the previous chapter. This corresponds 
to other findings in the literature; a MAPK-STAT3 axis was found to induce 
PD-L1 expression in human monocytes (Wölfle et al., 2011), and a study on 
melanoma cells found that the JNK-induced c-Jun transcription factor binds to 
the PD-L1 promoter to induce up-regulation and immunotolerance (Jiang et 
al., 2013). It can therefore be concluded that live NmB uses these pathways 
to induce PD-L1 up-regulation in the absence of other maturation marker 
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expression, as PD-L1 expression does not appear to be dependent on 
STAT1. 
Live NmB was able to suppress the induction of DC-mediated CD4+ T-cell 
proliferation at all ratios tested. In many donors, this was below the level of 
proliferation induced by the unstimulated control. This may have been due to 
the selective up-regulation of the potent T-cell inhibitory receptor PD-L1, as 
the use of a JNK inhibitor or a PD-L1 blocking antibody on DC infected with 
live NmB was able to enhance the ability of these DC to induce T-cell 
proliferation. Notably, these two treatments were not able to induce T-cell 
proliferation resembling the positive controls killed NmB and LPS, presumably 
because DC infected with live NmB remained CD86lo. 
There was a general trend for lower levels of proliferation at higher ratios of T-
cells. This is unsurprising, as fewer available DC results in a reduction in 
available positive signals per T-cell. Interestingly, there was always a notable 
background of proliferation in the unstimulated control. This may be explained 
by the fact that DC are not truly negative for any of the co-stimulatory 
molecules, such as CD40 and CD86. Indeed, DC maturation is an up-
regulation of these markers that are acquired upon differentiation from 
monocytic precusors. DC are phenotypically defined by the presence of these 
molecules, which are expressed at higher levels compared to other cell types 
even in an immature state; therefore it can be expected that even immature 
DC are capable of inducing a moderate level of proliferation. 
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It is possible that apoptosis may account for the suppression of DC infected 
with live NmB to induce T-cell proliferation. However, this is unlikely to be the 
main driver of suppressed T-cell proliferation for several reasons. Although 
live NmB induces higher levels of apoptosis in DC (Jones et al., 2007), DC 
viability stabilised upon the re-culturing of DC in fresh antibiotic-containing 
media, presumably because of the removal and killing of bacteria (data not 
shown). Additionally, the use of a blocking PD-L1 antibody markedly boosted 
the T-cell proliferation induced by DC infected with live NmB, and it is unlikely 
that a blocking antibody would affect DC viability. Together, these data 
enforce the importance of the DC surface marker repertoire in determining the 
resulting T-cell responses. 
A secondary effect was that T-cells co-cultured with DC that had been 
infected with live NmB were less able to produce IFN-γ in response to PMA 
and ionomycin stimulation. Killed NmB was found to effectively induce these 
TH1-type cytokines in T-cells, as has been previously published in a study 
investigating a panel of Gram-negative bacteria and their ability to induce 
TH1/TH17 responses (van Beelen et al., 2007). TH1-type responses have been 
shown to correlate with CD40 expression and the general maturation state of 
the DC. Hence, immature DC are more likely to induce a TH2-type response, 
while mature DC are more biased towards TH1-type responses (de Heusch et 
al., 2004; Langenkamp et al., 2000). There was also a non-significant trend 
between the ability of killed NmB and live NmB stimulated DC to induce IL-4 
production, as live NmB induced more of this cytokine in most (3 out of 5) of 
the co-culture assays. While interesting, these observations are most 
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probably less important than the overall suppression of T-cell responses, 
since the cytokine assays depended on expansion of the T-cells with 
exogenous IL-2 and supernantigen. 
A major limitation of these data is that the T-cell experiments were performed 
in an antigen-independent system. SEB and allogeneic MHC were used to 
induce T-cell responses, but these are non-specific and will always activate a 
certain percentage of T-cells. It would be interesting to replicate these 
experiments by using a specific recall antigen in vaccinated volunteers, such 
as tetanus toxoid (TT), as has been described elsewhere (Le Bert et al., 
2011). 
In summary, these data show that live NmB is able to disable two core DC 
functions: chemotaxis and T-cell stimulation. CD4+ T-cells are critical for the 
protection of mucosal surfaces, and so these data may represent a method of 
immune evasion by NmB via DC dysregulation. However, while these data 
suggest that the selective up-regulation of PD-L1 on DC may induce active 
repression of T-cell proliferation, they still do not uncover the mechanism of 
STAT1-Y701 dephosphorylation that is required for full maturation. The 
mechanism behind this dephosphorylation is explored in the following chapter. 
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6 Chapter 6: Reversing the immunomodulation of DC 
by N. meningitidis  
6.1 Introduction 
The data in the previous chapters shows that live NmB suppressed DC 
maturation by selective tyrosine dephosphoryation of STAT1. This correlated 
with reduced levels of maturation markers, reduced levels of anti-inflammatory 
SOCS genes SOCS1 and CISH, and enhanced cytokine production. 
Furthermore, these DC were poorly immunogenic in allogeneic co-culture 
models. Given the possibility that a host or bacterial effector might be 
interfering with this pathway, the mechanism(s) behind the deactivation of 
STAT1 were investigated. 
The manipulation of host cell signalling by pathogens is a relatively common 
occurrence. Many pathogens encode enzymes specifically for this purpose, 
and have no other known role in bacterial cell physiology. Bacteria usually 
require a secretion system to inject effectors into the host cell. A notable 
example is the type 3 secretion system (T3SS) of Yersinia spp., which can 
secrete immuno-modulatory proteins into human phagocytes. For example, 
Yersinia outer protein P (YopP) can prevent DC from functionally maturing by 
inhibiting the MAPK signal transduction cascade (Autenrieth et al., 2007).  
This requires direct contact between the human cell and the viable bacterium. 
Many pathogens, particularly viruses, have been shown to modulate the 
STAT1 pathway specifically (Goodbourn et al., 2000). For example, vaccinia 
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virus (VV) encodes a protein called VH1, which is a dual-activity tyrosine and 
serine phosphatase (Guan et al., 1991). This phosphatase can 
dephosphorylate STAT1, resulting in impaired signalling in cell lines and 
interference with IFN responses (Najarro et al., 2001). Furthermore, VV 
infection in vivo interferes with APC MHC Class II expression via STAT1 
deactivation, and thus limits effective T-cell responses (Li et al., 2005). 
Coincidentally, VV can also block human DC maturation by an unknown 
mechanism, and these two findings have not yet been linked by the authors of 
the studies (Engelmayer et al., 1999). Another prominent example is the 
measles virus, which encodes a protein known as 'Measles P Protein', which 
can prevent STAT1 binding effectively to the IFNR-JAK complex, thus 
preventing phosphorylation and signal transduction (Devaux et al., 2013).  
Pathogens can also prevent STAT1 signalling via host enzymes. 
Cytomegalovirus (CMV) can induce the activation of the host tyrosine/serine 
phosphatase SHP-2, which dephosphorylates STAT1 and thereby prevents 
the up-regulation of HLA-DR (Baron and Davignon, 2008). It is worth noting 
that CMV can also suppress DC maturation through an unknown mechanism 
(Moutaftsi et al., 2002) while inducing selective up-regulation of PD-L1 
(Benedict et al., 2008); although again, these phenomena have not been 
connected within the literature. Influenza A virus, too, can inhibit STAT1 signal 
transduction by hyper-activation of NF-κB (Pauli et al., 2008). Over-triggering 
of NF-κB can elevate SOCS3 protein levels, resulting in blockade of IFN 
signal transduction. 
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Modulation of STAT1 signal transduction is less well characterized for 
bacteria, however there are a few notable examples in the literature. Viable—
but not inactivated—enterohaemorraghic E. coli (EHEC) can down-regulate 
STAT1 phosphorylation by an unidentified, heat-sensitive secretory product 
(Ceponis et al., 2003). However, it is unknown what implications this finding 
has regarding immune responses to the bacterium. Similarly to Influenza A, L. 
monocytogenes can induce up-regulation of SOCS3 and prevent STAT1 
phosphorylation in macrophages (Stoiber et al., 2001). Using a systems 
biology approach, one study found that Brucella abortus down-modulates the 
IFN pathway in DC, correlating with less STAT1 transcriptional activity and a 
less mature phenotype (Gorvel et al., 2014). However, this is likely to be 
through TLR recognition, rather than a specific targeting of the IFN pathway. 
Currently, no data exist in the literature regarding the role of STAT1 in 
meningococcal infection. While STAT1 is required for DC to induce effective 
T-cell responses in vivo (Longhi et al., 2009), it has a complex and ambiguous 
role in bacterial sepsis and immunity. STAT1 signalling in DC is crucial for the 
protection of mice against lethal L. monocytogenes infection (Kernbauer et al., 
2012). The same study also found that STAT1-deficient mice have enhanced 
levels of inflammatory cytokines, consistent with the proposed model herein of 
meningococcal modulation of DC. Moreover, STAT1-dependent negative 
regulators of cytokine production, such as SOCS1, have been shown to 
restrict the inflammatory response in murine models of sepsis, implicating 
STAT1 in a protective role (Kinjyo et al., 2002; Nakagawa et al., 2002; 
Tanimoto et al., 2005). However, STAT1-deficient mice are noted for being 
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more resistant to the onset of septicaemia after endotoxin challenge 
(Kamezaki et al., 2004), correlating with reduced levels of pro-inflammatory 
cytokine in the peripheral blood. This discrepancy may be explained by the 
different stimuli used in these assays, such as the use of whole organisms 
versus specific components. Alternatively, STAT1-deficient mice may have 
more highly inflammatory DC (due to lowered SOCS protein expression), but 
the overall effect could be anti-inflammatory in certain circumstances due to 
the lack of DC-initiated, CD4+ T-cell-derived cytokines. 
In this chapter, the mechanism of STAT1 tyrosine dephosphorylation was 
explored further. Experiments were carried out to reverse STAT1 signal 
transduction modulation via pharmacological inhibitors, to determine if this 
would result in reversion of DC to conventional phenotype and function. 
Finally, possible bacterial factors responsible for the immunomodulation of DC 
were investigated. 
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6.2 Aims and Objectives 
The aim of this chapter was to reverse the phenotype exerted on DC by live 
NmB. To do this, various inhibitors were used to uncover the mechanism 
behind STAT1 tyrosine dephosphorylation. The hypothesis was that reversal 
of STAT1-Y701 dephosphoryation would revert all aspects of DC phenotype 
that were modulated by live NmB. 
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6.3 Results 
6.3.1 Dysregulation of DC maturation by live NmB is independent of 
apoptosis 
The role of apoptosis in the modulation of DC maturation was first 
investigated. Pathogens can induce DC apoptosis as a method of escaping 
cellular immune responses (Kushwah and Hu, 2010). It has previously been 
reported that live NmB can induce more apoptosis in DC than killed bacteria, 
but is likely to be independent to the inhibition of phenotypic maturation 
(Jones et al., 2007).  
Importantly, 'alternative activation' of STAT1 (serine phosphorylated, tyrosine 
dephosphorylated) has been described as having pro-apoptotic activity in 
immune and non-immune cells. The serine phosphorylation is critical for the 
induction of STAT1-mediated apoptosis (Kim and Lee, 2005; Stephanou et 
al., 2001). Biochemical analysis has revealed that this is via a caspase-
dependent mechanism. 
It was questioned whether the selective serine phosphorylation of STAT1 
could explain the earlier finding of increased apoptosis of DC in response to 
viable NmB infection. To test this hypothesis, an annexin-V assay, based on 
binding of annexin-V to 'flipped' phosphatidylserine only present on apoptotic 
cells, was used as a indicator of DC apoptosis. 
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Figure 6-1 Live NmB induces more apoptosis in DC than killed NmB. DC were 
stimulated for 24h with 100 ng/mL LPS, 10 MOI killed NmB or 10 MOI live NmB. 
Apoptosis was then measured by flow cytometry, using annexin-V+ DC as an 
indicator of apoptosis. Gates were set by an unstained control. Data are 
representative of three experiments. 
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To confirm previous findings, DC were stimulated for 24h with LPS, killed 
NmB or live NmB and stained for phosphostidylserine expression via FITC-
labelled annexin-V. Consistent with previous work (Jones et al., 2007), live 
NmB was found to induce more apoptosis than killed NmB and LPS (Figure 6-
1), as indicated by approximately three-fold more annexin-V+ DC (live NmB: 
30.9%, LPS: 9.11%, killed NmB: 11.4%). 
Since p38 has been reported to phosphorylate STAT1 on the S727 residue 
(Goh et al., 1999), and it was also found that live NmB induced p38 activation 
(as shown in Chapter 4), a well-characterised inhibitor (SB 203580) was used 
to reverse S727 phosphorylation. DC were infected with live NmB for 24h 
either in the presence of the p38 inhibitor or a vehicle control. Levels of 
STAT1-S727 phosphorylation were then determined by intracellular PhosFlow 
cytometry (Figure 6-2). As expected, the use of a p38 inhibitor was sufficient 
to reduce the levels of STAT1-S727 phosphorylation induced by live NmB.  
Next, to see if p38 inhibition could reverse the pro-apoptotic effects of live 
bacteria, DC were stimulated with LPS, killed NmB or live NmB for 24h and 
apoptosis was gauged by live FSC-SSC gating (as previously described 
(Handley et al., 2005)) and annexin-V staining. For some conditions, DC were 
stimulated in the presence of a p38 inhibitor.  
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Figure 6-2 STAT1-S727 phosphorylation induced by live NmB is dependent on 
p38. DC were stimulated for 18h with 10 MOI live NmB in the presence of the p38 
inhibitor SB 203580 (1 μg/mL) (white histogram) or equivalent vehicle control (0.1 
% DMSO) (red histogram). STAT1-S727 phosphorylation was then measured by 
intracellular PhosFlow cytometry. MFI values are displayed on the histograms. 
Data are representative of two experiments.  
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As Figure 6-3 shows, live NmB-infected DC cultured in the presence of a p38 
inhibitor showed a higher percentage of viable cells (p = <0.01) compared to 
the vehicle control, as determined by percentage of live gated DC. 
Furthermore, as shown in Figure 6-4, DC stimulated in the presence of a p38 
inhibitor showed markedly reduced apoptosis. This was more prominent in DC 
stimulated with live NmB, where p38 inhibition almost completely reverted the 
levels of apoptosis to that of the unstimulated control (live NmB DC: 28.6% 
annexin-V+ vs. live NmB + p38i DC: 10.8% annexin-V+). By contrast, p38 
inhibition had only a minor reduction on the apoptosis induced by killed NmB 
(7.03% annevin-V+ vs. 5.98% annevin-V+, respectively). 
To determine the specificity of p38 inhibition controlling apoptosis, a control 
JNK inhibitor (SP 600125) was also tested. This was used to determine 
whether apoptosis was a general property of MAPK activation, or specific to 
p38 alone. DC were infected with live NmB with either a vehicle control or 
JNK inhibitor for 24h, and annexin-V staining was determined by flow 
cytometry. Unlike p38 inhibition, JNK inhibition did not cause a reduction in 
annexin-V staining (Figure 6-5).  Moreover, there was a slight increase in 
apoptosis with JNK inhibition (29.7% vs. 40.7%, respectively).  
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Figure 6-3 Inhibition of p38 leads to an increase in viability in DC infected with 
live NmB. DC were infected with 10 MOI live NmB for 24h in the presence of p38 
inhibitor SB 203580 (1 μg/mL) or vehicle control (0.5% DMSO). Viability was then 
determined by flow cytometry, by measuring percentage of DC within the FSC-
SSC live DC gate. Data are from give donors. Significance was tested by paired t-
test. * p < 0.05 ** p < 0.01 *** p < 0.001 
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Importantly, p38 inhibition was not able to restore DC CD86 expression after 
24h infection with live NmB in these assays, highlighting the distinctness of 
maturation and apoptosis in this system (Figure 6-6). These data strongly 
suggested that p38 activation by live NmB induced selective STAT1-S727 
phosphorylation, which was the main driver of apoptosis in this infection 
model. However, this pro-apoptotic effect was distinct from the inhibition of 
DC maturation marker up-regulation. 
6.3.2 Live capsule, PilE, RmpM deficient NmB induce similar DC 
maturation profiles to live WT NmB 
N. meningitidis possesses several virulence factors that determine the 
pathogenic potential of the organism and also influence the interaction of the 
bacterium with the human immune system. Capsule- or LOS-deficient NmB is 
differentially recognised by human DC, eliciting a dissimilar phenotype to wild-
type organisms. It was hypothesised that these virulence factors might be 
responsible for the observed phenotype. To test this, DC were exposed to live 
and killed variants of several NmB mutants for 24h: SiaD, a capsule-deficient 
mutant, PilE, a pilus-deficient mutant and RmpM, a mutant deficient for an 
OmpA homologue, chosen for its similarity to a common protein across many 
bacterial species found to inhibit DC maturation (Mittal et al., 2009, 2010). 
Surface expression of CD40 was then measured by flow cytometry.  
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Figure 6-5 Inhibition of p38 does not restore DC maturation after infection with 
live NmB. DC were stimulated with 100 ng/mL LPS (green), 10 MOI killed NmB 
(blue), 10 MOI live NmB (red) or left unstimulated (grey) in the presence of vehicle 
control (0.5 % DMSO) or live NmB + p38 inhibitor SB 203580 (1 μg/mL) (black). 
Surface expression of CD40 and CD86 was then measured by flow cytometry. MFI 
are displayed on the histograms. Data are representative of two experiments. 
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Figure 6-6 JNK inhibition does not down-modulate apoptosis during infection 
with live NmB. DC were stimulated for 24h with 10 MOI live NmB in the presence 
of a vehicle control (0.5 % DMSO) or JNK inhibitor SP 600125 (1 μg/mL). 
Apoptosis was then measured by flow cytometry, using annexin V+ DC as an 
indicator of apoptosis. Gates were set by an unstained control. Data are 
representative of one experiment. 
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As Figure 6-7 displays, all viable mutants failed to induce the up-regulation of 
the maturation marker CD40 comparable to their isogenic killed counterparts. 
Therefore, it was concluded that the inhibition of DC maturation by live NmB 
was independent of these known virulence factors.  
6.3.3 Suppression of DC surface phenotype maturation by live NmB is 
independent of CEACAM1 and SHP-2 
Several lines of evidence have supported the notion that N. meningitidis can 
bind to CEACAM receptors and modulate intracellular signalling. As 
previously mentioned, Neisseria spp. express Opa proteins that can bind to 
CEACAM and induce host tyrosine phosphatase (SHP-2) activity (Boulton and 
Gray-Owen, 2002). A recent paper has found that gonococcal Opa binding to 
human CEACAM1 can down-regulate CD83 expression in DC, which is a 
marker of maturation (Yu et al., 2013). This was an attractive hypothesis to 
explain the dysregulation of DC maturation, since SHP-2 can selectively 
dephosphorylate STAT1 in the absence of STAT3 dephosphorylation (Liang 
et al., 2008). 
To investigate this possibility, a pan-CEACAM blocking antibody was first 
used to determine if live NmB was using this interaction to dysregulate DC 
maturation. DC were stimulated for 24h with either killed NmB or live NmB in 
the presence of a blocking CEACAM antibody. However, as shown in Figure 
6-8, a pan-CEACAM blocking antibody had only a minor effect on CD40 and 
CD86 expression during live NmB infection, which was dose-independent.  
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Figure 6-7 Conventional mutant strains of NmB fail to restore DC maturation 
when viable. DC were stimulated with 10 MOI killed (blue) NmB, 10 MOI live (red) 
NmB or left unstimulated (grey). Isotype controls are shown in the unshaded 
histogram. The wild-type (WT) parent strain (WT H44/76 or WT MC58) is shown on 
the top layer, and the mutant knock-out strain is shown on the bottom (siaD = 
capsule deficient, pilE = pili deficient, rmpM = rmpM protein deficient). After 24h, 
CD40 expression was measured by flow cytometry. Data are representative of two 
experiments. 
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Figure 6-8 The dysregulation of DC maturation by live NmB is not reversed by 
CEACAM blocking. DC were stimulated for 24h with 10 MOI killed NmB (blue), 10 
MOI live NmB (red) or left unstimulated (grey). For some conditions, DC were 
cultured in the presence of 50 μg/mL CEACAM blocking antibody (D14HD11) 
during infection with live NmB (red unshaded). Surface expression of CD40 and 
CD86 was measured by flow cytometry. MFI are displayed on the histograms. 
Data are representative of two experiments. 
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This small effect may have been solely due to dissociation of the bacterium 
from the DC. CEACAM blocking antibody had no effect on the induction of 
CD40 and CD86 by killed NmB (data not shown). 
Furthermore, SHP-2 activity was then measured by flow cytometry. DC were 
stimulated for 24h with LPS, killed NmB and live NmB. SHP-2 phosphorylation 
was then measured by intracellular PhosFlow flow cytometry. As Figure 6-9 
shows, it was found that LPS and killed NmB induced a mean 1.1-fold up-
regulation in SHP-2 phosphorylation, while live NmB did not appear to induce 
SHP-2 phosphorylation beyond the unstimulated control. Finally, the use of a 
SHP-2 inhibitor (NSC 87877) had no effect on the suppression of CD40 and 
CD86 up-regulation by live NmB, since DC cultured in the presence of this 
inhibitor and then infected for 24h by live bacteria had the same expression of 
these markers. Therefore, these data excluded the CEACAM-SHP2 signalling 
axis as a probable cause of DC dysregulation by viable NmB. 
6.3.4 Dysregulation of DC maturation requires active bacterial protein 
synthesis 
Bacteriostatic concentration of chloramphenicol was used to arrest bacterial 
protein synthesis. Chloramphenicol binds to the bacterial ribosome and 
inhibits peptidyl transferase activity, thus preventing any new protein 
synthesis. This is specific to prokaryotic cells, which means DC protein 
synthesis is unaffected in this system. 
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Figure 6-9 Live NmB does not induce enhanced SHP-2 activity compared to killed 
NmB. DC were stimulated for 18h with 100 ng/mL LPS, 10 MOI killed NmB or 10 
MOI live NmB and SHP-2 phosphorylation (p-Y452 MFI) was measured relative to 
an unstimulated control.  SHP-2 phosphorylation was determined by intracellular 
PhosFlow cytometry. Data are from four individual donors. Box plots depict 
medians and interquartile ranges. 
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Many bacteria up-regulate the transcription of virulence factors in response to 
cellular and physiological stresses, or by recognition of host immune cells and 
antimicrobial measures. To test if the suppression of DC phenotypic 
maturation was dependent on active bacterial protein synthesis, DC were 
treated with bacteriostatic levels of chloramphenicol (10ug/ml) at various time-
points after infection with live NmB, and CD40 and CD86 expression was 
measured by flow cytometry. Bacterial viability was confirmed by plating after 
washing and removal of chloramphenicol. As can be seen in Figure 6-10, 
chloramphenicol treatment before 4h duration of infection with live NmB led to 
a normal maturation response. Chloramphenicol had no effect on killed NmB 
or untreated DC (data not shown). These data suggested that the suppression 
of surface maturation marker expression requires bacterial protein synthesis. 
6.3.5 Sodium orthovanadate restores STAT1 phosphorylation in DC 
infected with live NmB 
Many bacteria actively secrete tyrosine phosphatases into the host cell. These 
proteins often have roles in bacterial cell physiology—such as capsule 
production—but some are encoded solely for the purpose of host cell 
modulation. The most well-characterised of these proteins may be the 
Yersinia spp. phosphatases, which can modulate host cell actin formation. 
These are actively secreted into the host cell via a T3SS complex.   
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While N. meningitidis does not possess a secretion system, it does have 
autotransporters and two-partner secretion systems that may enable the 
secretion of effectors into the host cell (Khalid and Sansom, 2006).  
It was speculated that NmB was secreting a bacterially encoded tyrosine 
phosphatase. This could explain the following observations: 1) the selective 
tyrosine dephosphorylation of STAT1, 2) the requirement for bacterial active 
bacterial protein synthesis, 3) the requirement for DC and NmB contact-
dependence as previously found by transwell experiments (Jones et al., 
2007), and 4) the marked hyporesponsiveness to IFN. To test this, sodium 
orthovanadate (vanadate) was used to inhibit any potential tyrosine 
phosphatases. Vanadate has been used in many infection models (Ceponis et 
al., 2003; Pauli et al., 2008), and pathogenic tyrosine phosphatases are 
exquisitely sensitive to this inhibitor (Guan et al., 1991). 
First, it was determined that vanadate did not affect bacterial viability —
although in some bacteria it has been shown that they use vanadate as a 
metabolite for respiration (Antipov et al., 2000). NmB was grown in various 
concentrations of vanadate for several h and then bacterial growth was 
measured by spectrophotometry (Figure 6-11). High doses (500 μM) of 
vanadate were shown not to effect bacterial growth.  
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Figure 6-12 Vanadate does not inhibit NmB growth. NmB was adjusted to OD600 
0.25 in RPMI without phenol red and grown at 37°C for up to 6h. For some 
conditions, NmB was treated with 100-500 μM vanadate. OD600 measurements 
were then taken at 3 and 6 h of growth. Data shown are from two independent 
experiments. Bars depict mean averages ± SEM. 
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To restore STAT1-Y701 phosphorylation, some DC were pre-treated with 
vanadate for 2h before infection with live NmB. At 18h post-stimulation, 
cellular lysates were assessed for the presence of phosphorylated STAT1-
Y701 by Western blot. As Figure 6-12 shows, vanadate treatment restored 
STAT1-Y701 phosphorylation in a dose-dependent manner. 
Next, DC were pre-treated with vanadate for 2h and stimulated with LPS, 
killed NmB and live NmB for 24h. DC maturation was then assessed by 
surface expression of CD86. Consistent with the restoration of STAT1-Y701 
phosphorylation, the use of vanadate greatly enhanced the expression of 
CD86, which was found to be significant amongst all donors (p = <0.01). By 
contrast, vanadate modestly lowered CD86 expression in DC stimulated with 
killed NmB, likely due to slight inhibitor toxicity (Figure 6-13). 
6.3.6 Vanadate restores SOCS1 and normalises cytokine production 
It was questioned whether vanadate would also enhance SOCS1 expression. 
SOCS1 is a STAT1-dependent regulator of DC cytokine production, and it 
was hypothesised that the enhanced levels of STAT1-Y701 phosphorylation 
would result in increased levels of SOCS1 protein. To test this, DC were 
infected with live NmB for 18h in the presence or absence of vanadate, and 
cellular lysates were probed for total SOCS1 protein by Western blot. In line 
with STAT1-Y701 phosphorylation, vanadate treatment greatly enhanced the 
levels of SOCS1 protein induced by live NmB (Figure 6-14). 
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Figure 6-13 Vanadate treatment restores STAT1-Y701 phosphorylation in 
response to live NmB infection. DC were infected for 18h with 10 MOI live NmB; 
for some conditions, DC were treated with 250-500 μM vanadate during the 
infection. Lysates were collected at 18h and probed for the presence of p-Y701 
phosphorylation by Western blot. Total STAT1 protein was used as a loading 
control. Data are representative of three experiments. 
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Figure 6-14 Vanadate treatment restores CD86 up-regulation in response to 
infection with live NmB. Left: DC were stimulated for 24h with  100 ng/mL LPS 
(green), 10 MOI killed NmB (blue), 10 MOI live NmB (red) or left unstimulated 
(grey). For some conditions, DC were also treated with 500 μM vanadate during 
stimulation (red unshaded: live NmB; blue unshaded: killed NmB). CD86 
expression was measured by flow cytometry. Data are from a representative 
donor. MFI values are displayed on the histograms. Right: Pooled CD86 MFI data 
from eight individual donors comparing 100-500 μM vanadate treated and 
untreated DC stimulated with live NmB. Box-plots depict medians and 
interquartile ranges. Significance was tested by paired t-test. *P<0.05, **P<0.01, 
***P<0.001. 
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Figure 6-15 Vanadate treatment enhances levels of SOCS1 protein induced by live 
NmB infection. DC were infected for 18h with 10 MOI live NmB; for some 
conditions, DC infected in the presence of 250-500 μM vanadate. Lysates were 
collected at 18h and probed for the presence of SOCS1 protein by Western blot. 
Total β-actin protein was used as a loading control. Data are representative of 
three experiments 
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Since SOCS1 is a master regulator of DC cytokine production, levels of pro-
inflammatory cytokines were measured after vanadate treatment. Some DC 
were pre-treated with vanadate for 2h and then stimulated with LPS, killed 
NmB or live NmB for 24h. Levels of intracellular IL-1β were then measured by 
flow cytometry, using a saponin-based cell permeabilisation protocol. It was 
found that vanadate treatment significantly lowered the levels of IL-1β 
production in DC (p = <0.01), correlating with the restoration of SOCS1 
(Figure 6-15). By contrast, vanadate had no real effect on the levels of IL-1β 
induced by killed NmB. As shown in Figure 6-16, similar results were found for 
secreted levels of IL-6 after stimulation with live NmB: vanadate effectively 
reduced the levels of IL-6 secretion by live NmB (mean 19,000 pg/mL vs. 
mean 11,250 pg/mL). 
6.3.7 Vanadate treatment enhances T-cell responses induced by live 
NmB 
Since vanadate restored STAT1-Y701 phosphorylation and increased 
maturation marker expression induced by live NmB, the functional 
consequences on T-cell proliferative responses were investigated. To test 
this, DC were pre-treated with vanadate for 2h and then stimulated with LPS, 
killed NmB and live NmB for 24h. DC were then washed, re-counted and 
cultured with CFSE-labelled allogeneic CD4+ T-cells for 5 days. T-cell 
proliferation was then measured by flow cytometry, as determined by the 
CFSEdim population frequency.  
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Figure 6-16 Vanadate treatment reduces the production of IL-1 β induced by 
infection with live NmB. Left: DC were stimulated with 100 ng/mL LPS, 10 MOI 
killed NmB or 10 MOI live NmB for 24h. Brefeldin A (1 μg/mL) was added during 
the final 4h.  For some conditions, DC were cultured in the presence of 500 μM 
vanadate. Intracellular IL-1β was measured by intracellular flow cytometry. E.C. = 
empty channel. Gate was set by an unstained control. Data show a representative 
donor. Right: Pooled data from three donors showing the frequency of IL-1β+ DC. 
Bars depict mean ± SEM. Significance was tested by paired t-test. *P<0.05, 
**P<0.01, ***P<0.001. 
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Figure 6-17 Vanadate reduces the amount of secreted IL-6 induced by live NmB 
infection. DC were stimulated for 24h with 100 ng/mL LPS,  10 MOI live NmB or 10 
MOI live NmB in the presence of 500 μM vanadate. Filtered supernatants were 
collected and assessed for total IL-6 protein by ELISA. Data are from two 
individual donors. Bars depict mean ± SEM. 
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As Figure 6-17 shows, in accordance with CD86 expression, the use of 
vanadate restored the allostimulatory capacity of DC infected with live NmB. 
Collectively, this set of experiments showed that the restoration of STAT1-
Y701 phosphorylation by vanadate could revert core aspects of conventional 
DC activation. 
6.3.8 A candidate virulence factor 
(With Dr Craig Ross, St George's University, London) 
The experiments thus far suggested that a tyrosine phosphatase—likely 
bacterially encoded—was responsible for the dysregulation of the DC 
maturation response. The use of the tyrosine phosphatase inhibitor, vanadate, 
successfully restored DC to conventional activation as evidenced by up-
regulation of CD86 expression, normalisation of the inflammatory cytokine 
profile, and reversion of allostimulatory capacity. 
Given that the most likely host tyrosine phosphatase SHP-2 had normal 
activity, and that inhibition of bacterial protein synthesis reverted the 
phenotype, it was hypothesised that a bacterial tyrosine phosphatase was 
mediating the tyrosine dephosphorylation of STAT1.  
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A search of the literature and the NmB genome revealed two putative tyrosine 
phosphatases of unknown function. The first was discovered by a group in 
2007 and the molecular structure was solved by X-ray crystallography 
(Krishna et al., 2007). This revealed an active site with homology to the 
eukaryotic tyrosine phosphatase PTP1B, which has been reported to 
dephosphorylate STAT1. However, the enzyme appeared to have a shallow 
active site domain, and also lacked the P-loop, critical for enzymatic activity. 
As yet, no ligand has been identified for this protein. Though initially identified 
in N. meningitidis serogroup A, a homologue was found in the NmB genome, 
identified as NMB_0495. 
A second candidate phosphatase was found by a search of the NmB strain 
H44/76 genome (Budroni et al., 2011). This was a 151 amino acid protein, 
designated NMB_0945, with putative tyrosine phosphatase activity based on 
the low molecular weight tyrosine phosphatase (LMW-PTP) motif. A molecular 
model of NMB_0945 was predicted using SWISS-MODEL online software 
(Biasini et al., 2014), which calculated good sequence homology to the 
Bacillus subtilis tyrosine phosphatase yfkJ, and this served as a model for 
structure prediction. Interestingly, these LMW-PTPs in B. subtilis are often 
expressed at very low levels, but are up-regulated during events of bacterial 
stress and cell cycle growth (Musumeci et al., 2005). As can be seen in Figure 
6-19, the predicted NMB_0945 model contained the classic 'P-loop' structure, 
which is required by PTPs to bind phosphate. Therefore, it was hypothesised 
that this protein was a more likely candidate than NMB_0495. 
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180° 
P-loop 
Figure 6-19 An in silico model of NMB_0945 predicted secondary and tertiary 
structure. The amino acid sequence of NMB_0945 was used to predict secondary 
and tertiary protein structure. Using SWISS-MODEL software, 44% homology was 
found to the B. subtilis phosphatase yfkJ and this was used to generate a 
prediction of protein structure. Top: A top-down view of the protein showing the 
P-loop determinant that allows phosphotyrosine binding and catalytic activity. 
Bottom: Two perspectives of the NMB_0945 active site, showing the cleft 
containing the P-loop. 
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To test the activity of these two candidate proteins in their ability to block 
STAT1 signalling, an in vitro IFN assay was used as a proof-of-principle pilot 
experiment. First, genomic DNA was extracted from NmB and tested for purity 
by spectroscopy. Genomic DNA was then sent to Dr Craig Ross (St George's 
University, London) who tested these genes in a well-characterised IFN signal 
transduction assay which had previously been used in their laboratory (Childs 
et al., 2012). Briefly, NMB_0495 and NMB_0945 were cloned into a 
eukaryotic vector and then transfected into Vero cells containing an ISRE 
reporter. Thus, any IFN-STAT1 signalling was measurable by β-galactosidase 
activity. Three positive control proteins were used: PIV5:V, FPV012 and 
FPV014, which are viral proteins that have all been shown to block IFN signal 
transduction (Childs et al., 2012; Laidlaw et al., 2013; Precious et al., 2007). 
Once transfected, Vero cells were then pulsed with IFN-β and ISRE activity 
was measured. As Figure 6-20 shows, PIV:5 caused a near-complete 
blockade of IFN signalling relative to the vector control, while FPV012 and 
FPV014 inhibited IFN signalling by 44% and 48% respectively. The two 
meningococcal proteins, NMB_0495 and NMB_0945, had differential effects 
on IFN signalling: the former enhanced IFN signalling by 141%, while the 
latter inhibited IFN signalling by 37%, comparable to the positive controls 
FPV014 and FPV016. These data described the first proof-of-principle 
example of a meningococcal protein disrupting a host signal transduction 
pathway, and also a promising candidate virulence factor that may be 
responsible for undermining cellular immunity to the meningococcus. 
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Figure 6-20 NMB_0945 expression represses IFN-β transcriptional activity. ISRE-
reporter Vero cells were transfected with proteins derived from Poxviridae 
viruses that were used as positive controls: PIV5:V, FPV012, FPV014. Cells were 
also transfected with the NmB proteins NMB_0495 and NMB_0945. Cells were 
then pulsed with 10 ng/mL IFN-β and β-galactosidase activity was measured as 
an indicator of ISRE activity. Values were calculated relative to the IFN-β-induced 
ISRE activity in the negative control (empty vector transfection). Data are from 
two experiments. Bars depict mean ± SEM.  
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6.4 Discussion 
It was found in this chapter that 'alternatively activated' STAT1 had a pro-
apoptotic effect in DC. The increase in apoptosis in response to live NmB has 
been observed previously (Jones et al., 2007), although the mechanism 
remained unknown. Notably, NmB can be anti-apoptotic or pro-apoptotic in 
various cell types. In B-cells, NmB can inhibit apoptosis by a PorB-dependent 
mechanism (Massari et al., 2000); while in epithelial cells, NmB can be pro-
apoptotic by a TNF-α dependent mechanism (Deghmane et al., 2009). In DC, 
maturation and survival are governed by separate (though overlapping) 
signalling nodes (Rescigno et al., 1998). Importantly, even bacterial stimuli 
that induce apoptosis can cause CD86 up-regulation (Lehner et al., 2001). 
The STAT1-S727 phosphorylation induced by live NmB was found to be 
dependent on p38, which was shown to be activated by live bacteria in a 
previous chapter. Inhibition of p38 dampened STAT1-S727 phosphorylation, 
and in turn reduced the amount of apoptotic DC. Since selectively serine 
phosphorylated STAT1 is pro-apoptotic, this is consistent with numerous 
reports in the literature (Stephanou et al., 2001). Importantly, this also 
excluded apoptosis as the driver of inhibited DC maturation. 
The S727 phosphorylation has recently been shown to be pro-inflammatory 
through an undefined, SOCS-independent mechanism (Luu et al., 2014). 
Therefore, the enhanced levels of pro-inflammatory cytokines may be caused 
by both direct and indirect mechanisms, i.e. not solely by SOCS protein 
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reduction. It is unknown if p38 inhibition would therefore lower cytokine 
production via a direct effect on STAT1, since p38 is also necessary for 
epigenetic modifications that allow transcriptional access to the promoters of 
these genes (Carter et al., 1999). In such an experiment, it would be difficult 
to infer if any observed cytokine reduction was due to either of these two 
effects. Interestingly, since alternatively activated STAT1 induces pro-
inflammatory cytokines, it is also unclear whether this resulted in direct or 
indirect apoptosis. Although serine phosphorylated STAT1 can activate 
caspases, the autocrine effect of excess TNF-α and IL-1β could also 
synergise in enhancing cell death.  
The data in this chapter also elucidate that STAT-Y701 dephosphorylation is 
not due to conventional virulence factors or likely host effectors. PilE, RmpM 
and SiaD mutants were all able to suppress DC maturation marker up-
regulation when viable. In further support of this, various OMVs (which contain 
many of these proteins) are reportedly able to fully mature DC (Jones et al., 
2014). However, chloramphenicol was able to reverse this effect if used early 
enough during infection, indicating that active bacterial protein synthesis was 
required for DC dysregulation. This observation is consistent with many 
virulence models in the literature. Numerous bacteria require direct cell 
contact in order to secrete effectors into the cytoplasm of the host cell. For 
example, Pseudomonas aeruginosa requires contact with the host cell in 
order to switch-on a regulon controlling the transcription of secreted virulence 
factors; this is dependent on direct contact with the host cell and also active 
protein synthesis (Cisz et al., 2008; Vallis et al., 1999). 
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The use of vanadate was also able to revert all tested aspects of DC 
activation. Treatment of DC with vanadate during infection with live NmB was 
sufficient to restore STAT1-Y701 phosphorylation, correlating with an increase 
in CD86 expression; vanadate also enhanced SOCS1 protein levels, while 
correlating with a reduction in pro-inflammatory cytokines. Although vanadate 
can enhance basal levels of STAT1 activation (Pauli et al., 2008), it is also a 
potent inhibitor of tyrosine phosphatases, and even pathogenic phosphatases. 
YopH from Yersinia spp. (Andersson et al., 1996), SptP from S. typhimurium 
(Kaniga et al., 1996) and VH1 from VV H1 (Guan et al., 1991) are all inhibited 
by the presence of vanadate.  
Endogenous PTPs such as TC-PTP, CD45, SHP-1, SHP-2 and PTP1B can 
dephosphorylate STAT1 under various conditions. However, these 
phosphatases are usually associated with a reduction in cytokine production. 
To the author's knowledge, only SHP-2 is capable of enhancing cytokine 
production while simultaneously dephosphorylating STAT1. This is due to its 
role in enhancing NF-κB activity and subsequently elevating IL-1 and IL-6 
production (You et al., 2001). Since CEACAM is a well-characterised ligand of 
the Neisserial protein Opa, which can in turn recruit SHP-2, it seemed a 
plausible hypothesis that live NmB might be ligating CEACAM and inducing 
SHP-2 activity to dephosphorylate STAT1 and arrest DC maturation. 
However, both a blocking antibody to CEACAM1 and various SHP-2 assays 
indicated that this was not likely to be the case. Furthermore, endogenous 
PTPs usually have activity against JAK family kinases (Shuai and Liu, 2003), 
which were shown to be activated by live NmB in a previous chapter. Given 
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these data, it can be concluded that the PTP responsible for STAT1-Y701 
dephosphorylation was likely to be bacterial in origin. 
One such bacterial candidate protein was NMB_0945, and this was able to 
inhibit IFN signalling in a eukaryotic cell line containing an ISRE binding 
domain, which is capable of binding a STAT1-STAT2 heterodimer in response 
to type I IFN. Though this was a modest reduction, it was still comparable to 
some of the positive controls. It is worth noting that while STAT1-Y701 was 
virtually completely dephosphorylated by live NmB in previous assays, 
NMB_0945 may still be an attractive candidate effector molecule for this 
phenomenon despite its moderate activity. Bacterial proteins are often subject 
to numerous post-translational modifications that enhance their function. 
Therefore, NMB_0945 may have needed further modifications—encoded by 
accessory bacterial proteins—in order to teach its full activity. Bacteria can 
methylate, lipidate, acetylate and phosphorylate their own enzymes (Cain et 
al., 2014). In order to reach optimal enzymatic activity reflective of complete 
STAT1-Y701 dephosphorylation, NMB_0945 may have needed to be 
expressed as part of a larger regulon. 
Another possibility is that NMB_0945 required a low pH in order to reach 
optimal enzymatic activity. An early paper on Neisserial protein phosphatases 
found that the activity of these enzymes increased in acidic conditions (Leahy 
et al., 1940). This is an intriguing observation that may hold the key to NmB-
mediated DC dysfunction, as there are notable examples of other pH-
dependent virulence factors in the literature. S. typhimurium requires a TLR-
triggered pH lowering in order to activate pathogenic tyrosine phosphatases 
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and transcribe various virulence factors. TLR signalling in DC induces an 
acidic extracellular and intracellular environment, such as the production of 
acid lactate and endosome acidification (Everts et al., 2014; Krawczyk et al., 
2010). For S. typhimurium, this acidification process takes approximately 4-5 
h after initial infection (Alpuche Aranda et al., 1992), which is the same 
'window' within which chloramphenicol can be added to prevent suppression 
of DC maturation by live NmB. It is tempting to speculate that this initial TLR-
mediated immune recognition, resulting in a pH drop, may be needed for 
NMB_0945 to reach optimal activity. Therefore, the dephosphorylation of 
STAT1 by NMB_0945 (or indeed another PTP) could hypothetically be 
considered to be a 'self-propagating inflammatory cycle', since dysregulated 
TLR signalling (via SOCS protein down-regulation) would likely encourage 
more lactate production and further acidification. 
In summary, these data showed that the serine phosphorylation of STAT1 
was pro-apoptotic, but that reversion of STAT1 tyrosine dephosphorylation 
could revert DC to conventional maturation. But more importantly, they 
implicated a putative bacterial tyrosine phosphatase— NMB_0945—in the 
specific targeting of a host transcription factor. These are novel findings for 
the pathophysiology of the meningococcus, and may have important 
ramifications for the understanding of natural immunity to the bacterium. 
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7 Chapter 7: Final Discussion and Future Work 
In recent decades there was no cross-protective vaccine against NmB. Cross-
protective vaccines had been developed for other meningococcal serogroups 
(such as group C) based on the polysaccharide antigen coupled to a protein 
carrier. These vaccines induced robust immune responses in the form of 
protective antibodies. However, an NmB vaccine was problematic due to the 
fact that the capsule was homogenic to human tissue. Therefore, a 'reverse 
vaccinology' approach was undertaken, which involved mining the NmB 
genome for conserved proteins that could serve as good vaccine antigens. 
This research produced the vaccine 4CMenB (also branded as Bexsero®). 
Clinical trials showed that it is effective in producing cross-protection against 
multiple strains of NmB, although there is significant scope for improvement 
(Shea, 2013). Given the relative rarity of disease, natural immunity arguably 
functions adequately in the protection of the host against meningococcal 
disease. Therefore, to develop optimum vaccine protection, it may also be 
important to understand the natural immune response to the bacterium.  
The immunological relationship between N. meningitidis and the human host 
is complex and not fully understood. The absence of good animal models has 
been a prohibitive factor in the understanding of immune responses to the 
meningococcus. Recently, a CEACAM1 transgenic murine model was 
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developed and this was shown to induce high levels of bacterial colonisation 
(Johswich et al., 2013). Such a model could allow a deeper understanding of 
natural immunity and pathogenesis in meningococcal disease. However, 
many of the key cellular receptors that determine the virulence potential of N. 
meningitidis are fundamentally different or entirely absent in the mouse. It has 
been shown that murine and human TLR4 respond differently to a lipid A pre-
cursor, which is the toxic component of LPS (Akashi et al., 2001). 
Correspondingly, penta-acylated meningococcal LOS activates murine but not 
human TLR4 (Steeghs et al., 2008). The phagocyte receptor DC-SIGN, which 
is a critical molecule for the recognition of Gram-negative bacteria (Zhang et 
al., 2006), is not expressed on murine cells. Terminal sugar moieties within 
meningococcal LOS allow the bacterium to bind to DC-SIGN, which results in 
uptake and phagocytosis (Steeghs et al., 2006). Mouse and human B-cells 
also respond differently to N. meningitidis. Previous reports have found that 
the bacterium can inhibit murine B-cell function (Melancon-Kaplan et al., 
1986), while human studies have found that meningococcal antigens are able 
to directly activate B-cells (Wetzler et al., 1996). 
Given these major differences in human and mouse immune responses to the 
N. meningitidis, even a transgenic mouse model may not be a good model 
with which to investigate immune responses to the bacterium. On the other 
hand, in vitro activation of human DC (particularly the up-regulation of surface 
maturation markers) by vaccine antigens corresponds extremely well to levels 
of protective antibodies in humans. The same study also found that there was 
no correlation between murine DC activation and levels of antibody protection 
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(Li et al., 2013). The use of human cells for understanding the immune 
response to N. meningitidis may therefore represent a rare example of 'in vitro 
veritas'. 
It is thought that immune evasion mechanisms may allow the bacterium to 
persist in the human host (Lo et al., 2009). These mechanisms are necessary 
because the meningococcus is an obligate coloniser of the human 
nasopharynx; a non-human animal or environmental reservoir has not been 
found. The exquisite adaptations that allow the bacterium to colonise the 
human mucosa are also key determinants of pathogenesis. A pertinent 
example of this is the bacterial capsule: while it is rich in sialic acid and can 
therefore disable complement deposition (which is abundant in the mucosal 
tissue), it also allows the bacterium to survive in the bloodstream during 
instances of invasive disease. A dominant paradigm in the literature is that N. 
meningitidis is an "accidental pathogen" (Stollenwerk and Jansen, 2003), and 
that it has evolved to rarely cause invasive disease. Indeed, symptomatic 
invasive disease represents an evolutionary 'dead-end' for the bacterium, as 
the death of the host prevents further infections. 
In this study, live NmB was shown to dysregulate DC maturation by selective 
tyrosine dephosphorylation of STAT1 — a model for this is proposed in Figure 
7-1. STAT1 is essential for the up-regulation of DC maturation markers—such 
as CD40 and CD86—and therefore DC infected with live NmB were 
phenotypically immature. But strikingly, DC were able to induce very high 
levels of inflammatory cytokines such as IL-1β, however normal NF-κB and 
MAPK activation was observed. Therefore, NmB was able to decouple two 
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fundamental aspects of DC maturation. Since pro-inflammatory cytokine 
production is an early-phase aspect of DC maturation, and up-regulation of 
maturation markers is a late-phase event, the effect of live NmB could be 
described as an 'arrest' of DC maturation in an early, hyper-inflammatory 
phase. 
DC are often described as the 'sentinels' of the immune system, due to their 
ability to control and dictate adaptive immune responses (Stockwin et al., 
2000). As well as being the most important APC for stimulating naive CD4+ T-
cells, DC are also essential for thymus-dependent antibody responses via 
germinal B-cells (Inaba et al., 1983). DC can also generate robust antibody 
responses via CD4+ T-cell-B cell interactions when targeted by vaccine 
adjuvants (Shortman et al., 2009). The suppression of the up-regulation of DC 
co-stimulatory and antigen presenting molecules could be an evolutionary 
strategy by which to persist in the human host. As previously mentioned, M. 
tuberculosis disables local T-cell responses in vivo by inducing a similar 
CD86loPD-L1hi phenotype to the one reported herein; restoration of DC 
function enables bacterial clearance (Schreiber et al., 2010). Hence, the 
dysregulation of DC maturation by live NmB may have important physiological 
relevance. 
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Figure 7-1 A proposed model of the dysregulation of DC by live NmB. 
Shown is a schematic of live NmB up-regulated/activated (red) and down-
regulated/deactivated (green) cellular targets and signalling axes, and the 
result of these modulations on DC phenotype. The disruption of STAT1-
Y701 phosphorylation arrests DC in a hyper-inflammatory, apoptotic state 
which correlates with low levels of SOCS genes SOCS1 and CISH. 
Moreover, DC are CD86lo, but MAPK-dependent PD-L1hi, resulting in 
impaired T-cell responses. 
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It was found that DC infected with live NmB were poor inducers of CD4+ T-cell 
proliferation, even compared to unstimulated DC. Part of this effect was due 
to the selective up-regulation of PD-L1, which was dependent on MAPK 
activity. Commensal bacteria can cause PD-L1 up-regulation to induce a 
tolerogenic environment in the airway mucosal tissue (Gollwitzer et al., 2014), 
but this is the first time that such an effect has been described with NmB. 
During the course of these experiments, a study was published that showed 
N. gonorrhoeae was able to restrict CD4+ T-cell responses via PD-L1 
expression on DC (Zhu et al., 2012). The authors showed that PD-L1 
blockade enhanced (but did not completely restore) T-cell proliferation. This 
effect of T-cell suppression could reflect a more general property of the 
Neisseria genus.  
However, there are important drawbacks to the study by Zhu et al. that are 
worth consideration. N. gonorrhoeae appeared to induce a normal maturation 
profile (CD86hiPD-L1hi), comparable to many bacterial stimuli, and so the 
blockade of PD-L1 leading to enhanced T-cell proliferation may have been an 
artefact based on the removal of a standard negative signal, rather than a 
reversal of the specific cause of gonococcal-mediated T-cell suppression. Due 
to a lack of positive controls in their study (e.g. LPS), it is difficult to ascertain 
whether N. gonorrhoeae induced quantitatively more PD-L1 up-regulation 
than would be normal. It is unlikely that the mechanism of gonococcal 
suppression of T-cell responses is similar to the one presented herein. 
Though it was found that live NmB dysregulated DC maturation via STAT1-
Y701 dephosphorylation and prevented T-cell proliferation, natural immunity 
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to N. meningitidis has been observed in humans. Serological analyses have 
revealed the presence of naturally occurring humoral immunity to NmB in 
adults and children. These antibodies are predominantly of the IgG1 and IgG3 
sub-class (Pollard et al., 1999a). Many of these antibodies are directed 
against the PorA surface protein, which is subject to intense phase-variation, 
yet appears to be a dominant immuno-stimulatory epitope. 
Cellular immunity to the meningococcus has received much less research 
attention than humoral immune responses. However, a small number of 
studies have addressed this topic. Early studies looking at cellular immunity to 
N. meningitidis used crude methods to assess this matter, such as stimulation 
of whole blood PBMCs with meningococcal OMV and measurement of 
cytokine profiles by ELISA. Though the authors of such a study concluded 
that older children induced a more TH2-type response (Pollard et al., 1999b), it 
is worth noting that many mononuclear cells can produce TH2-like cytokines. 
Monocytes can secrete vast quantities of IL-10 in response to bacterial 
antigens (Malefyt et al., 1991), which was the same read-out that the authors 
used as confirmation of a TH2 response. Hence, only extremely limited 
conclusions can be drawn from such reports. 
More advanced and relevant studies have used a different approach to 
investigate cellular immunity to the meningococcus: the stimulation of cells 
from excised palatine tonsils with meningococal OMV or bacterial antigens. 
These studies found a pronounced TH1-type naive and memory T-cell 
response after stimulation with OMV from NmB, and also the strong induction 
of T-cell proliferation (Davenport et al., 2003, 2007). This reflects another 
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prominent investigation, which also found the polarisation of a robust TH1-type 
profile after in vitro stimulation of DC with killed NmB (van Beelen et al., 
2007). It is worth noting that these previous studies have two important 
limitations: (1) the use of detergent-extracted OMV, which do not contain the 
full repertoire of outer membrane proteins (Koeberling et al., 2008), and (2) 
palatine tonsils are removed during cases of inflammation and infection, which 
may produce biased or inconsistent results. Regardless of these limitations, 
these studies raise an important question: if DC are disabled by live NmB as 
data in the present study suggest, why are there memory TH1 cells to 
meningococcal antigens in the tonsils? 
There are several evidence-based explanations that may answer this 
question. The first is that the TH1 memory cells identified in the studies by 
Davenport et al. may not in fact represent bona fide memory T-cells specific to 
the meningococcus. To justify their conclusions, the authors used the surface 
marker CD45RO in their experiments as an indicator of a T-cell memory 
phenotype. However, memory CD8+CD45RO+ T-cells express a variety of 
PRRs that can respond non-selectively to antigens such as LPS, inducing 
strong proliferative and cytokine responses (Komai-Koma et al., 2009). Similar 
results have been found with CD4+CD45RO+ memory T-cells, which can also 
respond to a variety of TLR ligands and subsequently produce high amounts 
of IFN-γ (Caron et al., 2005). This phenomenon has also been found in vivo: 
infection of mice with S. typhimurium induces non-specific naive and memory 
CD4+ T-cell IFN-γ production and proliferation, even in the absence of MHC 
Class II (Srinivasan et al., 2007). Since OMV contain high amounts of LOS 
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and other bacterial TLR ligands, this could explain the strong induction of IFN-
γ and proliferation in tonsillar memory T-cells, i.e. a non-specific response to 
general TLR stimulation.  
A second explanation is that commensal species of Neisseria, such as N. 
lactamica, may provide cross-protection against N. meningitidis. N. lactamica 
and N. meningitidis share many cross-reactive antigens (Troncoso et al., 
2000), and it has been found that colonisation of humans with N. lactamica 
can generate protective antibodies against N. meningitidis (Evans et al., 
2011). This has been explored as a promising strategy with which to offer 
protection against meningococcal disease. Beyond N. lactamica, it has also 
been found that even influenza vaccination can generate T-cell memory 
responses to bacterial antigens (Su et al., 2013). Indeed, the same study 
found that HIV-unexposed adults possessed endogenous T-cells with a 
memory phenotype to the virus. Hence, the scope of cross-protection by 
shared motifs in the human TCR repertoire may be larger than previously 
thought. Since the tonsils are rich in bacterial and viral antigens, other 
bacterial—or even viral—organisms may provide cross-protection due to 
similarity with meningococcal antigens. It may be speculated that the 
dysregulation of DC maturation by live NmB may necessitate another 
organism providing cross-protective immunity to the bacterium, which may be 
somewhat less vigorous than that of a direct meningococcal antigen, and 
therefore advantageous for colonisation.  
Finally, a third explanation is that the inhibition of DC maturation by live NmB 
may necessitate a different APC generating T-cell immunity. The immune 
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system has sometimes been described as being comparable to a football 
team (Sompayrac, 2012): when one player is removed from the game, other 
members of the team can step-in to fulfill the function of the missing player. 
Indeed, primary human DC deficiencies have been more well-described in the 
last ten years (Collin et al., 2011). While these patients are subject to a higher 
rate of bacterial infections, these are less severe and associated with lower 
rates of morbidity than would be expected, considering the importance of DC 
in orchestrating the immune system. Importantly, an increased incidence of 
meningococcal disease in these patients has not been found.  
In support of the hypothesis that a different APC might be generating T-cell 
immune responses to the meningococcus during natural infection, a 
prominent study found that patients with B-cell deficiency had impaired 
cellular immunity to N. meningitidis, despite these patients having relatively 
normal DC function in response to LPS (Morales-Aza et al., 2009). It may be 
that the dysregulation of DC maturation by live NmB may necessitate B-cells 
acting in a role of a 'compensatory APC' in generating and maintaining cellular 
immunity to the meningococcus. In further support of this hypothesis, the up-
regulation of co-stimulatory and antigen presenting molecules on human B-
cells may be more dependent on NF-κB signalling than in DC, as CD80 
transcription can be induced by NF-κB signalling alone in germinal center B-
cells (Niu et al., 2003). Thus, the tyrosine dephosphorylation of STAT1 
induced by live NmB may not have the same effect on these cells. Human 
tonsil mucosal tissue is rich in memory B-cells that can rapidly up-regulate 
CD80 and CD86, and subsequently stimulate T-cell responses (Liu et al., 
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1995). The less-specialised B-cell, as opposed to the professional DC, may 
thus be the prime inductor of T-cell immunity to the meningococcus, which 
could provide an advantage to the bacterium in terms of the strength and 
scope of the immune response. Indeed, it has been found that tonsillar T-cell 
immunity does not correlate to bactericidal antibodies (Davenport et al., 
2003), suggesting sub-par natural cellular immunity. 
Preliminary experiments found that live NmB appeared to induce a higher 
percentage of CD86+ B-cells than killed NmB (data not shown). It would be 
intriguing to investigate this further, by exposing human primary naive CD19+ 
B-cells to live and killed NmB, and then testing the ability of these B-cells to 
induce T-cell proliferation. Though an in vitro assay, this would elucidate 
whether B-cells are better able to respond to NmB, providing further support 
for the hypothesis that B-cells generate natural cellular immunity to the 
bacterium in vivo. 
Further, live NmB was found to significantly reduce the amount of TH1-type 
CD4+ T-cells compared to killed NmB via infection of DC. There was a non-
significant trend of enhanced IL-4+ TH2-type cells, which is consistent with 
lower expression of co-stimulatory molecules induced by live bacteria. TH1 
cells can produce IFN-γ, which can prime macrophages and other front-line 
leukocytes. Considering this, a reduction in TH1-type cells may be 
theoretically important for the survival of NmB in the mucosa. Further work 
could explore the ability of live NmB to induce TH17 and TREG cells via DC, as 
these are also important in maintaining the balance between inflammation and 
tolerance. IL-17 can up-regulate the production of defensins in human 
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epithelial cells, which are important for broad protection against bacterial 
infection (Kao et al., 2004). It may be that live NmB suppresses TH17 
responses in a similar way to TH1 responses. 
Another aspect of the model presented here is that live NmB was able to 
induce higher amounts of pro-inflammatory cytokine production. This 
correlated with a reduction in SOCS1 and CISH transcripts and protein. 
SOCS1 is a master controller of human DC cytokine production, and silencing 
of this gene can alone results in uncontrolled pro-inflammatory cytokine 
production (Hong et al., 2009). The use of vanadate restored STAT1-Y701 
phosphorylation, enhanced SOCS1 expression and also lowered the 
production of pro-inflammatory cytokines. Though SOCS1 is critical for 
controlling DC cytokine production, activated STAT1 also has a direct role in 
suppressing the inflammasome and restricting IL-1β production (Guarda et 
al., 2011). Thus, it is unclear to what extent the restoration of STAT1-Y701 
phosphorylation directly and indirectly contributed to the reduction of pro-
inflammatory cytokine production. It would be interesting to test how much 
SOCS1 contributes to the elevated levels of pro-inflammatory cytokines 
produced in response to live NmB infection. This could be investigated by 
lentiviral transfection of a high-copy SOCS1 construct into DC infected with 
live NmB, which could then be assessed for cytokine production. It is likely 
that both STAT1 itself and STAT1-induced SOCS1 may contribute towards 
the reduction in IL-1β after vanadate treatment. 
These data are interesting because LOS is classically regarded as the central 
driver of inflammation in meningococcal disease. However, repeated LPS 
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stimulation (such as might occur during sepsis) has been noted as being 
tolerogenic (Fan and Cook, 2004). Critically, the down-regulation of SOCS1 
could provide a mechanism that allows this inflammation to go unchecked and 
unregulated in the context of invasive disease, thus providing an important 
additional element to the pathophysiology of sepsis in meningococcal 
disease. SOCS1 silencing in mice exacerbates the cytokine storm after 
challenge with bacteria or endotoxin (Chung et al., 2007; Kinjyo et al., 2002; 
Nakagawa et al., 2002). Yet despite its importance in this role, SOCS1 has 
not been studied in the context of meningococcal infection.  A recent paper by 
Wang and colleagues has established that SOCS1 induction is likely to be a 
general property of Gram-negative bacteria (Zhang et al., 2014); in contrast, 
the data herein uniquely show that viable NmB can inhibit SOCS1 up-
regulation, which may represent a novel mode of pathogenesis. These data 
thus expand the paradigm of understanding the pathophysiology of 
meningococcal disease. 
While it is known that DC with low expression of co-stimulatory molecules are 
poor at clearing infection, the induction of pro-inflammatory cytokines is not a 
clear immune evasion strategy. However, an intriguing study has 
demonstrated that NmB can internalise human cytokines and use these as 
DNA-binding proteins to up-regulate complement resistance genes (Mahdavi 
et al., 2013). The induction of these pro-inflammatory cytokines may therefore 
be of benefit to colonisation, and these data could provide mechanistic 
precedent for these observations. Furthermore, early TLR signalling and 
cytokine production are now known to induce a rapid immuno-metabolic shift 
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towards lactate secretion by DC (Everts et al., 2014; Krawczyk et al., 2010); 
correspondingly, research by Tang and colleagues has previously found that 
lactate is essential for NmB colonisation (Exley et al., 2005). Thus, 
amplification of cytokine production by SOCS1/TLR dysregulation may aid the 
bacterium in both complement resistance and nutrient acquisition, but with the 
fitness cost of increased risk of dissemination in the host. In support of this 
hypothesis, a transgenic mouse model of NmB infection has shown that 
colonisation induces a rapid burst of pro-inflammatory cytokines, but that this 
does not correspond to immediate bacterial clearance, even several days 
post-infection (Johswich et al., 2013). Compelling new evidence has revealed 
the presence of meningococcal RNA thermosensors that induce up-regulation 
of immune evasion factors (e.g. capsule) during elevated temperatures (e.g. 
influenza infection) (Loh et al., 2013). This positions NmB as being uniquely 
capable of coping with the physiological penalties of enhanced pro-
inflammatory cytokine secretion, which may not result in bacterial clearance. 
But more importantly, these data suggest that NmB may exist in an 
equilibrium of low-level inflammation and non-productive adaptive immunity, 
which may be exacerbated by co-infection or a disruption of the host-
pathogen interface, leading to pathogenic behaviour.  
The question remains of whether live NmB would induce higher pro-
inflammatory cytokine secretion generally across many cell types, or if this 
observation is limited to DC. A previous report has found that live NmB 
induces higher levels of IL-6 in epithelial cells compared to killed NmB 
(Tezera et al., 2011); hence, it may be that this effect of enhanced cytokine 
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production is more widespread, and possibly mediated via STAT1 tyrosine 
dephosphorylation, as was found in the present study. Many analyses of the 
bacterial microbiome of the upper respiratory tract have determined that 
colonisation with N. meningitidis is associated with asthma and other 
conditions of chronic respiratory inflammation (Bisgaard et al., 2007; Hilty et 
al., 2010). Although these associative studies did not posit causation, it is 
tempting to venture that the excessive inflammation induced by live NmB 
across many cell types via a STAT1-dependent mechanism at the mucosal 
barrier may lead to low-level chronic inflammation, resulting in occasional 
airway inflammatory disease. 
Lastly, the present study found some evidence that a bacterial tyrosine 
phosphatase was targeting STAT1-Y701. Canonical STAT1 activation is 
essential for DC activation and the induction of T-cell responses, and is 
typically induced by an autocrine IFN loop that is fundamental for late-phase 
maturation. Emerging evidence suggests that this signalling axis may in fact 
supersede PRR engagement in terms of importance for DC functions (Pantel 
et al., 2014). Both type I (Kubo et al., 2013; Pollara et al., 2006) and type II 
(Fricke et al., 2006; Pan et al., 2004) IFNs have been noted in this process, 
although the type I IFN axis is sufficient for human DC. Studies on CD40 
regulation in murine phagocytes have shown that an early NF-κB signal is 
required to bind to the promoter, followed by a IFN-derived STAT1 signal, in 
order to achieve full up-regulation (Qin et al., 2005). In DC, blockade of either 
NF-κB (O’Sullivan and Thomas, 2002) or the autocrine IFN axis (Kubo et al., 
2013) can suppress the up-regulation of maturation markers.  
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The use of the PTP inhibitor vanadate to restore STAT1 tyrosine 
phosphorylation and DC maturation would support the notion of a bacterial 
tyrosine phosphatase targeting STAT1. Indeed, many viable bacteria actively 
translocate tyrosine phosphatases into host cells to modify function (Whitmore 
and Lamont, 2012), and many pathogenic tyrosine phosphatases (e.g. YopH 
from Yersinia spp. (Andersson et al., 1996), SptP from S. typhimurium 
(Kaniga et al., 1996) and VH1 from vaccinia virus H1 (Guan et al., 1991)) are 
exquisitely sensitive to vanadate. Furthermore, it was shown that 
bacteriostatic levels of chloramphenicol (which disrupts de novo bacterial 
protein synthesis) rendered DC resistant to the modulatory effects of live 
NmB. 
Tyrosine dephosphorylation of STAT1 was likely to be a direct targeting of the 
transcription factor for several reasons. Firstly, it was shown that the effect 
was dominant over the addition of exogenous stimuli (TLR ligands or IFN), 
therefore it is unlikely to be a lack of a signal per se but rather an active 
inhibition. Secondly, it was shown that the upstream IFN pathway (IFN 
secretion and JAK activation) was fully functional. And lastly, at saturating 
levels of stimulation, STAT1 can be tyrosine phosphorylated independently of 
the IFN-JAK axis. The tyrosine kinase Src, which was also activated by live 
NmB, can fulfill this function (Rawlings et al., 2004). LPS alone can activate 
Src (Napolitani et al., 2003), and given a high enough level of LPS stimulation, 
DC can still up-regulate CD86 even with blocked IFN receptors (Pollara et al., 
2006). Given this redundancy, it is therefore logical that a highly active 
bacterial phosphatase was targeting STAT1 directly. 
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Analysis of the meningococcal genome found two candidate proteins that had 
potential tyrosine phosphatase activity. Cloning of the proteins into a 
eukaryotic ISRE reporter cell line found that NMB_0945 alone caused a 
reduction in IFN-β signalling that was comparable to viral protein positive 
controls. Since meningococcal phosphatases possess optimum activity at a 
low pH (Leahy et al., 1940), it may be that the acidification that accompanies 
immune cell activation (Azuma et al., 1996) is required for optimal enzymatic 
activity, and therefore optimal dephosphorylation of STAT1-Y701. These data 
provide an exciting framework with which to explore the bacterial determinant 
of DC dysregulation. 
Homologues of this gene appear across the Neisseria genus, and are also 
present in N. lactamica, N. gonorrhoeae and other serogroups of N. 
meningitidis. Indeed, preliminary data have shown that DC respond similarly 
to N. lactamica (i.e. inhibited maturation marker up-regulation and enhanced 
cytokine secretion), and experiments within this study showed that both WT 
MC58 and WT H44/76 exerted a similar phenotype. Therefore, this could 
represent an important virulence factor across the Neisseria genus that 
endows these bacteria with pro-inflammatory properties. 
Important further work could involve knocking out the NMB_0945 gene in 
NmB with an antibiotic resistance cassette and then infecting DC with the 
viable mutant strain. STAT1-Y701 phosphorylation could then be measured, 
and the overall maturation response could be deduced. If this mutant strain 
were to restore DC maturation, it would be extremely compelling evidence 
that this could be considered an entirely novel inflammatory virulence factor 
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(and immune evasion factor) for the meningococcus. Also, any future vaccine 
would probably benefit from excluding this protein from the preparation, given 
its immunosuppressive properties. 
In conclusion, this study has shown that live NmB can dysregulate DC 
maturation by the precise targeting of a single tyrosine residue on the 
transcription factor STAT1. This had wide-ranging implications for the 
immunological functions of these cells, such as the impairment of adequate T-
cell responses. However, the reversal of this effect was sufficient to restore 
DC functions. This was linked to a possible protein encoded by the bacterium. 
These data could help to further our understanding of human immunity to the 
meningococcus, but they also link this to a novel mechanism of pathogenesis 
and immune evasion. Importantly, the proposed model of DC dysregulation by 
NmB links pathogenesis and immune evasion into a single mechanism, which 
is a wide-ranging motif in meningococcal research. Therefore, these data 
expand the paradigm of host-pathogen interactions for the meningococcus. 
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